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 Amyotrophic Lateral Sclerosis (ALS) is the most common progressive and fatal 
neurodegenerative disease and yet a cure remains unknown. Given the growing number of 
patients with ALS, it is imperative that behavioral health clinicians, medical providers, 
researchers, and policy makers are aware of their and their support persons’ unique biological, 
psychological, social, and spiritual health concerns, the impact of the disease on family 
functioning, and the general care management of those living with ALS. This dissertation was 
written to help identify the impact of ALS on patients and their support persons’ family 
functioning and biopsychosocial-spiritual (BPS-S) health. It includes three manuscripts: (a) a 
systematic review of the impacts of ALS on immediate family members’ health and interactional 
patterns, (b) a descriptive phenomenological study designed to explore the lived experience of 
eight patients and nine support persons living with ALS, and (c) a perspective piece that presents 
an argument for requiring increased competencies in medical education and residency education 
programs around ALS diagnosis, treatment, and family-centered care. The systematic review 
resulted in  3,557 articles with 3,509 meeting exclusion criteria and 48 meeting inclusion criteria 
for full review. The articles in the systematic review demonstrated that previous literature on the 
BPS-S health outcomes of support persons of patients with ALS is disjointed, with the health 
components studied independent of one another rather than simultanesouly for a comprehensive 
 
   
 
understanding. The literature reviewed also revealed a limitation in the amount of research that 
has focused on the impact of ALS on family functioning. The phenomenological study 
conducted as a part of this dissertation resulted in five themes relevant to patients and support 
persons’ experiences living with ALS: (a) Dynamic transformations of relational systems, (b) 
Biological changes and well-being, (c) Emotional processes, (d) Impacts on spirituality, and (e) 
Healthcare system interactions. The novel findings of this study include: (a) a broader 
understanding of patients’ with ALS (PALS) and SPs’ experiences with the impact of ALS on 
family functioning due to the inclusion of multiple participants in the same interview; (b) 
participants explanation of progression of physical symptoms and subsequent decrease in verbal 
communication abilities resulting in a more isolated and frustrated state; (c) participants 
reporting on their ability to reach acceptance and choose positivity; (d) and the participant’s 
expressing the need for medical providers outside of ALS clinics to have increased knowledge of 
proper ALS care. It is then recommended that future research should focus on the immediate and 
longitudinal whole health needs of PALS and SPs and their interactional effects, participant’s 
perspectives on the lack of knowledge by non-ALS specialists, and studies that continue to 
include multiple family members and SPs conjointly with the PALS to ensure that more robust 
systemic perspectives are represented. The final manuscript is a perspective piece based on 
existing literature in combination with findings from this disseration. It is used to highlight the 
need for increased education among medical professionals on ALS diagnosis, interdisciplinary 
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PREFACE 
In the summer of 2001, my mother’s youngest brother was diagnosed with Amyotrophic 
Lateral Sclerosis (ALS) at the age of 40. At the time, my family, and virtually everyone we knew 
was unfamiliar with this disease. At 10 years old, I taught myself as much as I could about the 
disease and shared that information with as many others as possible. I did not want our family to 
feel alone in our experience and felt that if I could teach others about what we were going 
through, then we would no longer feel alone. After four and a half years of living with ALS, my 
uncle died from the disease and I lost the energy to fight against what I had come to consider a 
losing battle.  
Twelve years following my uncle’s death, in the summer of 2017, I was preparing to 
enter the Medical Family Therapy doctoral program at East Carolina University. I spent that 
summer attempting to determine what I hoped to focus on in terms of research during my time in 
the program. During that summer I found an old high school project in which I had to make a 
one-year, five-year, and ten-year plan for myself, which included assisting in finding a cure for 
ALS. Finding that document re-kindled my passion for research related to ALS. Although I 
would not be working on a cure, I knew that my research as a Medical Family Therapist would 
allow me to connect with families living with ALS and learn from them so that new interventions 
and therapies could be developed that might alleviate some of the suffering that comes from 
living with this terminal illness. 
As I committed to this topic in the beginning of my time in the doctoral program, I 
quickly realized how much growth would need to happen for me to be successful in this 
endeavor. I was able to cling to the basic knowledge of ALS that I had learned several years ago 
and stretched that knowledge by centering each assignment around the topic so that I was 
 
   
 
learning everything there was to know about the disease. This growth not only happened in my 
literal knowledge of ALS but grew my understanding of the impact this disease had on my own 
family and on myself. While enrolled in the doctoral program, I wrote several papers about ALS 
and completed a systematic review (Chapter 2) on the biopsychosocial-spiritual (BPSS; Engel, 
1977; 1980) impacts of ALS on the patient and their familial caregivers.  
The results of the systematic review demonstrated the void of research relating to how 
these BPSS (Engel, 1977; 1980) components interact with one another in families with ALS, 
how the majority of ALS research focuses solely on the patient, and that the qualitative research 
on ALS is quite scarce. I was able to determine then that a qualitative study would allow for 
these patients and their families to more accurately describe their experiences with ALS, 
expanding and enhancing what has already been done quantitatively. A qualitative study would 
allow these families to describe in their own words, the impact this disease has had on their 
family as a whole, a gap in the literature. It would give these families a voice.  
Throughout my time working on this dissertation and following several conversations 
with my mentor, Dr. Jennifer Hodgson, I have come to understand that all of the hurdles, 
hiccups, and setbacks I have encountered during this journey are not all that important. What is 
important is reminding myself why I chose this area of research in the first place, to better 
understand and support the patients and families living with ALS. My hope is that my research 
will fill important gaps in the literature by providing a voice to patients with ALS and their 
families and support persons together. I also hope that this research will provide insight into how 
ALS is impacting the entire family unit from a BPSS perspective (Engel 1977; 1980) and how 
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CHAPTER 1: INTRODUCTION 
 Amyotrophic Laterals Sclerosis (ALS) is a relentlessly, progressive illness with no 
known cause or cure (Pagnini et al., 2012). Characterized by sudden onset, possible cognitive 
and behavioral impairment, and inevitable physical decline, the majority of ALS-related deaths 
occur within three years of onset (Galvin et al., 2016). The disease progression involves 
degeneration of the upper and lower motor neurons, which control muscular activity, causing 
progressive muscle weakness, atrophy or wasting away, and spasticity or continuously 
contracting muscles that leads to paralysis and eventual death (Calvo et al., 2015). Currently, the 
best treatment option involves palliative care (maintaining independence as long as possible, 
managing pain, and providing relief from stress and symptoms) (Aoun et al., 2013; Galvin et al., 
2016), leaving the patient, family and healthcare system to navigate a difficult path of illness 
management. The following chapter will provide general information about the incidence rates, 
age onset and progression rates, symptoms, and diagnosis of ALS, as well as information on the 
impact of ALS on the systems surrounding them. It will conclude with a description of the 
proposed dissertation study, implications for the Medical Family Therapy field, as well as 
descriptions of each of the chapters included in this dissertation.  
Incidence Rates 
 The lifetime risk of ALS has been estimated to be 1 in 400 (Larsson, Fröjd, Nordin, & 
Nygren, 2015) with approximately 5,600 patients newly diagnosed patients each year in the 
United States (Cruz et al., 2018). Incidence seems to occur more commonly in men than women, 
with an average male to female ratio of 1.5:1 (Kiernan et al., 2011; Wijesekera & Leigh, 2009). 
One possible explanation for the difference is women have protective hormonal factors leaving 




Leigh, 2009). Onset of the ALS typically occurs between the ages of 47 and 63 years (Kiernan et 
al., 2011) with only 5% of cases developing before 30 years (Wijesekera & Leigh, 2009). 
However, juvenile onset cases are on the rise.  
Disease Onset and Progression 
ALS is mercilessly progressive and terminal, with an average disease course of one to 
five years (Boillée, Vande Velde & Cleveland, 2006). As many as 50% of patients die within 30 
months of symptom onset and up to 20% survive between five and ten years (Kiernan et al., 
2011). Older age at symptom onset and respiratory muscle dysfunction have been related to 
shortened lifespan, while younger age at symptom onset and limb-onset of the disease are 
predictors of prolonged life spans (Kiernan et al., 2011). Patients with ALS (PALS) with bulbar 
onset (i.e., difficulties with speech and swallowing prior to difficulties with other body parts) 
have a median survival time of 26 months while PALS with limb onset (i.e., muscle atrophy of 
the legs and arms prior to other areas of the body) have a median survival of 32 to 33 months 
(Fujimura-Kiyono et al., 2011). It is also important to note that older adults and females tend to 
have higher rates of bulbar onset (Yates & Rafiq, 2016).  
Symptoms 
The most common presentation of ALS is limb-onset (70% of patients), which includes a 
combination of upper and lower motor neuron signs present in both the arms and legs (Kiernan et 
al., 2011).  Upper motor neuron (UMN) difficulties may include spasticity, muscle weakness, 
and/or brisk, deep tendon reflexes. Lower motor neuron (LMN) include difficulties with muscle 
atrophy or deterioration and muscle weakness in the limbs. The alternate presentation is bulbar 
onset (25% of patients) where slow, labored, and distorted speech, gag and jaw jerks, tongue 




several disorders that mimic ALS, a thorough diagnostic assessment is required (de Carvalho et 
al., 2008; Kiernan et al., 2011; Wijesekera & Leigh, 2009).  
Diagnosis 
The diagnosis of ALS is based on the presence of several clinical findings (Kiernan et al., 
2011). The ‘El Escorial’ diagnostic criteria was developed in 1994 but was revised during the 
2000 Airlie Conference to increase the sensitivity of the criteria. Subsequently, it was renamed 
the Airlie House diagnostic criteria (Brooks, Miller, Swash, Munsat, 2000). The Airlie House 
criteria for an ALS diagnosis included: (a) the presence of LMN degeneration by clinical, 
electrophysiological or neuropathological examination, (b) UMN degeneration by clinical 
examination, and (c) progressive spreading of symptoms without evidence of other disease 
processes (Brooks, Miller, Swash, & Munsat, 2000). Based on these criteria, patients were 
classified into ‘clinically definite,’ clinically probable,’ ‘clinically probable-laborartory 
supported,’ and ‘clinically possible,’ excluding the classification of ‘clinically suspected,’ which 
was previously used in the ‘El Escorial’ diagnostic criteria (Wijesekera & Leigh, 2009).  
The most recent diagnositic criteria, the Awaji-shima criteria, was developed in 2006 in 
Awaji-shima, Japan and again simplifies the diagnositic criteria (Wijesekera & Leigh, 2009). 
The Awaji-shima criteria made the following two changes to previous diagnostic criteria, (a) 
electromyography (EMG) analyisis is no longer considered a secondary consideration, but 
carries the same weight as a physical exam, and (b) the Awaji-shima criteria expanded the kinds 
of EMG data that can indicate ALS to include fibrillations (loss of nerve connections) and 
fasciculations (earlier loss of nerve supply)(de Carvalho et al., 2008). These changes in the 
interpretation of data render obsolete the ‘clinically probable-laboratory supported’ category and 




2008). The complexity of how ALS presents and is diagnosed rivals in comparison to its overall 
impact on the patient and those positioned to provide essential caregiving.  
ALS Caregiver Strain 
Multiple studies on caregiver burden associated with ALS, confirm that caring for a loved 
one with a neurological illness is a source of psychological distress that may impair quality of 
life (Burke et al., 2015; Galvin et al., 2016; Lillo, Mioshi, & Hodges, 2012; Pagnini et al., 2010; 
Rabkin, Wagner, & Del Bene, 2000). Pagnini et al. (2010) reported that ALS caregivers 
experience extreme emotional and physical problems due to the steady progression of the disease 
and lack of effective treatment. Due to the average age of onset being between the ages of 47 and 
63 years, caregivers are usually the patients’ spouses, but at times this duty may fall on the 
children (Kiernan et al., 2011; Tramonti, Bongionni, Leotta, Puppi, & Rossi, 2015). Previous 
studies, specifically on families with ALS, have determined that there is a high need for ongoing 
family support and that studying the evolution of specific diseases may be helpful in evaluating 
the impact of the disease on family life (Martin & Turnbull, 2001; Tramonti et al., 2015). In fact, 
health researchers studying family functioning in families of terminally ill patients, found 
successful intervention may ultimately lead to reductions in reported caregiver burden and its 
negative consequences (Arestedt, 2013; Tremont et al., 2006). However, ALS research lacks 
connection to theories and research that helps make sense of the systemic and relational impact 
patients and their family members experience while navigating this progressive fatal disease.    
Theoretical Conceptualization 
The proposed dissertation will utilize general systems theory (von Bertalanffy, 1950; 
1967), augmented by Beaver’s systems model of family functioning (Beavers, 1981), and the 




1996) to further understand the impact of ALS on family functioning and the BPS-S impact it 
has on PALS family members’ health. While von Bertalanffy identified in general systems 
theory how living systems depend on the constant interchange of resources within its 
environments (von Bertalanffy, 1950; 1967), Beaver’s systems model of family functioning 
helped to expand it by encouraging researchers and therapists to systemically study family 
functioning and competence in families (Beavers, 1981). The combination of general systems 
theory and Beaver’s systems model along with the BPS-S framework facilitates a whole health 
(biological, psychological, social, and spiritual) view of ALS, increasing the comprehensiveness 
of research that is informing its treatment. 
General Systems Theory 
 Through his general systems theory, Ludwig von Bertalanffy identified how living 
systems depend on the constant interchange of resources within its environments (von 
Bertalanffy, 1950, 1967). His ideas helped to think of systems as being more than the sum of 
their parts, but a product of the interaction within and among the parts and other systems 
surrounding it. He identified how the concepts of equifinality, equipotentiality, and homeostatic 
reactivity determine how and why systems initiate change, struggle to complete the process, and 
adapt accordingly (von Bertalanffy, 1967).  
The utilization of general systems theory as a grounding theory for the current 
dissertation proposal emphasizes the importance of including the entire family system, to include 
the patient and family members, during the treatment of patients with ALS. Within general 
systems theory, equifinality suggests that the same final state may be reached from different 
initial conditions and in different ways (von Bertalanffy, 1967). Equipotentiality suggests that all 




the mechanism within systems that seeks to maintain balance within the system (von Bertalanffy, 
1967). These terms indicate that all family systems are able to reach a final preferred state from 
all varieties of initial starting points, that all members within family systems possess equal 
potential, and that the family system seeks to reach a healthy, balanced state. The inclusion of 
systems allows for the recognition that growth within the patient’s system depends on the 
constant interchange of all of the available resources (von Bertalanffy & Sutherland, 1974). 
Beavers Systems Model of Family Functioning 
According to Beavers and Hampson (1993), the Beavers Systems Model was developed 
to help define core family functioning constructs and differentiate relationally and interactionally 
healthy families from less healthy families. Two of the central concepts of the Beavers Systems 
model are (a) family functioning, which includes the observable, live, interactive functioning 
within a family, and (b) family competence, which ranges from effective, healthy family 
functioning to severely dysfunctional patterns (Beavers & Hampson, 1993). It also includes the 
concept of family style, which refers to the degree of centripetal or centrifugal qualities in the 
family. Members in centripetal families seek satisfaction from within the family and pull inward 
and lean on one another when a stressor occurs; while, centrifugal family members look for 
satisfaction from the outside world and pull away from others within the family when stressors 
are experienced.  
According to the Beavers Systems Model (Beavers, 1981) there is a continuum of family 
functioning. On one end are optimal families who try many approaches to resolve problems 
within the family, are usually capable of achieving intimacy, and quickly resolve conflict among 
them. On the opposite end are dysfunctional families who disengage from one another, have poor 




another. With families existing along this entire continuum, the model can be useful to 
understanding patterns of functioning and how different styles impact the management of ALS, 
identifying opportunities for further research and intervention. Combining this model with the 
biopsychosocial-spiritual framework (Engel, 1977, 1980; Wright et al., 1996), discussed below, 
allows for clinical work and interventions to be tailored to all families from optimal to severely 
dysfunctional with a focus on whole health.  
Biopsychosocial-spiritual Framework 
The Biopsychosocial (BPS) model is a systems-theoretical construct rooted in the 
writings of biologists and general systems theorists, Paul Weiss and Ludwig Von Bertanlanffy 
(Schubert, 2010). It proposes that biological, psychological, social components operate 
simultaneously in connected subsystems that influence all aspects of mental and physical health 
(Engel, 1977; 1980). The spiritual component was highlighted by Wright et al. (1996) and 
includes the importance of a person’s spirituality in relation to their holistic health, giving way to 
the biopsychosocial-spiritual (BPS-S) framework.  
It has become increasingly common for complex biomedical problems, such as ALS, to 
be studied by multidisciplinary teams of researchers (Suls, Krantz & Williams, 2013). As a 
result, multidisciplinary models of care have emerged reducing the risk of death from ALS by 
45% at five years (Kiernan et al., 2011). According to Kiernan et al. (2011), multidisciplinary 
models of care are found in more specialized clinics as opposed to more general neurology 
clinics that might include treatment provided by neurologists only.  
Currently, the majority of research regarding the treatment of ALS seems to primarily 
focus on biological treatments and clinical trials that seem to delay the physical progression of 




reviewed the impact of ALS on the psychological, social, and spiritual well-being of patients, yet 
there has been little to no investigation on the impact these treatments have on the entire family 
unit and their BPS-S health. Few research teams have investigated the BPS-S health of PALS 
and family members at the same time or examined the overall family functioning and health 
impact on family members, and have instead focused solely on the person with the ALS 
diagnosis or the individual family caregivers. 
Purpose and Design 
Although there is an abundance of literature available on ALS and PALS, there are 
clearly gaps in the literature regarding the impact ALS has on the whole health of the family, and 
on the overall functioning of families living with ALS. Whereas previous studies have 
investigated the individual BPS-S impacts of ALS on family members and PALS (Ozanne et al., 
2015; Ozanne & Granneheim, 2017), none have identified how those health domains function 
synergistically. Furthermore, research looking at the BPS-S distinctions between bulbar and limb 
symptom onset seems largely understudied as well.  
Ultimately, variations in the pattern of spread based on symptom are not well known, but 
the recognition of these different ALS subsets, bulbar and limb, is important as prognosis may 
vary depending on the subset (Predat & Bruneteau, 2008; Turner, 2010).  Specifically, cases with 
bulbar onset are traditionally regarded as showing a poorer prognosis with associated symptoms 
including aspiration pneumonia, impaired quality of life, reduced will to live, and malnutrition 
(Fujimura-Kiyono et al., 2011; Lou, Moore, Gordon, & Miller, 2010; Marin et al., 2011; Tysnes, 
Vollset, Larsen, & Aarli, 2014). As the subsets present differently, a greater understanding of the 
pattern of symptom spreading for each will assist with developing more comprehensive and 




Finally, only limited research has been conducted on how ALS impacts family 
functioning (Tramonti et al., 2014). To adequately address these gaps in the ALS literature, 
Beaver’s systems model of family functioning (Beavers, 1981) and the BPS-S framework 
(Engel, 1977; 1980; Wright et al., 1996) were utilized within this dissertation study. If families 
are expected to provide essential ALS caregiving, addressing family functioning patterns and 
their influence is an important part of better understanding their lived experience with ALS. 
Since little in know about how family functioning is impacted among families living with 
ALS, a qualitative design was used. More specifically, a phenomenological approach was 
utilized to explore the experiences of families living with ALS. The research question guiding 
this study was, “What are the experiences of patients - and their identified primary support 
persons - living with ALS and how has it impacted family functioning and health?” The study 
consisted of semi-structured phenomenological interviews with the PALS and the PALS’ 
identified primary support person outside of their professional support system. The term support 
person(s) (SPs) is utilized throughout to identify any person outside of the PALS’ professional 
support system that provides any support to the PALS. This qualitative study aligned with 
Husserl’s (1970) descriptive phenomenological approach and utilized Colaizzi’s (1978) method 
of data analysis.  
Implications for the Medical Family Therapy Field 
 The research derived from the field of Medical Family Therapy (MedFT) illustrates 
considerable value as it contributes to an area of literature in which there is inadequate 
representation of the relational systemic voice. As a field, MedFT stresses the importance of 
collaboration between and among healthcare providers, the patient, and the patient’s 




reinforces the importance of integrating and implementing systems theory, the BPS-S 
perspective, collaboration, ethics, diversity, in the delivery of integrated care (AAMFT, 2018). 
Given the definition and competencies listed, this dissertation provides clinical, research, and 
policy-based implications for the field of MedFT along recommendations with advancements in 
the training, clinical protocols, policies, and study of ALS.  
 Clinically, this dissertation argues that care should include family members and support 
persons in treatment to ensure treatment is provided from a relational systemic perspective (von 
Bertalanffy, 1950). It supports through a comprehensive systematic review and original study the 
need for ALS and non-ALS specialists to engage in higher levels of integration and researchers 
to conduct comprehensive BPS-S studies. Foundational to all of this are the main goals inherent 
to the field of MedFT: agency and communion (McDaniel et al., 1992). Agency is the active 
involvement in and commitment to one’s own health care by making personal choices in dealing 
with illness and the health care system and communion is the sense of being cared for, loved, and 
supported by family members, friends, and medical providers (McDaniel et al., 1992). This 
dissertation is set to advance agency and communion by encouraging PALS to have a voice in 
their experiences with ALS and to access supportive systemic relationships to support them in 
those efforts. 
 From a research perspective, this dissertation was constructed to focus on the BPS-S 
health of patients with ALS and their family members/support persons. Currently, research 
studies conducted to study the family experience of ALS, with more than one family participant 
enrolled, are limited (e.g., Tramonti et al., 2014). As found from the systematic review 
conducted, research from this perspective would advance awareness regarding the BPS-S 




comprehensive care framework grounded in systemic data. The original study conducted for this 
dissertation adds to the body of evidence that patients with ALS and their family members prefer 
and benefit from a comprehensive BPS-S focused care, experience changes in their family 
functioning as a result, and need their healthcare providers to collaborate effectively to help them 
in better managing it. 
Finally, from a policy and education/training perspective, leaders in the field of MedFT 
could utilize the arguments presented in the dissertation to promote ALS family-centered policies 
and encourage more training about ALS during and beyond medical school. Specific policies 
informed by the systematic review and original study could be established for ALS treatment that 
utilize the BPS-S framework, offer family-centered care guidelines, strengthen the 
interdisciplinary team approach, and expand and enhance curriculum about ALS available to all 
levels of medical professionals.  
Summary 
 This dissertation was designed to expand and enhance the ALS literature, furthering the 
research on how family functioning and BPS-S health is impacted. General systems theory (von 
Bertalanffy, 1950) augmented by Beaver’s systems model of family functioning (Beavers, 1981) 
and the BPS-S framework (Engel 1977; 1980; Wright et al., 1996) formed the theoretical base 
for the study, attempting to explain how health and the functioning of families should be studied 
systemically and relationally. This focus will assist multidisciplinary clinicians in the 
development/implementation of future interventions for PALS and their families, generating 
evidence that is grounded in systemic and relational science and not just individually focused 
studies. Throughout this dissertation, the term support person was used to reference any family 




chapters include information in regard to the anchoring literature, methodology, results, and 
implications for the field of Medical Family Therapy, as well as future ALS research, clinical 
applications, and policies.  
 The second chapter is a systematic review of the literature of the BPS-S impact on family 
members and caregivers of PALS and on the overall family functioning. The research question 
guiding the systematic review was, “How does ALS impact the immediate family members’ 
health and interactional patterns?” In this chapter the support persons and family members are 
referred to as caregivers of PALS (CALS). The systematic review was conducted by the lead 
investigator and one co-investigator across three databases (PubMed, PsychINFO, and CINAHL 
Plus with Full Text) and resulted in 48 articles that met inclusion criteria. Of the final 48 articles 
included in the review, 21 studied at least one BPS-S variable of the caregiver’s health, 13 used 
two, ten used three, and three used all four, but none of the articles identified how the BPS-S 
variables may be impacting one another. Additionally, only two articles included in the review 
addressed family functioning, with results indicating that some family members (15%) felt as 
though the disease had been detrimental to family relationships, while others (67%) felt as 
though the disease brought them closer together (Martin & Turnbull, 2001) and that family 
members tended to become problematically close (Tramonti et al., 2015). Overall, the results of 
this systematic review illustrate how family caregivers of PALS are impacted biologically, 
psychologically, socially, and spiritually. Based on the reviewed articles it is also clear that ALS 
has an impact on the family functioning although few studies have explored patterns related to 
subset of ALS onset, progression, and access to resources. These results reinforce the need for 
future studies to determine how family caregivers of PALS complete BPS-S health and how the 




 The third chapter consists of a literature review of symptom onset and BPS-S symptoms 
in ALS.  This chapter provides a synopsis on what information is currently available on bulbar 
and limb onset in ALS, to include any differences that PALS and their families may encounter in 
their ALS experience based on symptom onset. This chapter also presents information on how 
each component of the BPS-S framework is impacted in PALS and their family members and 
family caregivers. Physical symptoms represent the biological component, mental health 
symptoms (i.e.; anxiety and depression) represent the psychological component, social support 
the social component, and religious and spiritual changes the spiritual component. Finally, this 
chapter provides recommendations for future research informed by the literature reviewed.   
 The fourth chapter responds to the call for more research by laying out the methodology 
for this dissertation’s phenomenological qualitative study. The qualitative inquiry method 
followed a Husserlian phenomenological approach (1970) with the interview data analyzed 
according to Colaizzi’s (1978) phenomenological analysis method. The research question 
guiding the study was, “What are the experiences of patients and their identified primary support 
persons living with ALS and how has it impacted family functioning and health?” Purposive 
sampling (Patton, 1990) was used in the study to enroll participants from a Southeastern 
academic medical center ALS clinic. Once participants were enrolled in the study and had 
consented to participation, a semi-structured interview guide (Bernard, 1988) was used to 
provide an interview in which all participants addressed similar topics related to their 
experiences with ALS. Verification strategies used to ensure the trustworthiness of the data 





The fifth chapter, written in manuscript format, reports the qualitative results of the 
dissertation’s phenomenological study outlined in the previous chapter. Eight participant groups, 
consisting of one PALS and at least one identified primary support person outside of their 
professional support system participated in in-depth, open-ended, semi-structured interviews. 
The data was then analyzed using Colaizzi’s (1978) method of data analysis, revealing 278 final 
significant statements which were then collapsed into 166 formulated meaning statements. These 
meaning statements were then grouped into 15 thematic clusters aligning under 5 emergent 
themes: (a) dynamic transformation of relational systems; (b) biological changes and well-being; 
(c) emotional processes; (d) spiritual adaptations and anchors; and (e) healthcare system 
interactions. An exhaustive description of the study’s findings highlighted how relational 
systems adapted to the illness by either coming together or pulling away from one another, 
weathered difficult social and emotional challenges often accompanied by a sense of acceptance 
of the ALS journey, involved a sense of spiritual well-being, and expressed appreciation for ALS 
Clinics and their specialists. It also captures participants’ desires for greater professional support 
during the diagnosis period and preparedness among providers outside of ALS clinics to detect, 
diagnose, and treat ALS, as well as and collaborate more often with ALS specialists.   
The sixth and final chapter serves as the dissertation’s implications chapter and is written 
as a policy manuscript to be submitted to a medical education peer reviewed journal. It utilizes 
information gathered from the participant interviews during the phenomenological study, as well 
as the systematic review, to establish an argument for the expansion of ALS related 
competencies in medical school, residency programs, and continuing education curriculums. A 
growing shortage of neurologists (Guttman et al., 2019), increasing number of patients with ALS 




dissertation point to the need for a revision in the detection and treatment of ALS to maximize 
quality of life for PALS and their families/support persons. The chapter also recommends that 
ALS education be expanded and enhanced for those who are not ALS specialists. This education 
would include diagnostic awareness, symptom management, interdisciplinary collaboration 
methods, BPS-S and family-based care protocols, as a way to promote more seamless care 
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CHAPTER 2: A SYSTEMATIC REVIEW OF THE IMPACTS OF ALS ON IMMEDIATE 
FAMILY MEMBERS’ HEALTH AND INTERACTIONAL PATTERNS 
(This manuscript was prepared in accordance with the submission reqirements for the journal, 
Annals of Behavioral Medicine.) 
Amyotrophic lateral sclerosis (ALS), more commonly known in the United States as Lou 
Gehrig’s disease, is a progressive, fatal neurological disease with no known cause or cure [1]. 
The disease involves degeneration of the upper and lower motor neurons, which control 
muscular activity, causing progressive muscle weakness, atrophy or wasting away, and spasticity 
or continuously contracting muscles [2]. In the United States as many as 30,000 live with ALS, 
with estimates of nearly 5,600 diagnosed annually [3] and an average age of onset between 47-63 
years [5,6]. Although much is known about the impacts of ALS on the patient directly, little 
research has been done on the impact of ALS on family functioning and family member’s 
biological, psychological, social, and spiritual health [2,4]. 
 Studies focused on caregiver burden found caring for a partner or family member with a 
neurological illness is a source of psychological distress that may negatively impact one’s quality 
of life [7-11]. For example, Pagnini et al. [10] reported that ALS caregivers often experience 
extreme emotional and physical problems due to the steady progression of the disease and 
delayed treatment. ALS interventionists recognize that caregivers need emotional, psychological, 
spiritual, and social support to help maintain their role and their own health [10, 12, 13].  
However, role changes and restructuring in the family are commonly experienced as diseases 
progress [17].  For some families the illness may bring members closer together while others 
become more distant from one another [17-20]. Based on these studies, and others with similar 




decrease caregiver burden and negative consequences [17, 19] and therefore is important to the 
development of research-informed protocols for assessing and treating families living with ALS 
[12].  
 Theory is critical for making sense of scientific observations.  General systems theory 
[21, 22] identifies how living systems depend on the constant interchange of resources within its 
environments. Beaver’s systems model of family functioning is an expansion on general systems 
theory, arguing that a more flexible and adaptive family is able to effectively deal with higher 
stress situations and is not bound to rigid behavior patterns and responses, allowing instead for 
more freedom to evolve and differentiate [23]. It is a method of explaining family competence 
and family style by examining family patterns. For example, families experiencing a health event 
may demonstrate centripetal behaviors (finds the most relationship satisfaction within the family) 
or centrifugal (finds the most relationship satisfaction outside the family) [23].  When faced with 
terminal illnesses such as ALS, centripetal families would likely respond by pulling inward and 
huddling together; whereas centrifugal families would likely respond by moving away and 
scattering apart [24].  Therefore, it is important to understand how family patterns and 
functioning impact patient and family members’ health and what parts of health are most 
effected.  
The biopsychosocial-spiritual (BPS-S) framework [14-16] helps researchers and 
clinicians make sense of the systemic implications of illness by viewing health through a more 
comprehensive lens. Approaching care from a BPS-S approach has emerged as a predictor of 
survival, reducing the risk of death in ALS patients by 45% at five years [5]. The combination of 




understanding how ALS impacts the family system as a whole.  It fills a gap in the science and 
literature by looking at health research more comprehensively. 
 This systematic review was designed to help answer the following research question: 
“How does ALS impact the immediate family members’ health and interactional patterns?” More 
specifically, the aims of this review are to: (a) conduct a systematic review of available peer-
reviewed literature where at least one component of the BPS-S framework was studied on at 
least one immediate family member of a person(s) with ALS (PALS), with immediate family 
members including the PALS’ spouse or partner, parents, children and grandchildren, siblings, 
and self-identified family members, (b) identify themes for centripetal and centrifugal factors 
related to BPS-S health outcomes for the immediate family members of PALS, and (c) provide 
clinical and research recommendations to help understand and address BPS-S factors related to 
PALS and their immediate family members based on the family type, centripetal or centrifugal.   
Methods 
 This systematic review was guided by Cooper’s [25] seven-step systematic review model. 
Step-one [25] involved identifying the problem and formulating the research question as noted 
above. Step two [25] included systematically sifting through the existing literature using three 
academic databases (e.g., PubMed, PsycINFO, and CINAHL Plus with Full Text) to identify 
titles and abstracts that may be admitted into the review. Key terms were used in conjunction 
with medical subject headings (MeSH) during this step. To ensure consistency of the search 
strategy across databases, the lead author consulted with health science and information services’ 
librarians to develop optimal MeSH and keyword search term strategies for each database (See 




 During step two [25] the lead investigator and a sub-investigator utilized the final MeSH 
and keyword search terms to conduct searches for articles within each search engine. From that 
initial search, 3,557 articles were identified as potentially appropriate. Each investigator was 
responsible for reviewing these article titles using Rayyan QCRI, an online tool designed to 
assist authors in the systematic review process [26]. When using this application, each 
investigator’s decision was visible to the other investigator. Any decision discrepancies were 
automatically identified and discussed by both investigators so that a final decision could be 
reached. Upon conclusion of this step, 3,371 articles were excluded as their titles indicated they 
were not a good fit, 76 of those being excluded based on duplication, resulting in 110 articles 
admitted for abstract review.  
 Step three [25]  included the identification of inclusion and exclusion criteria applied to 
potential articles identified from the searches. The inclusion criteria for title and abstract review 
were as follows: (a) articles that include at least one immediate family member of a PALS, (b) at 
least one BPS-S component of health studied, (c) qualitative and quantitative peer-reviewed 
journal articles, and (d) published in English. The exclusion criteria were: (a) cellular and genetic 
studies about ALS as the purpose of this systematic review was to focus on the personal level of 
the PALS and their family members rather than focusing on the cellular level of the disease, (b) 
biological intervention studies, and (c) non-peer reviewed grey literature (i.e., reports, policy 
documents, etc.), editorials and opinion writings, and conceptual articles. Subsequent to the 
abstract review, 44 additional articles were excluded and 66 were admitted for full-text review. 
Of note, when adequate information to determine inclusion/exclusion could not be obtained from 




 To confirm appropriateness for admission into this review, the two investigators both 
examined the first 20 of the 66 (30%) articles that were included for full text review. Of these 20 
articles, the investigators were in agreement on 14 of the 20 (70%) and were in disagreement on 
six of the 20 (30%). The investigators shared their decision process with one another so that they 
were ultimately able to come to agreement on each of them. As the investigators encountered 
discrepancies or uncertainties on whether or not to include those articles, an investigator 
discussion was utilized to resolve them. The investigators then independently screened the 
remaining 46 articles to determine if they were eligible for inclusion based on the full text 
review, resulting in 22 of the 66 articles being excluded. Of those 22 articles, five did not meet 
the family member criteria, eight did not meet the BPS-S component criteria, two articles were 
based on genetic information only, five were in a language other than English, and two were not 
peer-reviewed. The reference lists of the remaining 44 articles were screened with twenty-two 
additional articles identified and four of the twenty-two being admitted following the abstract 
and full-text reviews for a final total of 48 articles admitted into the final review. There was 
100% agreement from both investigators to include all 48 of the remaining articles for this 
review. A summary of the inclusion and exclusion review process can be found in Figure 1, 
PRISMA flowchart of paper selection process.  
During the final steps [25], five investigators analyzed the articles and integrated the 
outcomes from each included study. The results of the study were broken down into each 
component of the BPS-S framework; biological, psychological, social, and spiritual health 
outcomes. Results in the psychological health component were separated by either symptoms of 
depression, anxiety, or overall burden and emotional well-being as these were the only specified 




interpreted separately from the BPS-S outcomes. The investigators were each responsible for 
extracting the study characteristics and outcomes for 24 of the 48 final articles. In the following 
section, the results generated from this process are provided, as well as compared and contrasted 
to help identify where the science can be expanded and enhanced. 
Results 
In total, 48 articles published between 1988 and 2018 met the inclusion criteria from the 
3,557 originally identified by keyword search in Pubmed, Psychinfo, and CINAHL. Following a 
discussion about study characteristics, findings related to the biological, psychological, social, 
and spiritual health outcomes of caregivers of ALS patients (CALS) are discussed. Results 
related to family functioning will then follow. As a reminder, patients with ALS will be referred 
to throughout the remainder of the article as PALS.  
Study Characteristics  
Across all 48 admitted studies, 4,037 CALS were enrolled as participants. Approximately 
2,402 participants identified as female and 1,377 as male. Five articles did not report 
participants’ gender [27-31]. Participants’ ages ranged from 5 to 86 years old and family 
members’ relationship to patient participants approximately consisted mainly of spouse or 
partner (78%) with the remainder being children (14%), parents (2%), siblings (1%), or other 
relatives (5%). However, not every article included complete demographic information on the 
PALS and CALS relationship [31, 32] and two of the articles did not include the age of the 
family member or caregiver [29, 33]. Only nine of the articles reported participant race/ethnicity 
with a total of approximately 546 white non-Hispanic participants, nine Black or African 




Due to the lack of consistent demographic information reported, the interpretation and 
application of it is limited.   
Biological Health Outcomes 
 The question guiding this review, “How does ALS impact the immediate family 
members’ health and interactional patterns?” called for a focus on the BPS-S health outcomes of 
the CALS. Out of the 48 articles reviewed, 17 included outcomes on the biological health impact 
of ALS on CALS. The majority of studies reported that CALS’ physical well-being tended to 
decrease over the course of the disease and that the CALS often rated themselves with high 
scores of physical burden, indicating poorer physical health, on a variety of caregiver burden 
measures [6, 12, 29, 36-42]. Four out of 17 articles reported that CALS demonstrated poor 
physical health outcomes: CALS (a) worried over their own physical and biological health [10], 
(b) disclosed feelings of fatigue and somatic complaints [33], (c) described being physically tired 
most of the time [42], and (d) indicated declines in physical health occurring simultaneously to 
the PALS’ declining physical health [44]. Although the studies revealed that family member and 
caregiver physical health decreased over the course of the disease, there was no mention of how 
the psychological, social, and spiritual health components were related to their biological health.   
Three of the 17 articles did not reveal CALS as experiencing biological health decline. 
Olsson et al. [30] found no differences in the physical health of the CALS overtime in the entire 
next of kin group, while Trail et al. [13] found that 89% of CALS rated themselves as being in 
excellent health. In a study comparing health outcomes of CALS and PALS to health outcomes 
of the general Swedish population, Olsson et al. [29] found that there were no differences in 
physical health capacity between the CALS and the general Swedish population. These results 




or even due to the family’s ability to obtain assistive devices that eased the physical aspect of 
care. Although there is information available on how CALS’ biological health is impacted by 
ALS, none of these studies included psychological health outcomes and how the two might relate 
to one another.  
Psychological Health Outcomes 
 Of the 48 articles reviewed, 46 reported CALS experiencing challenging psychological 
outcomes. Due to the large number of articles that included psychological outcomes, these 
results were organized into the following categories: depression, anxiety, and overall emotional 
burden.   
Depression  
Out of the studies reviewed, 29 focused on depression among CALS. Results were mixed 
with 13 articles reporting CALS endorsed symptoms of depression and 16 reporting they did not. 
Of the 13 articles which focused on CALS’ symptoms of depression, one article [45],  found that 
nearly 50% of CALS identified symptoms of depression and 25% found that CALS had a score 
above the depression cut-off on various measurement tools. Furthermore, Watermeyer [46], 
found greater functional impairment among PALS was associated with higher caregiver 
depression; whereas, Chio et al. [47] found cognitive decline among PALS was directly related 
to depression in CALS. 
Three studies found that CALS reported increased symptoms of depression as the disease 
progressed [7, 33, 36]. Chen et al. [28] found 24.7% of CALS were diagnosed with depression, 
and Olsson Ozanne et al. [48] found CALS endorsed worse depression symptoms than the 




they experienced significantly higher levels of depression than children in a control group whose 
parents had no diseases.  
To understand how 16 studies found depression to not be a significant outcome for 
CALS, one must look at how depression symptoms were assessed. First, studies utilized several 
measures to determine levels of depression. Rabkin et al. [44] used the PHQ-9 [49] and found 
77% of CALS had no depression at the initial assessment and 90% had no depression at the last 
assessment, with no intervention provided between assessments. Galvin et al. [8] concurred and 
found that the mean depression scores of CALS was 5.9 on the HADS [50] (scores under 7 being 
within the normal range). Furthermore, 7 articles demonstrated that the majority of CALS had 
scores on the Zung Depression Scale [51], the Depression and Anxiety Scale [52], Beck’s 
Depression Inventory [53] or Beck’s Depression Inventory-II [54] that were lower than the cutoff 
for depression [9,37,47, 55-58].  
Only two articles found CALS had no clinical depression [44] or depression symptoms 
[32]. Both of these studies had mean BDI scores for all CALS below the cutoff for depression. 
However, the participants in each of these studies were recruited from single multidisciplinary 
ALS clinics [32, 44]. These centers often offer more support, practical assistance, and a more 
positive approach for the PALS and their families, potentially diminishing any symptoms of 
depression [44]. Furthermore, more depressed CALS may be less likely to participate in projects 
described as studying how people cope with serious illness [44]. Additional studies (n=4) found 
that depression symptoms were not above the cutoff for depression in CALS [13, 29, 59, 60], 
that few CALS endorsed symptoms of depression [13], and that no significant differences in 




The variations in outcome of these studies with 13 studies indicating levels of depression 
in CALS and 16 indicating no depression, may be a result of several components. The PALS and 
CALS with less depressive symptoms may have had higher levels of social support or 
spirituality, resulting in the relief of any depressive symptoms. There may have also been 
differences in age, gender, access to mental health services, or even access to other supportive 
devices between those with depressive symptoms and those without that may have eased these 
symptoms. In addition to studying levels of depression, several articles also focused on anxiety 
in CALS.  
Anxiety 
Unlike depression, all of the CALS studied reported experiencing some anxiety 
symptoms. Higher levels of anxiety were associated with higher levels of caregiver strain [35]. 
Goldstein et al. [61] found that the mean HADS scores did not indicate a diagnosis of anxiety for 
CALS although symptoms of anxiety were present. Garcia et al. [62], similarly found that 42% 
of CALS had scores above the lower cutoff to suggest presence of anxiety although not to the 
extent of warranting an anxiety diagnosis. A specific study on the impact of ALS on children 
demonstrated significantly higher anxiety scores for the children of a PALS than children in a 
control group with healthy parents [2]. 
While some articles evidenced lower CALS anxiety levels, there were no studies 
reporting no anxiety at all. Anxiety levels in four studies [9, 56, 60, 65] identified moderate 
anxiety levels in CALS. In one study [29] there were no differences found between PALS and 
CALS scores on the HADS [29]; however, one study noted CALS had higher levels of anxiety 
than the general population [58]. In reviewing these articles, it is clear that in every study, some 




additional BPS-S components influence one another and consequently symptoms of anxiety. 
Family functioning is also not studied to understand how family support and cohesion might 
alleviate anxiety symptoms. Following a focus on depression and anxiety symptoms, the 
remaining articles investigated overall quality of life, burden, and emotional well-being 
independent of depression or anxiety symptoms. 
Caregiver Emotional Burden  
Twelve of the articles included results on overall caregiver burden and emotional well-
being. Patients often rated CALS as being more burdened than CALS rated themselves [70] and 
overall emotional burden was the domain with the lowest (worst) score on the Caregiver Burden 
Inventory [41]. One of the articles included general quality of life scores (QOL) with the 
summary mental capacity scores of CALS being significantly lower than the national standard 
[40]. Studies found that caregiver outcome scores resulted in increased psychological distress 
overtime [37] and that the severity of the disease was directly connected to caregiver emotional 
burden [60]. Two studies found female CALS reported having higher emotional burden than 
males [6, 39] and female partner emotional burden was significantly higher in adult child CALS 
[6]. Based on the results, it is clear that CALS are impacted emotionally in several ways. 
However, it remains unclear as to how the psychological health of the CALS are impacted by the 
other BPS-S health components. In addition to the reviewed articles that included biological and 
psychological health outcomes, 20 articles included in this systematic review focused on the 
social health outcomes of CALS.  
Social Health Outcomes 
 Twenty of the 48 articles reviewed addressed social health outcomes of CALS. Twelve of 




lives [8, 39, 43], limited personal time and social isolation [31, 36, 63, 64], disconnection with 
peers [34], and the need to confide in and receive social support from someone, with little time to 
make that happen [65]. Additional articles indicated that female CALS had worse overall social 
burden scores [41, 55] and that overall CALS’ social health decreased over time [42]. 
 Two of the 20 articles on social health reported marital intimacy implications. Atkins et 
al. [27] found that reduction in the everyday, interpersonal experiences in which the patient-
spouse dyad had previously engaged contributed to reduced perceptions of the quality of their 
relationship. Further, Watermeyer et al. [46] reported that pre-illness marital intimacy scores 
were significantly higher than current scores and that when the PALS had greater behavioral 
symptoms, poorer outcomes in martial satisfaction were predicted.  
 An additional two articles focused primarily on the social health aspect of the PALS’ 
family cohesion and overall family relationship satisfaction [41, 67]. Martin and Turnbull [67] 
studied the lasting social health impact on families after the loved one with ALS died. They 
collected information from surviving CALS using author designed questionnaires with no 
available psychometrics to support its reliability and validity. Results indicated that 15% of the 
27 CALS characterized the disease as detrimental to family relationships, 18% felt that there was 
little change, and 67% believed the disease brought the family closer together [67]. Using the 
FACES III questionnaire [68], Tramonti et al. [41] studied the impact of ALS on family cohesion 
and adaptability. Results indicated that there was a high and increasing number of unbalanced 
families with “chaotically enmeshed” (highly adaptable with extreme closeness between family 
members) families being the most representative subtype based on the circumplex model [68]. 
Although there is no best level for relationships based on this circumplex model of family 




 In addition to the previously described outcomes, Trail et al. [13] found that 6.8% of 
CALS studied chose worries about the patient’s illness progression, concerns about the patient’s 
swallowing and eating difficulties, and worries about loved ones’ (PALS’) emotional and 
physical well-being as their primary stressors. Hwang et al. [38] attempted to understand what 
might alleviate CALS burden so that they might have more personal time. The results of this 
study indicated that the use of the eye-tracking device (used by PALS for communication) 
allowed CALS to participate more often in social activities and in taking care of other family 
members. As mentioned previously, none of the articles that included the social component 
discussed how the social health of CALS may be impacted by the remaining BPS-S components. 
Therefore, it remains unknown how the social health of CALS may be impacted by their 
biological, psychological, or even spiritual health. After focusing on the biological, 
psychological, and spiritual health outcomes of CALS, the following section will discuss the 
remaining component of the BPS-S framework, spiritual health outcomes.   
Spiritual Health Outcomes  
 Of the 48 articles reviewed, seven discussed the spiritual impacts on the CALS. Trail et 
al. [31] found that 63% of CALS continued to regularly attend church and that church was the 
CALS primary or even sole community activity. Calvo et al. [66] found that CALS’ private 
religiousness was positively associated with caregiver quality of life and was the second most 
important predictor of quality of life after anxiety. Another study on the existential well-being 
and spirituality of PALS and their CALS resulted in higher existential well-being in the PALS 
than the CALS, but also showed that the higher levels of existential well-being in the PALS was 
directly related to higher existential caregiver well-being [69]. Similarly, Roach et al. [42] found 




Although these few studies uncovered adverse spiritual impacts on the CALS, Murphy et al. [57] 
found spirituality was a major determinant of CALS quality of life while actively involved in the 
caregiving role. Finally, Trail et al. [13] found that 0% of CALS were concerned about their 
religiosity and were instead much more concerned about a sense of loneliness and time to 
themselves for hobbies and leisure activities. Again, based on the included articles, it seems as 
though spiritual health outcomes of CALS have not been considered simultanesouly with the 
biological, psychological, and social health of CALS. It is still unclear as to how the whole, BPS-
S health and family functionoing of CALS is impacted by ALS. 
Discussion 
This systematic review was conducted to better understand the impact ALS has on 
CALS’ BPS-S health and patterns of family functioning. Clinical and research recommendations 
are provided to demonstrate ways to apply the findings and advance the literature. Previous 
studies found that CALS are heavily impacted emotionally and physically by the steady 
progression of ALS, possibly due to caring for a partner or family member with a neurological 
illness negatively impairing quality of life [7-9] and family functioning [41, 67]. Supporting the 
value of studying BPS-S health factors simultaneously, alongside their family functioning, the 
Beaver’s systems model of family functioning [23] and BPS-S framework [14-16] was applied to 
the findings as a way of interpreting the ALS literature in accordance with theory.  
As a result of the systematic review, evidence was found that ALS has BPS-S impacts on 
CALS. While the 48 articles reviewed did include at least one BPS-S health outcome variable, 
several (n = 17) focused on biological health. They found CALS’ physical well-being tended to 
decrease throughout the course of the disease resulting in higher scores of physical burden and 




psychological health outcomes focused mainly on symptoms of depression (n=29), anxiety 
(n=11), and caregiver emotional burden (n=12).  
Of the 20 articles that examined the social health component, the majority focused on 
non-specific social health outcomes such as restricted social lives [8, 39, 43], limited time for 
self, and social isolation [31, 36, 64]. Two studied marital intimacy, finding reductions in the 
patient-spouse relationship quality [27, 46]. Among the ALS literature reviewed, only two teams 
focused on family functioning [41, 67]. Both noted the majority of families pulled together 
(centripetal) during the illness experience; however, neither studied changes in family 
functioning patterns after the patient had died. Also, it is unclear what is happening among those 
families who push apart (centrifugal). In addition, researchers have not looked at the BPS-S 
health benefits or challenges experienced by centripetal or centrifugal family functioning 
patterns. In addition to articles on social health outcomes, seven included spiritual health 
outcomes. The vast majority of spiritual health outcomes revealed that ALS had no negative 
impacts on CALS’ spirituality or existential well-being, however, these outcomes were not 
corroborated with any other biological, psychological or social health outcomes.  
Future Research 
Although each of the BPS-S components were addressed in some way throughout the 
reviewed studies, none attempted to understand how the components were influencing one 
another. It continues to remain unknown how the CALS’ biological health is negatively or 
positively impacted by the amount of social support received or even by their spiritual beliefs. 
Likewise, higher levels of depression and anxiety were not related back to their own biological 
health, social support, or spiritual beliefs. In order to appropriately apply the BPS-S model, the 




systemic whole [14-16]. Finally, as only one article studied the impact of ALS on the CALS 
following the PALS’ death, this remains an area to be further explored [67].  
Family functioning patterns among families with ALS are also inadequately represented. 
Although two of the included studies focused on family functioning [41, 67], the results of these 
studies do not represent all families with ALS. The results of these studies are also not expanded 
upon to determine what the health benefits or disadvantages are when the families become 
chaotically enmeshed. Furthermore, it remains unknown how family functioning may change 
within families throughout the duration of the illness or how family functioning may differ 
amongst families based on their ability to access additional supportive devices, participate in 
support groups, or even continue to participate in pre-illness routines (i.e., attending religious 
services, school events, family vacations, etc.). There is also space to discover how family 
functioning may change as the BPS-S health outcomes of the PALS and CALS change 
throughout the illness and even following the PALS’ death.   
This systematic reviewed highlighted that although researchers have been investigating 
BPS-S health outcomes of CALS, studies fall short in understanding the role healthy family 
functioning plays. Of the final 48 articles included in the study, 21 used one of the BPS-S 
variables, 13 used two, ten used three, and three used all four, again indicating a limitation of 
failing to incorporate each component of the BPS-S framework. Future studies should attempt to 
gather information related to each of the BPS-S health outcomes in a single study to more 








 This systematic review has its limitations. First, the research team included two 
investigators who implemented safeguards such as the utilization of MeSH and keyword 
searches and crosschecked searchers to help reduce omission of relevant articles. However, these 
strategies do not eliminate the risk of overlooking or missing relevant articles including 
conference presentations, theses and dissertations, or non-peer reviewed research reports 
contained in gray literature [25].  
Conclusion 
 Currently, there is a wealth of information on the individual BPS-S health outcomes of 
CALS. Research has shown that CALS are impacted biologically, psychologically, socially, and 
spiritually, although there has been no study that has reviewed each of these components 
simultaneously. Based on the reviewed articles it is also clear that ALS has an impact on the 
family’s functioning although this research is limited. Future research is needed to determine 
how CALS’ complete BPS-S health and how the family’s functioning is impacted by ALS. 
Findings from this research can help to better address the BPS-S health needs of the entire family 
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Table 1  
MeSH and Keyword Search Terms 
Database  MeSH and Keyword Search  
Pubmed "Amyotrophic Lateral Sclerosis"[Mesh] OR “Charcot Disease”[tiab] OR “Lou Gehrig Disease”[tiab] OR “Lou Gehrig's Disease”[tiab] OR 
“Lou-Gehrigs Disease”[tiab] OR “ALS”[tiab] OR “Gehrig's Disease”[tiab] OR “Gehrig Disease”[tiab] OR “Gehrigs Disease”[tiab] OR 
“Guam Form of Amyotrophic Lateral Sclerosis”[tiab] OR “Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1”[tiab] OR 
“Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1”[tiab] OR “Guam Disease”[tiab] OR “Amyotrophic Lateral 
Sclerosis With Dementia”[tiab] OR “Dementia With Amyotrophic Lateral Sclerosis”[tiab] OR “Motor Neuron Disease” [tiab] OR “Motor 
Neurone Disease” [tiab] OR “MND” [tiab] 
AND 
"Family"[Mesh:NoExp] OR "Nuclear Family"[Mesh:NoExp] OR "Siblings"[Mesh] OR “Parents"[Mesh:NoExp] OR "Spouses"[Mesh] OR 
Family[tiab] OR Families[tiab] OR “family member”[tiab] OR “family members and caregivers”[tiab] OR Stepfamily[tiab] OR 
Stepfamilies[tiab] OR “reconstituted family”[tiab] OR “reconstituted families”[tiab] OR Filiation[tiab] OR Kinship[tiab] OR 
Relatives[tiab] OR “Nuclear Families”[tiab] OR Child[tiab] OR Children[tiab] OR Kid[tiab] OR Kids[tiab] OR offspring[tiab] OR 
Sons[tiab] OR Son[tiab] OR Daughters[tiab] OR Daughter[tiab] OR Siblings[tiab] OR Sibling[tiab] OR Sisters[tiab] OR Sister[tiab] OR 
Brothers[tiab] OR Brother[tiab] OR Parent[tiab] OR Parenthood[tiab] OR “Step-parents”[tiab] OR “Step-parent”[tiab] OR “step 




parent”[tiab] OR Stepparent[tiab] OR Stepparents[tiab] OR Father[tiab] OR Fathers[tiab] OR Mother[tiab] OR Mothers[tiab] OR 
Spouse[tiab] OR spouses[tiab] OR “Married persons”[tiab] OR “Married person”[tiab] OR Husbands[tiab] OR Mate[tiab] OR Mates[tiab] 
OR companions[tiab] OR companion[tiab] OR Husband[tiab] OR “Domestic partners”[tiab] OR “Domestic partner”[tiab] OR Wives[tiab] 
OR Wife[tiab] OR “significant other”[tiab] OR “significant others”[tiab] OR Partner[tiab] OR Partners[tiab] OR Caregiver[tiab] OR 
Caretaker[tiab] OR Caregivers[tiab] OR caretakers[tiab]  
PsychInfo "Amyotrophic Lateral Sclerosis"[Mesh] OR TI (“Charcot Disease” OR “Lou Gehrig Disease” OR “Lou Gehrig's Disease” OR “Lou-Gehrigs 
Disease” OR “ALS” OR “Gehrig's Disease” OR “Gehrig Disease” OR “Gehrigs Disease” OR “Guam Form of Amyotrophic Lateral 
Sclerosis” OR “Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1” OR “Amyotrophic Lateral Sclerosis Parkinsonism 
Dementia Complex 1” OR “Guam Disease” OR “Amyotrophic Lateral Sclerosis With Dementia” OR “Dementia With Amyotrophic 
Lateral Sclerosis” OR “Motor Neuron Disease” OR “Motor Neurone Disease” OR “MND) OR AB ( "Amyotrophic Lateral 
Sclerosis"[Mesh] OR “Charcot Disease” OR “Lou Gehrig Disease” OR “Lou Gehrig's Disease” OR “Lou-Gehrigs Disease” OR “ALS” 
OR “Gehrig's Disease” OR “Gehrig Disease” OR “Gehrigs Disease” OR “Guam Form of Amyotrophic Lateral Sclerosis” OR 
“Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1” OR “Amyotrophic Lateral Sclerosis Parkinsonism Dementia 
Complex 1” OR “Guam Disease” OR “Amyotrophic Lateral Sclerosis With Dementia” OR “Dementia With Amyotrophic Lateral 
Sclerosis” OR “Motor Neuron Disease” OR “Motor Neurone Disease” OR “MND”)  
AND 




"Family"[Mesh:NoExp] OR TI ( "Nuclear Family"[Mesh:NoExp] OR “Family members and caregivers”[Mesh:NoExp] OR "Siblings"[Mesh] 
OR “Parents"[Mesh:NoExp] OR "Spouses"[Mesh] OR Family OR Families OR “family member” OR “family members and caregivers” 
OR Stepfamily OR Stepfamilies OR “reconstituted family” OR “reconstituted families” OR Filiation OR Kinship OR Relatives OR 
“Nuclear Families” OR Child OR Children OR Kid OR Kids OR offspring OR Sons OR Son OR Daughters OR Daughter OR Siblings 
OR Sibling OR Sisters OR Sister OR Brothers OR Brother OR Parent OR Parenthood OR “Step-parents” OR “Step-parent” OR “step 
parent” OR Stepparent OR Stepparents OR Father OR Fathers OR Mother OR Mothers OR Spouse OR spouses OR “Married persons” 
OR “Married person” OR Husbands OR Mate OR Mates OR companions OR companion OR Husband OR “Domestic partners” OR 
“Domestic partner” OR Wives OR Wife OR “significant other” OR “significant others” OR Partner OR Partners OR Caregiver OR 
Caretaker OR Caregivers OR caretakers ) OR AB ( "Nuclear Family"[Mesh:NoExp] OR “Family members and caregivers”[Mesh:NoExp] 
OR "Siblings"[Mesh] OR “Parents"[Mesh:NoExp] OR "Spouses"[Mesh] OR Family OR Families OR “family member” OR “family 
members and caregivers” OR Stepfamily OR Stepfamilies OR “reconstituted family” OR “reconstituted families” OR Filiation OR 
Kinship OR Relatives OR “Nuclear Families” OR Child OR Children OR Kid OR Kids OR offspring OR Sons OR Son OR Daughters 
OR Daughter OR Siblings OR Sibling OR Sisters OR Sister OR Brothers OR Brother OR Parent OR Parenthood OR “Step-parents” OR 
“Step-parent” OR “step parent” OR Stepparent OR Stepparents OR Father OR Fathers OR Mother OR Mothers OR Spouse OR spouses 
OR “Married persons” OR “Married person” OR Husbands OR Mate OR Mates OR companions OR companion OR Husband OR 
“Domestic partners” OR “Domestic partner” OR Wives OR Wife OR “significant other” OR “significant others” OR Partner OR Partners 










S1: "Amyotrophic Lateral Sclerosis"[Mesh] OR TI ( “Charcot Disease” OR “Lou Gehrig Disease” OR “Lou Gehrig's Disease” OR “Lou-
Gehrigs Disease” OR “ALS” OR “Gehrig's Disease” OR “Gehrig Disease” OR “Gehrigs Disease” OR “Guam Form of Amyotrophic 
Lateral Sclerosis” OR “Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1” OR “Amyotrophic Lateral Sclerosis 
Parkinsonism Dementia Complex 1” OR “Guam Disease” OR “Amyotrophic Lateral Sclerosis With Dementia” OR “Dementia With 
Amyotrophic Lateral Sclerosis” OR “Motor Neuron Disease” OR “Motor Neurone Disease” OR “MND ) OR AB ( “Charcot Disease” OR 
“Lou Gehrig Disease” OR “Lou Gehrig's Disease” OR “Lou-Gehrigs Disease” OR “ALS” OR “Gehrig's Disease” OR “Gehrig Disease” 
OR “Gehrigs Disease” OR “Guam Form of Amyotrophic Lateral Sclerosis” OR “Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia 
Complex 1” OR “Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1” OR “Guam Disease” OR “Amyotrophic Lateral 
Sclerosis With Dementia” OR “Dementia With Amyotrophic Lateral Sclerosis” OR “Motor Neuron Disease” OR “Motor Neurone 
Disease” OR “MND”) 
S2: "Family"[Mesh:NoExp] OR TI ( "Nuclear Family"[Mesh:NoExp] OR "Siblings"[Mesh] OR “Parents"[Mesh:NoExp] OR "Spouses"[Mesh] 
OR Family OR Families OR “family member” OR “family members and caregivers” OR Stepfamily OR Stepfamilies OR “reconstituted 
family” OR “reconstituted families” OR Filiation OR Kinship OR Relatives OR “Nuclear Families” OR Child OR Children OR Kid OR 
Kids OR offspring OR Sons OR Son OR Daughters OR Daughter OR Siblings OR Sibling OR Sisters OR Sister OR Brothers OR Brother 
OR Parent OR Parenthood OR “Step-parents” OR “Step-parent” OR “step parent” OR Stepparent OR Stepparents OR Father OR Fathers 




OR Mother OR Mothers OR Spouse OR spouses OR “Married persons” OR “Married person” OR Husbands OR Mate OR Mates OR 
companions OR companion OR Husband OR “Domestic partners” OR “Domestic partner” OR Wives OR Wife OR “significant other” 
OR “significant others” OR Partner OR Partners OR Caregiver OR Caretaker OR Caregivers OR caretakers ) OR AB ( "Nuclear 
Family"[Mesh:NoExp] OR "Siblings"[Mesh] OR “Parents"[Mesh:NoExp] OR "Spouses"[Mesh] OR Family OR Families OR “family 
member” OR “family members and caregivers” OR Stepfamily OR Stepfamilies OR “reconstituted family” OR “reconstituted families” 
OR Filiation OR Kinship OR Relatives OR “Nuclear Families” OR Child OR Children OR Kid OR Kids OR offspring OR Sons OR Son 
OR Daughters OR Daughter OR Siblings OR Sibling OR Sisters OR Sister OR Brothers OR Brother OR Parent OR Parenthood OR 
“Step-parents” OR “Step-parent” OR “step parent” OR Stepparent OR Stepparents OR Father OR Fathers OR Mother OR Mothers OR 
Spouse OR spouses OR “Married persons” OR “Married person” OR Husbands OR Mate OR Mates OR companions OR companion OR 
Husband OR “Domestic partners” OR “Domestic partner” OR Wives OR Wife OR “significant other” OR “significant others” OR Partner 
OR Partners OR Caregiver OR Caretaker OR Caregivers OR caretakers ) 
S3: ("Family"[Mesh:NoExp] OR TI "Nuclear Family"[Mesh:NoExp] OR "Siblings"[Mesh] OR “Parents"[Mesh:NoExp] OR "Spouses"[Mesh] 
OR Family OR Families OR “family member” OR “family members and caregivers” OR Stepfamily OR Stepfamilies OR “reconstituted 
family” OR “reconstituted families” OR Filiation OR Kinship OR Relatives OR “Nuclear Families” OR Child OR Children OR Kid OR 
Kids OR offspring OR Sons OR Son OR Daughters OR Daughter OR Siblings OR Sibling OR Sisters OR Sister OR Brothers OR Brother 
OR Parent OR Parenthood OR “Step-parents” OR “Step-parent” OR “step parent” OR Stepparent OR Stepparents OR Father OR Fathers 




OR Mother OR Mothers OR Spouse OR spouses OR “Married persons” OR “Married person” OR Husbands OR Mate OR Mates OR 
companions OR companion OR Husband OR “Domestic partners” OR “Domestic partner” OR Wives OR Wife OR “significant other” 
OR “significant others” OR Partner OR Partners OR Caregiver OR Caretaker OR Caregivers OR caretakers OR AB "Nuclear 
Family"[Mesh:NoExp] OR "Siblings"[Mesh] OR “Parents"[Mesh:NoExp] OR "Spouses"[Mesh] OR Family OR Families OR “family 
member” OR “family members and caregivers” OR Stepfamily OR Stepfamilies OR “reconstituted family” OR “reconstituted families” 
OR Filiation OR Kinship OR Relatives OR “Nuclear Families” OR Child OR Children OR Kid OR Kids OR offspring OR Sons OR Son 
OR Daughters OR Daughter OR Siblings OR Sibling OR Sisters OR Sister OR Brothers OR Brother OR Parent OR Parenthood OR 
“Step-parents” OR “Step-parent” OR “step parent” OR Stepparent OR Stepparents OR Father OR Fathers OR Mother OR Mothers OR 
Spouse OR spouses OR “Married persons” OR “Married person” OR Husbands OR Mate OR Mates OR companions OR companion OR 
Husband OR “Domestic partners” OR “Domestic partner” OR Wives OR Wife OR “significant other” OR “significant others” OR Partner 




CHAPTER 3: UNDERSTANDING SYMPTOM ONSET AND BIOPSYCHOSOCIAL-
SPIRITUAL IMPACTS OF AYMOTROPHIC LATERAL SCLEROSIS 
 Amyotrophic Lateral Sclerosis (ALS) is a progressive, incurable disease that is likely to 
have a devastating impact on patients with ALS (PALS) and their families (O’Brien, Whitehead, 
Jack, & Mitchell, 2011). In ALS, muscle weakness continuously spreads to encompass all 
voluntary muscles, including respiratory muscles, leading to death within two to five years of 
symptom onset (Couratier et al., 2016). Currently, there are as many as 30,000 PALS living 
within the United States with approximately 5,600 individuals being newly diagnosed with ALS 
annually (Cruz et al., 2018). ALS has been characterized by sudden onset of progressive motor 
deficits that develop within weeks or months, possible cognitive and behavioral impairment and 
inevitable physical decline (Galvin et al., 2016). With no known cure, ALS is a fatal disorder 
with devastating symptoms that lead to eventual paralysis and death (Cruz et al., 2018).  
  ALS has traditionally been classified into either the sporadic or familial form (van Es et 
al., 2017). Approximately 90% of ALS cases are sporadic, meaning the cause of the disease 
remains unknown (Brooks, Miller, Swash, & Munsat, 2000).  The remaining five to ten percent 
of cases are due to genetic mutations inherited from a family member. When two or more family 
members are diagnosed with ALS, the disease is considered familial. In addition to ALS cases 
being classified as sporadic or familial, the disease is often classified by site, pattern of onset, or 
by degree of upper motor neuron or lower motor neuron involvement (van Es et al., 2017). 
Although these classifications exist, variations in the pattern and spread of ALS are not well 
understood (Fujimara-Kiyono et al., 2011).  
An additional area of ALS literature that has not been thoroughly understood from both 
the PALS’ and their family members’ perspective is quality of life through the lens of the 




biopsychosocial-spiritual framework (BPS-S; Engel, 1977; 1980; Wright, Watson & Bell, 1996). 
The BPS-S framework proposes that biological, psychological, social, and spiritual components 
of health operate simultaneously in connected subsystems that influence all aspects of mental 
and physical health (Engel, 1977; 1980; Wright et al., 1996). Several researchers have reviewed 
the impact of ALS on individual components of the BPS-S framework for both PALS and family 
members and caregivers, with the results being somewhat varied (Makkonen et al., 2018; Olsson 
et al., 2010; Oyebode et al., 2013; Trail et al., 2003). For example, some research has shown that 
PALS and their caregivers report symptoms of depression (Chen et al., 2015), while other studies 
have shown that PALS and their caregivers report little to no symptoms of depression or anxiety 
(Rabkin, Albert, Rowland, & Mitsumoto, 2009). 
Although research has been conducted on the BPS-S impact of ALS, little attention has 
been paid to all four domains simultaneously for patient and family members and how this might 
differ based on type of symptom onset, either bulbar or limb. Thus, this review will cover peer 
reviewed literature in attempt to highlight gaps and opportunities for future research. Ultimately, 
this review will (a) describe the staging systems for ALS, (b) explore the differences between 
bulbar and spinal onset, (c) detail the impact of ALS on PALS’ and family members’ BPS-S 
health, and (d) provide recommendations for future researchers who aim to optimize the care and 
quality of life for PALS and their family members.  
Stages in ALS 
 Identified stages in ALS allow patients and caregivers to better understand the course of 
the disease and to better differentiate progression of the disease and subsequent quality of life 
(Chiò, Hammond, Mora, Bonito, & Filippini, 2013). Staging criteria for the disease help to 
provide a universal and objective measure of disease progression, resulting in benefits for patient 




care, research classifications, and resource allocation (Roche et al., 2012).  Various stages 
methods of ALS have been proposed, with the most widely studied methods being the Milano-
Torino (MiTos) functional staging system (Chiò et al., 2013) and King’s clinical staging system 
(Roche et al., 2012).  
 The King’s system uses five stages (1 to 5) and is based on disease burden as measured 
by clinical involvement and significant feeding or respiratory failure (Roche et al., 2012). This 
staging system consists of stage 1: symptom onset (involvement of one central nervous system 
(CNS region), stage 2A: diagnosis, stage 2B: involvement of a second CNS region, stage 3: 
involvement of a third region, stage 4A: need for gastrostomy, and stage 4B: need for respiratory 
support (non-invasive ventilation). Symptom onset in stage 1 includes functional involvement by 
weakness, wasting away of muscles, spasticity, or continuously contracting muscles, dysarthria, 
or weakness in the muscles used for speech, or dysphagia, difficulty swallowing. Each of these 
stages occur in sequential order without reversion to earlier stages with the stages being reached 
at predictable, consistent times through the course of the disease. This staging system has been 
described as easy to use because it corresponds to information relevant to a neurologist and 
symptoms reported by the patient. While King’s staging system focuses on anatomical disease 
spread and significant involvement of respiratory muscles, the MiTos staging system focuses on 
the distinction of functional capabilities during the spread of the disease (Fang et al., 2017).  
 The MiTos staging system is based on the validated ALS Function Rating Scale-Revised 
(ALSFRSR) and also identifies relevant stages of the disease (Chiò et al., 2013). This system 
uses six stages with stage 0 being normal function and stage 5 being death. Stage 1 includes the 
loss of independence in one domain of the ALSFRSR, stage 2 includes the loss of independence 
in two domains, stage 3, the loss of independence in three domains, and stage 4, the loss of 




independence in four domains. Similarly to the King’s staging system, this system also found 
that the distribution of patients across stages and the probabilities of transition between stages 
were consistent with sequential disease progression. Although these staging systems slightly 
differ, research supports the use of both systems (Fang et al., 2017).  
 Both the King’s and MiTos staging systems summarize different aspects of patient 
information (Fang et al., 2017). King’s system summarizes the clinical or anatomical spread of 
the disease while MiTos staging summarizes the functional burden of the disease. Although 
King’s system is better able to differentiate early to mid-disease stage well, MiTos staging is able 
to differentiate late stages more effectively. Even though there are slight differences between 
these staging systems, research supports the use of both to describe ALS stages as together they 
provide a concise summary of disease spread and functional burden. Understanding the clinical 
stages of ALS is likely to be useful in the treatment of the disease. Similarly, understanding the 
differences in disease course based on symptom onset may be equally beneficial to PALS, their 
family members, and to the design and development of more beneficial research, treatment plans, 
interventions, and patient-family centered policies.  
Symptom Onset  
 In order to more thoroughly understand the progression of ALS, it is important to 
consider the variations in the disease that occur based on symptom onset. The following section 
will provide an overview of (a) the different types of symptom onset in ALS, (b) how it 
progresses, (c) and information as to how each type is a predictor of prognosis. A characteristic 
feature of the ALS concludes that in 90-98% of cases the first symptoms occur in only one body 
region with subsequent progression confined largely to that same region before involvement of 
additional regions (van der Kleij, 2015). The disease is often classified by site or pattern of 




symptom onset to include bulbar and spinal, or limb, onset in Classic ALS with research 
showing that the pattern of spread following symptom onset is a predictor of prognosis (van der 
Kleij, 2015; van Es et al., 2017).  
Limb-onset 
 Approximately two-thirds (66%) of PALS have a spinal form of the disease (limb-onset; 
van Es et al., 2017). These PALS most often present with symptoms related to central muscle 
weakness and wasting with the symptoms starting either distally (farthest away from the point of 
origin) or primally (closest to the point of origin) in the upper and lower limbs. In limb-onset 
ALS, spasticity may develop in the weakened limbs, which can affect dexterity and gait. PALS 
may also notice muscle wasting before onset of weakness and some patients may even present 
with spastic paraparesis, progressive weakness and stiffness in the legs (Wijesekera & Leigh, 
2009).  
 Weakness due to limb-onset ALS usually comes on slowly, with PALS noticing that 
these symptoms are exacerbated by cold weather (Wijesekera & Leigh, 2009). Following 
asymmetrical symptom onset, originally unaffected limbs develop eventual weakness and 
wasting, resulting in bulbar and eventually respiratory symptoms. Limb-onset ALS symptoms 
commonly also experience bladder dysfunction and sensory issues (i.e., numbness, tingling, 
and/or pain), along with cognitive and behavioral symptoms (i.e., dementia, reasoning and 
judgement impairments, and emotional regulation challenges). The remaining one-third (33%) of 
PALS present with bulbar symptoms. 
Bulbar-onset 
 Bulbar-onset of the disease, and bulbar dysfunction overall, is often associated with 
poorer prognosis or outcomes (Felgoise, Zaccheo, Duff, & Simmons, 2016; Fujimara-Kiyono et 




al., 2011; Green et al., 2013). Bulbar-onset most commonly targets muscles in the face, head, and 
neck (Simmons, 2005) and is more common in females and older age groups (Wijesekera & 
Leigh, 2009). Although it has been determined that individuals with ALS do not always notice 
the earliest changes in their bulbar function (Allison et al., 2017), people with ALS demonstrate 
various speech symptoms at the time of diagnosis (Makkonen, Ruottinen, Puhto, Helminen, & 
Palmio, 2018). The presence of bulbar-onset is associated with progressive reduction in speaking 
and articulatory rates (i.e., an increase in the number and duration of pauses during speech). The 
initial symptoms of bulbar-onset often include a slight, intermittent slurring of speech, a hoarse, 
nasal quality to the voice, a decrease in speech volume, slow and limited movements of the 
tongue, lips, and pharynx, resulting in progressively decreasing intelligibility and eventually 
complete loss of speech (Simmons, 2005). This loss of effective communication is often 
considered one of the worst aspects of the disease by PALS (Makkonen et al., 2018).  
 Previous research on bulbar and limb onset ALS has suggested that PALS’ quality of life 
(QOL) can differ based on verbal speech ability (Felgoise et al., 2016). PALS with limb-onset 
are often referred to speech therapy sooner than those with bulbar-onset because they are usually 
already being monitored for other symptoms, resulting is substantially more time to organize 
communication aids for limb-onset patients (Makkonen et al., 2018). The resulting loss of the 
ability to communicate has been found to have devastating psychologic and social consequences 
(Simmons, 2005). This aspect of the disease, loss of speech, is often considered one of the worst 
aspects of the disease, with PALS most commonly asking how long they will be able to speak 
during clinical visits (Makkonen et al., 2018). Ultimately, changes in and loss of speech are 
found in both bulbar and limb-onset PALS, yet these changes tend to occur earlier in bulbar-
onset PALS.  




 Overall, the type of initial onset of ALS, either limb or bulbar, is a major determinant of 
overall survival (Turner et al., 2010). Bulbar-onset of the disease, along with older age at 
symptom onset and earlier respiratory muscle weakness are most often associated with reduced 
survival (Kiernan et al., 2011). Limb-onset however, in addition to younger age at symptom 
onset and longer diagnostic delays, is a predictor of prolonged survival. Due to the symptom 
onset type being a predictor of outcomes in ALS, it is imperative that PALS and their support 
persons’ experiences  are more thoroughly understood to plan care more effectively (Turner et 
al., 2010). In addition to a scarcity of research comparing the lived experiences across ALS onset 
types, there are no known studies that have looked in to the psychosocial and spiritual 
experiences of PALS and their support systems regarding onset type, diagnosis experience, or 
disease progression. In that the BPS-S framework declares that each of the health components 
impact one another (Engel, 1977; 1980; Wright et al., 1996), it is essential that the simultaneous 
impact of each BPS-S component for both PALS and their support persons is adequately 
understood.  
Biopsychosocial-spiritual Health 
 Exploring the impacts of ALS on PALS and their support persons through the BPS-S 
framework (Engel, 1977; 1980; Wright et al., 1996) assists researchers and clinicians in better 
understanding the systemic and relational implications of the disease by viewing health through a 
comprehensive lens. Utilizing the BPS-S framework has even emerged as a predictor of survival, 
with results indicating that the risk of death in PALS might be reduced by 45% at five years 
(Kiernan et al., 2011). Thus far, the research related to BPS-S health in ALS remains siloed with 
the majority of the research being independently patient-focused or independently focused on the 
support persons. However,  a dearth of literature does  explain how ALS effects the biological, 




psychological, social, and spiritual, although these components have only ever been studied on 
their own, without determining how they might be influencing one another. The following 
section will provide a brief overview of the literature on BPS-S health in PALS and their support 
persons, as it exists, with the impacts on each component (biological, psychological, social, and 
spiritual) being explained independently of the others.  
Biological 
 As ALS naturally results in progressive muscle weakness, it is clear that PALS are 
physically impacted by the disease in other ways as well (Creemers et al., 2015).  They 
commonly experience malnutrition, weight loss, dehydration, and respiratory issues as their 
muscles begin to shut down (Simmons, 2005). PALS also report pain due to muscle spasticity 
and cramping. Although the support persons of PALS do not experience these same biological 
changes, they do experience other biological differences as the physical caregiving demands 
increase (Olsson, Markhede, Strang, & Persson, 2010; Pagnini et al., 2010). 
 Researchers found support persons often disclose feelings of fatigue and somatic 
complaints (Gelinas, O’Connor, & Miller, 1998; Roach, Averill, Segerstrom, & Kasarskis, 
2009). They describe their physical health declining simultaneously to the declines in the PALS’ 
physical health (Rabkin et al., 2009). Similar findings occur in the psychological literature noting 
evidence of a corresponding decline as the PALS’ physical health deteriorates. 
Psychological 
 The impact ALS has on PALS’ psychological health varies from patient to patient 
(Simmons, 2005). Depression is one mental health condition that is commonly reported. Several 
factors seem to play a role in determining whether or not PALS become depressed, including 
individual pain levels, social support, and perceived family and caregiver burden. Depression 




rates in PALS have ranged in various studies from 2% of PALS having major depressive 
disorder in one study (Rabkin, Wagner, & Del Bene, 2000) to anywhere from 11% to 75% 
having major depressive disorder in other studies. Anxiety has also been found to be very 
common in PALS with as many as 67% of PALS endorsing symptoms of anxiety (Chen et al., 
2015). Symptoms of anxiety in PALS has been found to become increasingly severe as the 
disease progresses and has been found to determine subsequent depression in PALS (Atassi et 
al., 2011). Pseudobulbar affect and fronto-temporal dementia are additional conditions 
(impacting cognitive, emotional, and behavioral states) that are common in PALS (Ng, 
Rademakers, & Miller, 2015; Thakore & Pioro, 2017). Pseudobulbar affect manifests in 
uncontrollable episodes of crying or laughter, which are incongruent with the emotion or 
situation and has been found to be prevalent in PALS (Thakore & Pioro, 2017). Fronto-temporal 
dementia is a progressive brain disease with changes in behavior, personality, and language 
dysfunction due to loss of nerve cells that often occurs in PALS (Ng et al., 2015). Due to 
growing research on ALS’ impact on patient’s psychological health, it is important to expand the 
research to all areas of the BPS-S framework. It is also necessary to study not only PALS but 
their support persons as well so science can better inform treatment. 
 Due to the extensive time commitment of caregiving, its significant emotional burden, 
and due to the majority of ALS support persons being the PALS’ spouses (Tramonti, Bongionni, 
Leotta, Puppi, & Rossi, 2015), extensive research has been conducted to evaluate the 
psychological health of support persons (Qutube, Lacomis, Albert, & Feingold, 2014). Similar to 
studies conducted with PALS, caregivers often experience extreme emotionality due to the 
steady progression of the disease and lack of effective treatment (Pagnini et al., 2010). Several 
studies (Chiò et al., 2010; Tremolizzo et al., 2016; Watermeyer et al., 2015) found nearly 50% of 




support persons reported symptoms of depression and 25% had had a score above the cut-off for 
clinical depression on various measurement tools (Tremolizzo et al., 2016) with their symptoms 
of depression increasing as the disease progressed (Burke et al., 2018; Gauthier et al., 2007; 
Gelinas, et al., 1998). Interestingly, two research teams found little to no symptoms of depression 
(Qutub et al., 2014; Rabkin et al., 2009) with differences in cultural background, income, access 
to healthcare, level of support, sample size, or even the utilization of varying assessment tools 
potentially modifying the outcomes.  
Symptoms of anxiety in the support persons of PALS have also been studied extensively. 
The vast majority of research on symptoms of anxiety in the support persons of PALS has found 
that all support persons indicated at least some symptoms of anxiety (Creemers et al., 2016; 
Garcia et al., 2017; Grabler et al., 2018; Pagnini et al., 2012a). In addition to the psychological 
research on support persons of PALS covering anxiety and depression, this area of research has 
also focused on the overall caregiver burden and emotional well-being. The results of these 
studies have indicated that the psychological distress of these caregivers increases over time and 
that the severity of the disease has been directly connected to increased emotional burden in 
caregivers (Goldstein et al., 2006; Pagnini et al., 2012b). While there are extensive findings that 
endorse the notion that ALS psychologically impacts patients and their caregivers, previous 
studies havemainly focused on either the PALS or the support person, without investigating how 
the disease impacts social relationships.  
Social 
 Social health is important to the overall quality of life (QOL) of PALS (Makkonen et al., 
2018). For PALS, social integration is often impacted by impaired mobility and communication, 
even though positive effects on coping have been directly related to social involvement (Hecht et 




al., 2002). Previous researchers found PALS may purposefully limit their social interactions due 
to embarrassments related to or fear of functional impairments (Kukulka, Washington, 
Govindarajan, & Mehr, 2019). In addition to previous social research on PALS, several research 
teams focused on non-specific social health outcomes of support persons caring for someone 
with PALS. Researchers found that support persons often report limited personal time and 
restricted social lives (Gauthier et al., 2007; Oyebode, Smith, & Morrison, 2013), disconnection 
from peers (Siciliano et al., 2017), and desire to confide in someone for social support but with 
little time to make that happen (Bolmsjö, & Hermerén, 2013). Ultimately, both PALS and their 
support persons seem to identify social groups and time with peers as being beneficial to their 
social health (Kukulka et al., 2019).  
 Due to PALS and support persons experiencing limited social interactions because of 
PALS’ difficulties communicating and moving and support persons having little time to 
participate in social activities, interventions aimed at maintaining the social support of PALS and 
their support persons have proven to be effective (Isle et al., 2015; Loane & D’Alessandro, 
2013). For example, PALS have been found to benefit socially from participation in on-line 
health related support groups as these groups allow them to participate regardless of the lack of 
mobility or communication skills (Loane & D’Alessandro, 2013). These on-line support groups 
have been found to essentially replace lost or deteriorating “real-life” social networks, with 
PALS positively benefiting from regular reminders that they are not alone in their ALS journey.  
Likewise, support persons of PALS have also benefited positively from social support 
groups to include both face-to-face and online support groups (de Wit et al., 2018). Specifically, 
these support persons benefit from mutual support groups (Cipolletta, Gammino, Francescon, & 
Palmieri, 2018). Mutual support groups are informal networks of individuals who share a 




common experience or issue and who can learn from each other's new adaptive behaviors. These 
groups allow support persons to interact socially with others who have experienced similar 
challenges due to the everyday care of a family member and can improve their knowledge of the 
disease, encourage the acceptance of difficult situations and aid the development of new coping 
strategies. As support persons of PALS often experience a lack of personal time for social 
interaction, a blend of online and face-to-face groups allow access to support at any time, 
effectively improving their social health (de Wit et al., 2018). Similarly to participation in social 
support groups, PALS’ and support persons’ spirituality and participation in religious practices 
has been found to be beneficial to their health.  
Spiritual 
 Several studies have focused on the spiritual impact that ALS has on PALS and their 
support persons. It has been found that although overall QOL may not be correlated with 
religiosity early in the course of ALS, a significant relationship develops over the course of the 
disease (Bremer, Simone, Walsh, Simmons, & Felgoise, 2004). Murphy and colleagues (2000) 
found that PALS who were more spiritual or religious had more hope and were less likely to 
consider assisted suicide. Support persons reported attending church services and events to be the 
only community activity they were able to engage in regularly (Trail, Nelson, Van, Appel, & Lai, 
2003). Calvo et al. (2011) found support persons’ private religiousness was positively associated 
with QOL and was the second most important predictor of QOL after anxiety. Another study on 
the existential well-being and spirituality of PALS and their support persons demonstrated higher 
existential well-being in the PALS than the support persons (Pagnini et al., 2011). However, 
higher levels of existential well-being among PALS were directly related to higher existential 
well-being among caregivers.  





 To comprehensively assess the impact of ALS based on symptom onset and on the 
simultaneous impact of each BPS-S component and how those components potentially affect one 
another, additional research is needed in each of these areas. Previous literature has demonstrated 
that PALS have differing experiences based on bulbar or limb-onset, with bulbar-onset PALS 
often having poorer prognosis (Felgoise et al., 2016). The existing literature attempts to identify 
how the PALS and their support persons’ BPS-S health is impacted (e.g., Makkonen et al., 2018; 
Olsson et al., 2010; Oyebode et al., 2013; Trail et al., 2003), yet it does not attempt to explain 
how each of these components potentially interact with, elevate, exacerbate, moderate, or even 
alleviate one another. In addition, few researchers have studied the comprehensive BPS-S health 
effects of ALS, with research sparse on how those health components are impacted by type of 
symptom onset. Finally, the current literature has shared how ALS impacts PALS and support 
persons, but studies contributing to this body of research have been done primarily with 
individuals. The comprehensive health of these individuals has yet to have been studied from the 
perspective of the entire family unit or support system.  
Future studies focusing on comprehensive BPS-S health patterns and outcomes among  
PALS and their support persons’ would allow for each of these existing, disconnected pieces to 
be conjoined.  One place to begin would be to focus on how each BPS-S components of health 
interact with one another, while simultaneously considering how type of symptom onset may 
result in variations of these health components. It is also important to explore the experiences 
with ALS from the perspective of the entire support system or family unit. As ALS results in 
PALS becoming increasingly dependent on others, family members and additional support 
persons are often deeply involved with the disease (Tramonti, Bongionni, Leotta, Puppi, & 




Rossi, 2015). Studying the experiences of the disease from a systemic perspective would allow 
for the previous research on the individual perspectives of PALS and their support persons to be 
combined and compared to one another (von Bertalanffy, 1967).  
It may also prove beneficial for future research on these topics to be conducted using 
qualitative methods. Thus far the majority of ALS research has utilized quantitative methods. 
The use of qualitative methods would not only allow for multiple members of the PALS’ system 
to share their own perspective of ALS but would also all for participants to elaborate on a variety 
of social determinants of health that might otherwise remain unknown when quantitative 
methods alone are use. Although it remains that ALS has no cure, future research on this topic 
can continue to provide valuable information and recommendations for multidisciplinary care 
that will optimize the quality of life for PALS and their family members. 
Conclusion 
 Due to ALS having no known cure and no ability to stop the progression of the disease, 
the primary goal in caring for PALS and their support person has often been considered to be the 
optimization of QOL (Simmons, 2005). This review of the literature explored how QOL in 
PALS might differ based on symptom onset, finding that PALS with bulbar-onset have worse 
outcomes (Felgoise et al., 2016). The review of the literature also found that the results of 
previous studies on BPS-S health outcomes have been varied for both PALS and their support 
persons. When studying the impacts of ALS by symptom onset through the lens of the BPS-S 
framework, it is essential that the each of the BPS-S components are studied simultaneously. 
Given that the existing literature on the varying experiences of living with ALS based on 
symptom onset and BPS-S health outcomes remains limited, it is apparent that more research in 
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CHAPTER 4: METHODOLOGY 
Amyotrophic lateral sclerosis (ALS) is an incurable, progressive neurodegenerative 
disease characterized by a loss of motor neurons and increasing muscular weakness that 
inevitably leads to death (Knibb et al., 2016).  The disease has long been recognized as a fatal 
condition, with median survival time estimated to be 20 to 48 months from symptom onset 
(Paulukonis, 2015).  Since clinical manifestations and speed of progression for ALS vary widely 
among affected individuals, it is difficult to accurately predict the course of the disease, 
including the progression of disability for a given individual (Creemers, Grupstra, Nollet, van 
den Berg, & Beelen, 2015).   
Patients diagnosed with ALS (PALS) gradually need increased assistance with their 
activities of daily living due to the disease’s progressive course (Krivikas, Shockley, & 
Mitsumoto, 1997; Mockford et al., 2006). Eventually, ALS compromises their ability to speak 
and move without assistance (Rabkin et al., 2009). It has been estimated that ALS caregivers 
spend an average of 11 hours every day helping patients maintain a good quality of life 
(Krivikas, et al., 1997). As most caregivers are the patients’ spouses, and at times even the 
patients’ children (Kiernan et al., 2011; Tramonti et al., 2015), it is imperative to understand how 
families successfully navigate this disease and modify their roles and functioning to adapt.  
Caregiver and family burden associated with ALS is known to negatively impact their 
physical (Hwang, Weng, Tsai, & Chang, 2014; Tramonti et al., 2015), emotional (Burke et al., 
2017; Pagnini et al., 2012; Tremolizzo et al., 2016), social (Galvin et al., 2016; Sicilliano et al., 
2017), and spiritual health (Roach, Averill, Segerstrom, & Kasarskis, 2009), yet little is known 
about how family functioning is impacted. Beavers systems model explains that negentropic 
(flexible and adaptive) families are more capable of negotiating and dealing effectively with 




stressful situations (Beavers, 1981).  This model further describes family compentence along the 
horizontal and the family style on the vertical axes. The horizontal axis, describing family 
competence, relates to the structure, available information, and adaptive flexibility of the system. 
Flexible and adaptive families can better negotiate, function, and effectively deal with stressful 
situations. Highly competent families have structure and the ability to change structures, as well 
as an approach to relationships that does not bind them to rigid behaviors. Less competent 
families tend to have poorer boundaries, lack communication, and are systemically rigid.  
The vertical axis of the model, family style, describes families as either centripetal or 
centrifugal. Centripetal families are inner oriented with family members having difficulty 
separating from one another and feeling as though the family is the most trustworthy source of 
satisfaction. They are outer oriented with independence encouraged and satisfaction expected 
more often from the outside environment rather than from the family. Beaver’s concept of 
centripetal and centrifugal family styles can be particularly useful in examining the impact that 
illnesses (i.e., ALS) have on family functioning. 
Families of PALS are challenged by their need to adapt to new roles and reorganize their 
family structures as the disease progresses (Newby, 1996). Beavers and Voeller (1983) noted 
that chronic disease often exerts a centripetal pull on the family system with the family members 
focusing all role changes and uncertainty about the illness inward. The authors further argued 
that if during the onset of an illness the family gravitates toward a centrifugal style, it would 
likely result in a prolonged centrifugal period, with family members persistently pulling away 
from one another as the disease progresses (Newby, 1996). However, progressive diseases, such 
as ALS, are described as being inherently more centripetal in their effect on family stress 
(Newby, 1996). It is apparent that the centripetal and centrifugal reactions may vary greatly over 




time, with that variability having important effects on the family’s functioning throughout the 
illness. In addition to considering the family’s style, either centripetal or centrifugal, it is also 
important to consider the PALS’ type of symptom onset. 
PALS primarily present with bulbar-onset disease (approximately 25%) or limb-onset 
disease (approximately 70%) with the remaining 5% presenting with initial trunk or respiratory 
involvement (Vucic, Burke, & Kiernan, 2007). Bulbar-onset consists of spastic dysarthria, slow, 
labored, and distorted speech often with a nasal quality, tongue wasting and weakness, and 
difficulty swallowing (Kiernan et al., 2011).  PALS with bulbar-onset have obvious speech 
deterioration before definitive diagnosis (Makkonen et al., 2016). This loss of ability for 
effective communication may result in difficult psychological and social problems (Simmons, 
2005), with PALS often considering the potential loss of speech to be one of the worst aspects of 
the disease (Hecht et al., 2002). Limb-onset consists of muscle spasticity, continuously 
contracting muscles, muscle weakness and wasting away, and fasciculations, spontaneous 
contractions causing flickers of movement under the skin (Kiernan et al., 2011). Bulbar-onset 
disease, as well as older age at symptom onset and early respiratory muscle dysfunction are 
independently associated with reduced survival, while limb-onset disease, as well as with 
younger age at symptom onset, and longer diagnostic delay are independently associated with 
prolonged survival (Talbot, 2009). Making sense of how these symptoms impact PALS and their 
families is important to advancing the research and treatment. 
According to the Beaver systems model (Beavers, 1981), negotiation between and 
amongst family members is necessary for successfully managing stressful situations. An illness 
event may draw families closer together or push them farther apart. In addition to focusing on the 
impact of ALS on the family’s functioning, the biopsychosocial-spiritual (BPS-S; Engel, 1977; 




1980; Wright, Watson, and Bell, 1996) framework is used to study the comprehensive impact of 
ALS and the patient and their family system. It was developed as a scientific model that takes 
into account the missing elements of the biomedical model, including the psychological, social, 
and spiritual components of  health. The framework suggests that all BPS-S components of 
health operate simultaneously and influence all aspects of mental and physical health. Thus far, 
the majority of ALS research on BPS-S health has been disjointed with studies focusing on only 
one or two health components at a time and failing to incorporate how those components may be 
impacting one another. The research also shows a lack of consideration as to how family 
member’s BPS-S health may be impacting the family’s functioning. The inclusion of the BPS-S 
framework, in conjunction with Beaver’s systems model of family functioning allows for the 
opportunity to further investigate the simultaneous impact of ALS on a family’s functioning and 
their overall BPS-S health.  
This chapter presents the methodology for the dissertation investigating the experiences 
of patients and family members living with ALS and how family functioning and health are 
impacted.  It is designed as a qualitative study, to be conducted with PALS and a primary 
support person, using Husserl’s descriptive phenomenological method of inquiry (1901; 1970). 
This qualitative study provides a rich description on how family functioning styles are impacted 
by symptom onset. The following research question guided the study: “What are the experiences 
of patients - and their identified primary support persons - living with ALS and how has it 
impacted family functioning and health?” 
Study Design  
 The qualitative study consisted of in-person, audio-recorded, in-depth, open-ended, 
phenomenological interviews. This qualitative study was designed in alignment with Husserl’s 




(1901; 1970) descriptive phenomenology. The research question guiding the study was: “What 
are the experiences of patients and their support persons living with ALS and how has it 
impacted family functioning and health?” It consisted of audio-recorded, in-depth, open-ended, 
semi-structured phenomenological interviews with PALS and their support person at a set time. 
The lead researcher conducted all interviews using a semi-structured interview guide (see 
Appendix E) to ensure all participants addressed similar topics and issues related to ALS and its 
impact on family functioning and BPS-S health. This study was approved by the East Carolina 
University and Medical Center Institutional Review Board (IRB) prior to participant recruitment 
(see Appendix A). 
Setting 
 Patient participants were recruited from the Jim “Catfish” Hunter ALS Clinic at Vidant 
Medical Center, a Southeastern academic medical center. This center is one of only four 
multidisciplinary ALS clinics in the state of North Carolina and was opened in September 2008. 
Currently there are 25 patients at this clinic, with approximately 30 unique patients each year. As 
this ALS Clinic is located in rural, eastern, North Carolina, some of the current patients are from 
the neighboring eastern states, with a few patients traveling more than two hours to attend the 
clinic. The ALS clinic at Vidant Medical Center employees several multidisciplinary employees 
including, a neurologist, a neuropsychologist, a speech therapist, a dietician, a physical therapist, 
an occupational therapist, a respiratory therapist, an ALS association representative, and a local 
equipment consultant who patients meet with as needed.  
The semi-structured interviews took place at the ALS clinic at Vidant Medical Center, via 
Web-Ex, and in participant’s homes. In addition to conducting in-person interviews with PALS 
and at least one support person, any family members or support persons who wished to 




participate, but were unable to be physically present, were given the option to utilize WebEx and 
participate from afar.    
In person interviews were recorded using handheld, digital voice recorders. At the close 
of the interviews, the lead researcher immediately uploaded the audio-recorded interviews to a 
secure Piratedrive. In the event that support persons wished to participate but were unable to 
participate in person, secure, encrypted technology, through the use of CISCO WebEx, an online 
videoconferencing application, was utilized to conduct confidential video and/or audio-based 
interviews. Information about potential confidentiality risks of utilizing this technology was 
included in the consent forms, which participants read and signed prior to participating in the 
interviews. Immediately following interviews that utilized CISCO WebEx, the lead researcher 
downloaded and saved the audio/video recordings to a secure Piratedrive.  
Participants 
 Participants consisted of a purposive sample of PALS and a member of their non-
professional support system (e.g., partner, adult child, neighbor, extended family member, 
parent, etc.). Participants were considered eligible for participation in the study if they meet the 
following inclusion criteria: (a) English-speaking; (b) aged 18 or older; (c) the PALS has a 
formal diagnosis of ALS, and (d) both a PALS and at least one primary support person agree to 
participate in the study. Patient participants identifyed the support persons for possible inclusion 
in the study.  
Exclusion criteria for this study included: (a) PALS’ positive screening for 
frontotemporal dementia or other types of dementia as determined by Vidant ALS Clinic staff, 
(b) support person’s cognitive impairment that would interfere with the ability to consent to 
participate, and (c) communication challenges that are unable to be resolved with technological 




assistance already in use by the participant. Upon meeting the study criteria, participants were 
asked to consent to the study which includes their completion of a demographics survey and 
participation in a one-time, audio-recorded, in-depth, open-ended, semi-structured interview. 
Contact information was collected by a triangulated researcher who is employed by Vidant 
Medical Center and was used by the research team to schedule interviews and for member 
checking purposes. This information was stored on a separate password protected file on the lead 
researcher’s Piratedrive.  As part of the consent process, the lead researcher or triangulated 
researcher explained to participants that they were not obligated to participate and that they could 
elect to discontinue enrollment at any time without consequence to the care received at the ALS 
clinic. It was also included in the informed consent that none of the information would become 
part of their electronic health record and it would be deidentified to protect their confidentiality. 
Throughout the qualitative study, participants were recruited, and interviews were 
conducted until thematic saturation was reached and no new themes emerged from participant 
interviews for both bulbar and limb onset groups (Glaser & Strauss, 1967). According to the 
literature, saturation depends on several factors, a large number of articles, book chapters and 
books suggest anywhere from five to 50 participants as adequate (Dworkin, 2012). In a study on 
sample size and saturation, Mason (2010) found that the most common sample sizes for 
phenomenological studies were 20 and 30 participants; however, Creswell (1998) suggested 
anywhere from five to 25 total interviews.  
Researcher Roles 
Lead Researcher 
In a phenomenological study, the researcher suspends knowledge in an attempt to 
understand a phenomenon on a deeper level and to elicit rich and descriptive data unique to the 




lived experiences (Merleau-Ponty, 1956).  Within the Husserlian phenomenological approach, 
epoche, or bracketing, is a process utilized in setting aside one’s own beliefs, feelings, and 
perceptions in order for the true, unbiased experiences of the phenomena to present themselves 
(Colaizzi, 1978; Streubert & Carpenter, 1999). Moustakas (1994), when focusing on Husserl’s 
concept of bracketing, argued that researchers might embrace this idea when beginning a project 
by describing their own experiences with the phenomenon and bracketing their views before 
collecting participant data.  
 To fully engage in epoche, or bracketing (Tufford & Newman, 2010), the lead researcher 
engaged in reflexivity, suspending any pre-conceived notions, thoughts, and feelings around the 
possible lived experiences of family members of a PALS. Epoche is a concept in which 
investigators set aside their experiences as much as possible in order to take a fresh perspective 
toward the phenomenon under investigation. When engaging in reflexivity, the researchers 
should position themselves within a qualitative study, meaning that the researcher conveys their 
background, how it informs their interpretation of the information in a study, and what they have 
to gain from the study (van Manan, 2014). This means that the researcher is conscious of the 
biases, values, and experiences that they brings to a qualitative study (Hammersley & Atkinson, 
1995). The reflexivity process in the current study included an ongoing reflexive journaling 
throughout the entirety of the dissertation process that assisted the lead researcher in identifying 
her beliefs, assumptions, and biases related to the dissertation topic (van Manan, 2014).  
Triangulated Researcher  
The triangulated researcher participated in the recruitment process and the data analysis 
process. Throughout the study the triangulated researcher assisted the lead researcher in these 
processes and triangulated the data as the lead researcher and the triangulated researcher 




compared their data analyses. This data analysis comparison allowed the lead researcher and 
triangulated researcher to challenge one another’s biases until agreements could be made about 
the findings and interpretations from the interviews. Any researchers, to include the lead 
researcher and any triangulated researchers, participating in data analysis prepared a bias 
statement of advance of participating in the data collection or analysis phases of the study. The 
lead researcher’s and triangulated researcher’s bias statements are included as an appendix (see 
Appendix G).  
Data Collection and Procedures 
 The following section will include the procedures that the lead researcher engaged in to 
recruit, enroll, and consent participants. The specific details of the data collection process will 
also be included. Finally, the section will include a description of the plan for data analysis.   
Recruitment, Enrollment, and Consent 
 Following approval from the university’s Institutional Review Board, a two-pronged 
recruitment procedure was implemented. Individuals who meet the eligibility criteria were 
contacted from the Jim “Catfish” Hunter ALS Clinic by a triangulated researcher. This 
triangulated researcher is also an employee of the Jim “Catfish” Hunter ALS clinic and contacted 
the PALS by phone to inform them of the possibility of participating in the study using a 
standard telephone script (see Appendix B). The script that the triangulated researcher used to 
contact potential participants asked PALS to provide contact information for the support 
person(s) they wished to participate in this study with them. If these PALS wished to participate 
and agreed to have their contact information shared, the triangulated researcher passed this 
information on to the lead researcher who then contacted them to schedule an interview.  




Recruitment also took place in-person at the ALS clinic. Once a month, the ALS clinic 
sees its patients. Once a patient is placed into an exam room, the same triangulated researcher 
entered the room and introduced the study to eligible PALS and any support persons in 
attendance. The study and consent process were explained to potential participants utilizing a 
recruitment script (see Appendix B). If the PALS expressed interest in participating, they were 
asked to identify a primary support person over the age of 18 who the patient identified as a 
member of their non-professional support system. If a primary support person was able to be 
identified who also met the study’s inclusion criteria, the lead researcher scheduled an interview 
with them. If the PALS’ primary support person was not onsite with the patient, the lead 
researcher attempted to contact that person with the PALS present and inquired to that person’s 
willingness to participate. If the researcher was unable to contact that person, the PALS 
participant was encouraged to notify the potential primary support person in advance that they 
would be receiving a phone call from one of the study researchers so they were aware of its 
relevance and that a call would be coming in from one of the study researchers. If the primary 
support person was not available to answer the phone, the researcher left a voice message using a 
telephone script (see appendix B) that included the lead researcher’s name, the name of the 
study, and a contact number that they could be reached at in response.  
Following the explanation of the study, the consenting researcher addressed any 
questions or concerns expressed by either the PALS or the primary support person. After the 
study had been explained to participants and they expressed interest in participating, the lead 
researcher scheduled interviews to take place at the Vidant ALS Clinic, in their homes or via 
Web-Ex. Once the PALS, support persons, and lead researcher were together for the interview, 
the informed consent documents were provided to the participants prior to the start of the 




interview, explaining that their participation was optional and that they were able to end their 
participation at any time with no consequences. Following the completion of the consent 
documents by both the PALS and all participating support persons, the participants were asked to 
complete the demographics survey. The interview began only after the consent documents and 
demographics survey were complete.   
Data Collection 
 The current study involved data collection from qualitative interviews. To ensure 
confidentiality, the researcher assigned pseudonyms in place of participants’ actual names to de-
identify the data collected. Pseudonyms were used in the transcripts and in any 
presentations/publications that result from this study. Pseudonyms were assigned to participants 
at the time of their enrollment unless they were able to provide one themselves. Pseudonyms 
were added to the participant’s contact information (i.e., phone number and email) and were 
stored in a password protected file on the lead researcher’s secure Piratedrive. Note: if during the 
interviews, the participants mentioned actual names of anyone, those names were changed to 
pseudonyms as well to protect their identity. However, only the pseudonyms of consenting 
members were stored along with their actual names and contact information in a pass protected 
document. A master list of all pseudonyms used were stored in a separate pass protected file on 
the study’s Pirate Drive as well. This master list helped the investigation team refrain from 
accidentally repeating a pseudonym during the transcription process.  
Demographic Information 
Demographic information was gathered from participants after the consent process. 
Information collected included age, sex, race/ethnicity, highest level of education, employment 
status, household income, relationship status, religious identification, approximate date of first 




symptoms, symptom onset type (limb or bulbar) and date of diagnosis. The demographic survey 
information was collected REDCap electronic data capture tools hosted at East Carolina 
University (Harris et al., 2009). REDCap (Research Electronic Data Capture) is a secure, web-
based application designed to support data capture for research studies (see Appendix D).  
In-depth, Open-ended, Semi-structured Interviews 
Prior to the start of the interview, participants were reminded of the study’s purpose, the 
consent forms they initially signed, and their right to discontinue participation at any time 
without question or consequence to care being received at the ALS clinic. The interview was 
conducted during a one-time, hour long session with all participants simultaneously and was 
guided by a series of semi-structured interview questions (see Appendix E).  Each interview 
began with the same grand tour question, “How do you believe ALS has impacted you and your 
support system?” The interview was digitally tape-recorded or recorded on WebEx and was 
uploaded immediately onto the study’s Piratedrive, and transcribed verbatim using NVIVO 
Transcription. As some PALS may not have the ability to verbally communicate, these 
participants were given the option to write, type, or speak their responses. In the event that the 
PALS chose to write or type their responses, the lead researcher clarified and verablized their 
answers out loud so that they would be audio-recorded. Any interviews digitally recorded using a 
hand held device were immediately erased once the researcher confirmed it had successfully 
uploaded onto Pirate Drive. All consent documents, demographic data, pseudonym, and contact 
information files were stored in the study’s assigned password-protected Piratedrive folder. This 
folder was only accessible to the researchers analyzing the data. It will be maintained for seven 
years by the faculty supervisor for this study in accordance with IRB regulations.   




 The lead researcher facilitated all interviews and utilized probing questions to encourage 
participants to expand upon on their answers to the grand question (Appendix E). Once the 
interview was complete, the lead researcher informed participants that they had the opportunity 
to verify their transcript and the results to help ensure the accuracy and trustworthiness of the 
findings (Lincoln & Guba, 1985). Participants who responded that they would like to participate 
in this part of the verification process, were provided with a copy of the transcripts by email and 
were asked to confirm that those results accurately reflected their own lived experiences. 
Participants who chose to participate were tracked on the same document that contains 
participant contact information and included which verification portions they chose to participate 
in, the transcripts, the results, or both. Those participants were asked to proof the transcripts and 
to add or change any information that they were not able to provide during the interview or that 
they thought of following the interview. Line numbers were added to each transcript for 
participants to refer to when offering added or edited text. Emailed transcripts were asked to be 
returned via email. Changes made to the transcripts by participants were added to the original 
transcripts and highlighted in yellow so that it was clear that the changes were added following 
the interview. Final transcripts were determined after all participants who wished to verify the 
results had either returned their copies or communicated verbally to the lead researcher that no 
changes were needed.   
Data Analysis 
 This study employed Colaizzi’s (1978) data analysis methodology for phenomenological 
studies. Colaizzi’s method was chosen for the current study as it provides researchers with clear, 
logical, and sequential steps, and increases the reliability and dependability of the obtained 
results (Wirihana et al., 2018). It differs from other methods of phenomenological data analysis 




as it provides participants the opportunity to validate the findings to ensure accuracy and 
credibility. Following Colaizzi’s method of analysis, the following steps were taken: (a) read the 
transcripts; (b) identify significant statements; (c) form meaning statements from the significant 
statements; (d) cluster themes from the meaning statements and form emerging themes; (e) 
create and exhaustive description; and (f) validate the findings. Reflexive journals were used 
throughout the analysis process to allow the researchers to continuously critically examine their 
roles in the research process and how their biases may affect the data (Orange, 2016). This 
reflexivity enhanced several areas of the study to include data collection, data analysis and 
ethics. 
Reading the Transcript 
In following the first steps of Colaizzi’s (1978) analysis method, the researchers read and 
re-read each transcript to obtain a global sense of the phenomenon prior to identifying themes 
from the recorded interviews. The researchers bracketed ideas and potential biases that came 
from these readings in their reflexive journals.  
Identifying Significant Statements 
The second step consisted of extracting phrases or sentences (i.e., significant statements) 
directly from each transcript that pertain to the phenomenon being studied. To ensure that 
researchers participating in the data analysis part of the study were interpreting the data 
similarly, researchers coded the first transcript individually and then met to address any 
discrepancies. If an agreement could not be reached, a member of the researcher team served as a 
peer debriefer who was brought in to resolve any disagreements regarding the interpretations of 
the interview. Disagreements between the researchers were documented in the audit trail to 
include when the disagreement took place and what was done to resolve it. The peer debriefer 




was only consulted when the lead researcher and triangulated researcher had attempted to reach 
an agreement but were unable to do so on their own.  
Forming Meaning Statements 
In the third step, researchers developed meaning statements from the significant 
statements (Colaizzi, 1978). They established fidelity to the participant’s experiences by 
ensuring that the statements illuminated the meanings hidden within the context of the transcripts 
(Colaizzi, 1978). These meaning statements were formulated by using “creative insight” to 
interpret the meaning of the participants’ statements.  
Clustering Themes 
The fourth step consisted of significant statements and their formulated meanings being 
grouped into themes and then into thematic clusters (Colaizzi, 1978). Themes and thematic 
clusters were validated against the original transcripts to ensure that the interpretation of the data 
could be traced successfully back to the raw data (i.e., participant interview responses). During 
this process, investigators tracked thematic clusters back to themes, meaning statements, and 
significant statements. A spreadsheet containing the line number(s) associated with each 
significant statement, among with its corresponding meaning statement, theme, and thematic 
cluster was maintained by the lead researcher to ensure interpretations were trustworthy and 
could be accounted for in the analysis. 
Creating an Exhaustive Description 
In the fifth step, all findings were integrated into an exhaustive description pertaining to 
the phenomenon under investigation. This was accomplished by the researchers involved in the 
analysis re-examining the transcripts, thematic clusters, and themes many times to study any 
contradictions or different perspectives and to ensure the interpretation of the exhaustive 




description is thorough. This exhaustive description was written to capture all of the themes 
listed from participant’s transcripts in the prior steps and included a context that unified them 
into one cohesive summary of the participants’ lived experiences. 
Validating the Findings 
To confirm that the exhaustive description and fundamental structure of the phenomenon 
accurately depicts the participants’ experiences of the phenomenon, the participants were asked 
to confirm their validity (Colaizzi, 1978). This step is similar to member checking, defined by 
Lincoln and Guba (1985) as the most crucial technique for establishing credibility, whereby data, 
interpretations, and conclusions are tested with members of the stakeholding groups from whom 
the data were originally collected. In this step, the lead researcher reached out to participants 
who expressed interest in validating the statement of identification and exhaustive description by 
telephone or email. The lead researcher asked whether or not the exhaustive description 
adequately represented the participant’s experiences. If contacted by email, participant’s were 
asked to return their responses by email. The responses from this step were also included in the 
study findings (Colaizzi, 1978). 
Verification Strategies 
 This study followed Lincoln and Guba’s (1985) recommendations for trustworthiness to 
establish credibility, transferability, dependability, and confirmability of its findings. Credibility 
was established through the use of triangulation, peer debriefing, and member checking. Thick 
descriptions were used to ensure transferability. Finally, dependability was ensured through the 
use of an inquiry audit and confirmability was ensured through the use of an audit trail, including 
a reflexive journal that was used to record ideas about potential themes and to check biases. 
These processes are further explained in the following paragraphs.  





Credibility is defined by Lincoln and Guba (1985) as the confidence in the “truth” of the 
findings, which can be established through activities that make it more likely that credible 
findings and interpretations will be produced and through activities that provide for the direct 
testing of findings. Lincoln and Guba suggested four modes of triangulation, to improve the 
probability that findings and interpretations will be found credible. One of these four modes, the 
use of different investigators, ensures that one team member is kept more or less honest by 
additional team members. In the current study, credibility was ensured through triangulation, 
peer debriefing, and member checking.  
Triangulation was achieved by interviewing multiple participants and by including a 
triangulated researcher in the data analysis process. The triangulated researcher participated at an 
equal level to the lead researcher in the coding process. Researchers independently read through 
and coded each interview transcript prior to joining together to discuss and resolve any 
differences in coding. If the lead researcher and triangulated researcher were unable to resolve 
disagreements, a peer debriefer was consulted. 
 Peer debriefing was also used to establish credibility. Peer debriefing consisted of a peer 
researcher reviewing the lead and triangulated researchers’ analyses. This was done in the hopes 
of resolving discrepancies and confirming that the interpretation and analysis process was 
correctly being followed and was absent from researcher biases. The peer debriefer was involved 
at the end of each data analysis phase, when the lead researcher and triangulated researcher were 
unable to resolve disagreements on their own. 
 Finally, member checking, wherein the data, interpretations, and conclusions are tested 
with members of the group from whom the data was collected, was used as a crucial technique 




for establishing credibility (Lincoln & Guba, 1985). Member checking occurred in this study 
following the transcription of interviews and following the data analysis as it exists as the final 
step of Colaizzi’s (1978) data analysis. The lead researcher reached out to participants who 
agreed to participate in the member checking process by telephone or email to ask whether or not 
the transcriptions and exhaustive description adequately represented the participant’s 
experiences. Again, the participants who agreed to participate in member checking were tracked 
on the same document as participant contact information and included if they chose to participate 
in verification of the transcriptions, final results, or both.  
Transferability 
Transferability is the extent to which the findings can be applied to other cases beyond 
the current study (Lincoln & Guba, 1985). Thick descriptions are thoroughly detailed 
presentations of the findings that enable a reader to determine whether or not the findings are 
transferable to other cases. The lead researcher used thick descriptions in the writing of the 
results by describing the findings in great detail, using participants’ words, phrasing, and direct 
quotes.  
Dependability 
Dependabiliy shows that the findings are consistent and can be repeated (Lincoln & 
Guba, 1985). In the current study, dependability was established through the use of an inquiry 
audit, in which a researcher who was not involved in the data collection and anlaysis processes 
examined these processes and the results of the study. An inquiry audit comfirmed the accuracy 
of the findings and ensured that the findings are supported by the data. A member of the research 
team who was not involved in the data collection or data analysis portions of the current study 
completed the inquiry audit.  





According to Lincoln and Guba (1985) confirmability is the extent to which the findings 
of a study are shaped by the respondents and not by researcher bias, motivation or interest. Audit 
trails were used to ensure confirmability in the current study (Lincoln & Guba, 1985). The audit 
trail consisted of a research log and the lead researcher’s reflexive journal. The audit trail 
materials were electronic documents that were stored in the study’s Piratedrive. The research log 
included a continuous documentation of the entire research process to include any decisions 
made regarding the protocol and any contacts and communication with others involved in 
decisions regarding this study. The reflexive journals consisted of the lead researcher and 
triangulated researcher participating in continuous journaling throughout the research process to 
identify their own experiences and biases related to the study. This included the lead researcher’s 
thoughts related to the understanding of the participants, insights and biases related to the 
participants and data, and an on-going process of bracketing those biases by setting aside those 
experiences and thoughts as much as possible to take a fresh perspective of the phenomenon 
under investigation (Moustakas, 1994).  Several entries from the reflexive journal are included as 
an appendix (see Appendix H). 
Ethical Considerations 
 The design of this study included several safeguards to ensure the well-being of the 
participants and be in adherence with the ethical guidelines of the American Association for 
Marriage and Family Therapy (AAMFT, 2015) and East Carolina University’s, University and 
Medical Center Institutional Review Board. The current study involved minimal risk to 
participants including time and energy spent completing the surveys and participating in the 
interviews. Any potential discomfort or emotions that arose from the interview questions related 




to the ALS experience were validated by the lead researcher during the interview and 
community-based resources were provided for additional support if needed (see Appendix F). 
These minimal risks were accounted for with appropriate safeguards intended to reduce them.  
 Participants were informed that they were free to pause their participation in interviews 
or that they could withdraw from participation entirely, at any time during the study if they felt 
overwhelmed and unable to continue. Safeguards implemented during the recruitment, 
enrollment, and data collection processes included the de-identification of participants using 
pseudonyms and password protected files stored on the University’s IRB approved Pirate Drive 
server. Lastly, this researcher commited to following the study through to dissemination of its 
results. It is important to honor the participants’ time and contributions by having and following 
through with a dissemination plan. This plan may include professional presentations and 
publications and will include all dissertation committee members unless they opt out of each 
opportunity as it is presented.  
Summary 
 This qualitative study was designed to investigate the impacts of ALS on family 
functioning and members’ BPS-S health. Utilizing qualitative methods allowed for further 
exploration of how the type of symptom onset, either bulbar or limb, and BPS-S components 
may impact the family functioning and health of PALS and their participating support persons. 
The results of this study will inform future ALS research studies, as well as help craft policy and 
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CHAPTER 5: THE EXPERIENCE OF ALS THROUGH A SYSTEMIC LENS: A 
PHENOMENOLOGICAL STUDY  
 There are approximately three to five new cases per 100,000 people diagnosed with 
Amyotrophic Lateral Sclerosis (ALS) each year in Europe and the United States (Brown & Al-
Chalabi, 2017).  ALS is a progressive, neurodegenerative disease, marked by muscle weakness, 
swallowing difficulties, slow or slurred speech, respiratory failure and eventual death (Edge et 
al., 2019). This non-curative, progressive, neurodegenerative disease most commonly begins 
with symptoms and weakness in the limbs (limb onset), with about one third of the cases 
presenting with difficulty chewing, speaking, or swallowing (bulbar onset; van Es et al., 2017). 
However, as this disease leads to a loss of abilities, the support system steps into a critical role of 
assisting their loved one with managing its impacts (Krivikas, Shockley, & Mitsumoto, 1997; 
Mockford et al., 2006; Rabkin et al., 2009).    
 Caregivers spend an average of 11 hours every day helping patients maintain a good 
quality of life (Krivikas et al., 1997). Due to the essential caregiving needs of patients with ALS, 
family members reported negative health impacts that are physical (Hwang, Weng, Tsai, & 
Chang, 2014; Tramonti et al., 2015), emotional (Burke et al., 2018; Pagnini et al., 2012; 
Tremolizzo et al., 2016), social (Galvin et al., 2016; Sicilliano et al., 2017), and spiritual (Roach, 
Averill, Segerstrom, & Kasarskis, 2009) in nature. However, each of these studies has focused 
on the biological, psychological, social and spiritual (BPS-S) domains individually versus 
interactively, and without considering how the family’s style of functioning impacts it.   
The biological, psychological, social, and spiritual (BPS-S) framework (Engel, 1977; 
1980; Wright, Watson & Bell, 1996) helps researchers and clinicians make sense of the 
comprehensive implications of illness by viewing health through a more systemic lens. Its intent 




is to encourage researchers and clinicians to assess, understand, and treat systems as a whole 
versus only focusing on one individual or health domain. Beavers systems model of family 
functioning (Beavers, 1981) identified two family types that emerge in response to stressors like 
a terminal illness. Centripetal families respond by pulling inward and huddling together; whereas 
centrifugal families psychologically, socially, and physically create distance (Kelsey-Smith & 
Beavers, 1981). Thus far, the ALS research on families focuses on individual family members’ 
experiences. For example, spouses reported experiencing fear, lack of understanding (Ozanne & 
Graneheim, 2017), and even isolation (Ozanne, Graneheim, & Strang, 2015) in their caregiving 
roles. What is unknown is how caregivers’ BPS-S health is impacted by the systemic family 
functioning within the family. Exploring the impact of ALS, utilizing a systemic measure of 
family functioning and the BPS-S components of health by using multi-person data, fills a gap in 
the science and literature by looking at health research and caregiving resources more 
comprehensively. 
To gain a more thorough understanding of the experiences of living with ALS and the 
impacts of the disease on the patients with ALS’ (PALS) and their family members’ BPS-S 
health and family functioning, a descriptive phenomenological design (Husserl, 1970) was 
utilized in the current study. A phenomenological design was chosen to explore the lived 
experiences of PALS and their support persons (SPs) and further the research on how family 
functioning is impacted, as well as family members’ BPS-S health. The following section 
provides a detailed description of the phenomenological method used in this study.  
Method  
Descriptive phenomenology, as understood by Husserl (1970) focuses on the 
commonalities of lived experiences, concepts, or phenomena amongst several individuals. Its 




basic purpose is to collect individual narratives and analyze them to capture the universal essence 
among their lived experiences. The following research question was selected for the current 
study, “What are the experiences of patients - and their identified primary support persons - 
living with ALS and how has it impacted family functioning and health?” Approval was obtained 
from the East Carolina University and Medical Center Institutional Review Board (IRB) for this 
qualitative study (see Appendix A). 
Participants 
 Purposive sampling was used to enroll participants from a Southeastern academic 
medical center ALS clinic. The ALS Clinic serves approximately 30 unique patients each year. 
PALS were considered eligible for participation in the study if they met the following inclusion 
criteria: (a) English-speaking; (b) aged 18 or older; (C) the PALS has a formal diagnosis of ALS, 
and (d) both a PALS and at least one primary SP agreed to participate in the study. Patient 
participants identified SPs for possible inclusion in the study. SPs were considered eligible for 
participation based on the following inclusion criteria: (a) English-speaking; (b) aged 18 or 
older; (c) is a SP of a PALS who has a formal diagnosis of ALS; and (d) both a PALS and at 
least one primary SP agreed to participate in the study.  
 Exclusion criteria for PALS included: (a) PALS’ positive screening for frontotemporal 
dementia or other types of dementia as determined by ALS Clinic staff; and (b) communication 
challenges unable to be resolved with technological assistance already in use by the patient 
participant. In addition, the one exclusion criterion for SPs involved any cognitive impairment 
that would interfere with the SP’s ability to consent to participate. It is important to note that 
participant recruitment and data collection was completed prior to the start of COVID-19 
pandemic in the United States. Investigators believe given the nature of this study, the pandemic 




would have altered participant responses related to family functioning and social distancing 
requirements.  
Following the enrollment of participants based on inclusion and exclusion criteria, the 
lead researcher then conducted the audio-recorded, in-depth, open-ended, semi-structured 
interviews until saturation of themes was reached. Saturation of themes was determined to have 
occurred when the analysis of additional data from participant interviews yielded no new themes 
(Glaser & Strauss, 1967). Out of nine eligible PALS, eight participated in the study. One eligible 
patient was not enrolled because the lead researcher was unable to contact the individual to 
schedule an interview. All nine PALS had at least one SP participate in the interview, while one 
PALS chose to have two SPs participate. Participants in the study included five male PALS, 
aged 59 to 76, and three female PALS, aged 43, 48 and 79, with two male SPs, aged 44 and 49, 
and seven female SPs, aged 49 to 75 (see Table 1 for participant demographics). Of the included 
PALS, one had a known diagnosis of bulbar onset ALS, five had a known diagnosis of limb 
onset ALS, and two shared that they did not know their exact onset of ALS.  
Data Collection and Procedures 
 Eligible patients were recruited using a two-pronged recruitment process. A recruitment 
script was used in either approach to ensure all eligible participants heard the same information. 
The first recruitment strategy took place over the phone. A triangulated researcher, who 
participates as a secondary researcher in a study in order to validate findings, (Lincoln & Guba, 
1985) employed within the clinic, would screen for PALS who met the inclusion criteria and 
contact them to determine if they were interested in enrolling in the study. Interested PALS were 
asked to identify a SP who might also be interested in participating. This potential SP participant 




was contacted by the lead researcher to explain the study’s intent and if willing to participate, 
schedule the interview.  
The second recruitment strategy took place in-person at the ALS Clinic. Once a month 
the ALS clinic devotes a full day to seeing new and returning PALS. The study’s triangulated 
researcher would screen PALS for eligibility and any SPs in attendance. If they agreed to 
participate, their contact information was shared with the lead researcher who contacted them at 
a later date to schedule an interview.  
Prior to beginning the in-depth interviews, PALS and all participating SPs first completed 
the consent document and demographics survey. Of the eight interviews conducted, one took 
place via video teleconference, two were conducted at the ALS Clinic, and five were conducted 
in patient’s homes. This strategy was done to help accommodate the varied physical and 
communication abilities and accessibility needs of each participant.  
 At the beginning of each interview, the lead researcher invited participants to choose 
pseudo names for themselves to de-identify the collected data and protect their confidentiality. If 
the participants did not wish to select their own pseudo names, the lead researcher chose for 
them. Following the interviews, the interviews were transcribed verbatim using NVivo 
qualitative data analysis software (QSR International Pty Ltd. Version 12, 2018). Once the 
interviews were transcribed, participants who expressed interest in member checking 
opportunities were emailed their transcripts and asked to add to or clarify any responses so as to 
better reflect their experiences. Of the seven participant groups who expressed interest in this 
member checking process, one participant shared additions to be added to the interview 
transcript. These were added to the original transcripts and were highlighted in yellow to identify 
them as additions. The lead researcher, with the help of a triangulated researcher and a peer 




debriefer, coded the transcripts until thematic saturation was reached. The peer debriefer is a 
noninvolved professional with whom the researchers discuss and resolve difficult processes 
throughout the study (Lincoln & Guba, 1985). Although all interviews began with the same 
grand tour question: “How do you believe ALS has impacted you and your support system?” the 
lead researcher used an interview guide to provide a semi-structured interview experience in 
which all participants addressed similar topics related to their BPS-S experiences with ALS (See 
Appendix E for Interview Guide). 
Data Analysis  
Following each interview, the lead researcher and co-researcher applied Colaizzi’s (1978) 
phenomenological data analysis methodology to the data. The clear, sequential steps outlined in 
Colaizzi’s method increases the reliability and dependability of the results (Wirihana et al., 
2018). In following Colaizzi’s data analysis method, the following steps were taken: (a) read the 
transcripts; (b) identify significant statements; (c) form meaning statements from the significant 
statements; (d) cluster themes and identify emergent themes; (e) create an exhaustive description, 
and (g) validate the findings. It was determined to merge the exhaustive description with 
Colaizzi’s step of forming a statement of identification in this study based on previous literature 
(Kristianingrum, Wiarsih, & Nursasi, 2018; Yambo et al., 2016; Yodchai, Hutchinson, & 
Oumtanee, 2018).  
The first step consisted of identifying and coding significant statements. The lead 
researcher and a triangulated researcher both worked through all transcripts and identified an 
initial 304 significant statements, resolving any disagreements as they were presented. Duplicate 
significant statements were removed, resulting in a total of 278 significant statements. The 
researchers then formed meaning statements from the significant statements. The triangulated 




researcher participated in 50% of meaning making statements from the significant statements 
resulting in 278 meaning statements, with 98% inter-rater agreement. The researchers discussed 
any disagreements until agreements were reached. Finally, 112 duplicate meaning statements 
were removed, resulting in 166 final meaning statements at 100% inter-rater agreement.  
The lead researcher and triangulated researcher categorized meaning statements by 
thematic clusters, resulting in 15 thematic clusters with 97.5% inter-rater agreement. The 15 
thematic clusters were then reduced to 5 emergent themes (Table 2). As the two researchers were 
unable to decide on the inclusion of a fifth theme, impacts on spirituality, a peer debriefer was 
consulted to help reach a decision. Selected examples of narratives and emergent theme 
formation are included in Table 3.  Lastly, an exhaustive description was developed to capture all 
emergent themes in one comprehensive narrative.  
Following the creating of the statement of identification, the results were validated using 
a second level of member checking. Participants who wished to participate in the second level of 
member checking were emailed the exhaustive description and final statement of identification 
developed from the findings. They were requested to provide feedback of either agreement or 
disagreement with the summative results. Out of the 15 participants who wished to participate in 
the member checking process, 7 confirmed that the exhaustive description appropriately reflected 
their lived experience. The remaining participants could not be reached for confirmation. 
Verification Process  
Since qualitative studies determine trustworthiness of its findings differently than 
quantitative, Lincoln and Guba’s (1985) recommendations for increasing confidence in 
qualitative results was applied. Credibility (i.e., internal validity) was established through the 
utilization of a triangulated research, peer debriefer, and use of a two-step member checking 




strategy. Transferability (i.e., external validity) was established through the utilization of thick 
descriptions. This involved writing of the results using participants’ exact words, phrasing, and 
direct quotes so consumers of the study could determine its applicability to their context. 
Dependability (i.e., reliability) was monitored through the use of an inquiry audit. Each member 
of the research team who was not involved in the data collection and analysis processes 
examined these processes and the results of the study to ensure all findings were grounded in the 
actual participant data and all methods were followed appropriately. Audit trails were used to 
ensure confirmability (i.e., objectivity) in the current study and consisted of a research log and 
the lead researcher’s reflexive journal stored in a pass protected file saved to a secured and 
encrypted server. The reflexive journals were utilized by the researchers to engage in the 
bracketing of biases. The researchers engaged in bracketing throughout the analysis process to 
ensure that the findings were true to participant experiences and were not altered by researcher 
bias. The research log included a continuous documentation of the entire research process and 
the reflexive journals consisted of the lead researcher and triangulated researcher participating in 
continuous journaling throughout the research process to identify their own experiences and 
biases related to the study.  
Findings 
 Eight interviews were completed with 17 participants, eight PALS and nine SPs. 
Participant groups is used throughout to describe the groupings of participants in interviews with 
the PALS and at least one SP. Interviews with the seven dyadic units and one triad yielded 278 
final significant statements which were reduced to 166 formulated meaning statements. In 
response to the original research question, “What are the experiences of patients - and their 
identified primary support persons - living with ALS and how has it impacted family functioning 




and health?” five themes emerged when meaning statements were collapsed into thematic 
clusters. The themes capture a common, recurring pattern in the data that are organized around a 
central concept, while the thematic clusters exist within a theme, sharing the central concept but 
focusing on one specific element of the theme (DeSantis, & Ugarriza, 2000). The five themes are 
as follows: (a) dynamic transformation of relational systems; (b) biological changes and well-
being; (c) emotional processes; (d) spiritual adaptations and anchors; and (e) healthcare system 
interactions. These themes were initially identified by the lead researcher and triangulated 
researcher after analyzing the data. The study’s peer debriefer assisted in combining and naming 
of the five final themes after reviewing the actual data and discussing it with the research team. 
The following section provides an in-depth description of each theme, including participants’ 
quotes. This section concludes with an exhaustive description that captures the lived experiences 
of PALS and their SPs.  
Theme 1: Dynamic Transformations of Relational Systems 
 All participant groups reported changes in their relational systems with six participant 
groups sharing that ALS has brought them closer together and two participant groups sharing 
that their ALS experience has not pulled them apart, but it has not necessarily brought them 
closer together either. Three thematic clusters emerged within this theme that reflect how 
dynamic relationships are altered in response to the intrusion of ALS. These three clusters 
include social persons becoming closer, social persons pulling away, and challenges with social 
interactions and support.  
Thematic Cluster 1a: Support Persons Becoming Closer 
Participants expressed how relationships with family members and friends had grown 
emotionally closer or improved since living with ALS. When discussing how ALS brought 




relationships closer together, SP Sharron reported, “I think it's brought us closer. I feel like we're 
more. We've grown closer almost because we've had to.” Emotional closeness seemed to be a 
binding force that strengthened the families. PALS Sarah said, “It's brought us closer…More of a 
stronger heart bond and not so much as a physical one.” The impact of ALS not only brought 
already close members together, but also extended emotionally distant members the opportunity 
to heal longstanding wounds. SP Kathy shared, “For 20 years, she [PALS] didn't speak with her 
[daughter]. So, this is sort of like, you know mom has ALS, we've got to go see her. So, it 
opened up the love line again.  Everybody came.” 
In addition to family members and how closeness intensified, participants noted the 
positive impact friends had as well.  SP Rosie said, “We have a lot of friends and they visit, and 
they've gone through the part where he could speak some. Then he couldn't speak. But they still 
come and it's good to have them visit.” 
Thematic Cluster 1b: Support Persons Pulling Away 
 In addition to ALS having brought the family and other SPs closer together, participants 
also experienced friends and some family members grew distant. SP Sharron observed, “A lot of 
his friends don’t come around and stuff anymore. And um, he doesn’t get out much, you know, 
to go see them.” Understanding why this was happening was attributed to very different causes. 
SP Rosie explained that the physical effects of losing speech was a notable cause for changes in 
their social network. She said, “Some [friends] that they'll visit with me and just speak to him 
and leave because they know he can't talk. In fact, he has a brother that didn't come from the 
longest time.” However, others observed that family members who struggled with the diagnosis 
itself pulled away much sooner. SP Ruby shared… 




I still don't think he's [my son] totally accepted that he's, his father has ALS. We have a 
walk every year and the first couple of years he didn't come at all. He did come twice, 
and he says, "I'm not coming anymore", then I thought, you know, that to me is just 
telling me something. It just it really upsets me because everybody that has got ALS, 
their family's there. I have more friends come than I have family. 
PALS Frank expanded on this and the hopefulness that he believes is at the root of his adult 
child’s distancing behavior. He explained, “My daughter. I don't think she really understands a 
lot about me. I mean, she thinks I'm to get rid of this [feeding tube]. I don't think I'll ever get rid 
of this. 
Thematic Cluster 1c: Challenges with Social Interactions and Support 
 In addition to observations of family and members of the support system being brought 
closer together or apart after an ALS diagnosis, participants discussed challenges when 
attempting to increase social interactions and support. Challenges that inevitably lead to feelings 
of social isolation. SP Tonya explained that many challenges with socialization begin with 
identifying a location that will meet their needs. She said, “We have to plan any trip outside our 
home to ensure our destination is accessible and [that we] know where an accessible bathroom 
is.” PALS Frank explained, “It's hard for people to understand what I need to get in and out of 
the car and up the steps.” They also noted how hard it is to move about in crowds and navigate 
physical spaces to socialize with others. For SP participants even leaving the PALS alone to 
socialize seemed unrealistic. SP Daniel shared, “I want to go out sometimes, you know, like go 
to town for a couple hours, but I don't feel good going when I get there because …there's nobody 
here [with her].”    
 




Theme 2: Biological Changes and Well-being  
 Both PALS and SPs shared how living with ALS had impacted them biologically. 
Participants spoke about how they have experienced the progression of ALS symptoms and 
specifically the challenges associated with changes in communication. Additional biological 
changes included general changes in physical well-being to include fatigue, aches and pains, lack 
of exercise, and even difficulty concentrating. Thematic clusters within this theme include: (a) 
participants’ reactions to the slower progression of symptoms, (b) communication challenges that 
result as symptoms progress, and (c) general biological and physical challenges.  
Thematic Cluster 2a: Responses to Slower Progression 
 Several participants shared experiences with slower symptom progression. SP Tanya 
spoke about the unpredictable progression of her husband’s ALS and the gratitude she had for 
more time with him. She shared… 
When he was diagnosed his doctor told him he had about two years to live. That was 
seven years ago so we’re very fortunate his ALS progresses slowly...this allowed us to be 
more prepared for the day to day and the future. 
Others noted that the ALS symptom onset type (i.e., bulbar or limb) made a difference in their 
physical adjustment to ALS, preferring limb over bulbar onset. SP Kathy shared, “[PALS Sue] 
feels like this [limb onset] gives her a longer life by starting in her legs.” Bulbar onset appeared 
to be the ALS pathway that was more disruptive and challenging to participant groups.  
Thematic Cluster 2b: Communication Challenges 
 Distinct from the physical challenges of bulbar onset, were the actual communication 
challenges experienced as symptoms progressed. SP Linda explained what it has been like for 
her husband to no longer have the ability to communicate verbally. She shared, “The 




communication thing, it just shuts you off.” PALS Jon, who communicates with an electronic 
device shared, “I am used to talking as a former teacher and principal. I cannot talk to my dear 
wife or anyone else.” Finally, SP Claire spoke of the challenges they face with the PALS’ 
inability to communicate, “You don't know what's going on and we can't help him and he's trying 
to tell us. You don't know what to do and I feel so sorry for him because he's trying to tell you.” 
Thematic Cluster 2c: General Physical Challenges 
 In addition to experiencing physical challenges related to symptom progression and 
communication difficulties, participants also expressed challenges with their general physical 
well-being in addition to the physical progression of ALS. PALS Frank said, “My back hurts so 
much sometimes I just have to sit. Because I feel like I'm gonna be so weak in the next minute 
that I'm gonna fall. PALS Jon explained for his wife, “It is hard on Linda as it fatigues her. She 
has to pick up the load I can no longer carry.” Furthermore, SP Rosie shared how her caregiving 
responsibilities had impacted her biological well-being, “I’m tired. Having the nurses is a 
blessing through the day. It’s kind of rough to do nights and days, so I try to do my stuff and rest 
a little bit and I'm still not ready for the nighttime.” 
Theme 3: Emotional Processes 
 Throughout the interviews, participant groups expressed a variety of feelings related to 
their journeys with ALS. Participants’ responses included denial about having ALS as well as 
anger and frustration over the continuous progression of symptoms, subsequent changes in 
ability, and unrelenting adaptations to communication challenges. Participants also shared 
moments of depression and other difficult emotional processes related to the diagnosis period 
with all reaching a place of acceptance of the illness. Thematic clusters that emerged in this 




theme included feelings of (a) denial, (b) anger and frustration, (c) depression and other 
emotional difficulties, and (d) acceptance of living with ALS.  
Thematic Cluster 3a: Denial 
In the beginning stages of living with and adjusting to a diagnosis of ALS, participants 
shared feelings of denial about the diagnosis or about decreasing biological functioning and 
abilities.  PALS Lisa shared that she was not convinced of her shocking diagnosis when she 
stated, “That’s one of the reasons I haven’t accepted the diagnosis. I know something’s wrong, 
but other than my speech, I have the justification for everything except my speech.” Other 
participants did not entirely deny the diagnosis but were in greater denial over the PALS’ 
increasing lack of ability. PALS Donald said, “I get frustrated a lot. I have to sit down and think 
about it, what I used to do and what I can’t do,” while PALS Frank explained his process of 
coming to terms with his limitations, “Some days I can get up and get in this [walker] and walk 
around and go outside and do that. But then some days I depend too much on the cart and I’ll sit 
there, and I get comfortable.” Just as participants shared periods of denial throughout their 
journey with ALS, they frequently spoke about their anger and frustration as well. 
Thematic Cluster 3b: Anger and Frustration 
 Anger and frustration seemed to be commonly experienced among participants. These 
experiences were more pronounced with the progression of symptoms as challenges could no 
longer be ignored. Participants expressed feelings of anger in response to changes in biological 
functioning, SP Rosie said, “Well, I want to be angry at times. And, I think he (PALS Ronald) 
does too.” Interestingly, expressions of frustration were more tied to relational issues such as 
lack of recall related to caregiving needs or PALS’ inability to communicate what is needed. 
PALS Frank explained, “It’s frustrating for her [his wife and SP] to remember everything [I 




need],” SP Claire shared, “It can be really frustrating when I don't know what he wants, and he 
can't communicate that with me.” Several other participants used words other than anger to 
express their mood state. For example, SP Daniel explained, “Well, I ain’t angry. It just frustrates 
me.”  
Thematic Cluster 3c: Depression and Emotional Processes 
As participant groups continued to explain their experiences of living with ALS, their 
shared experiences with denial, anger, and frustration often then turned into conversations about 
depression and other emotional difficulties. SP Linda spoke openly about her and her husband’s 
depression, stating, “He was terribly, he was depressed. I was depressed.” Observations of 
depression noted that it appeared to worsen as ALS progressed. PALS Sue explained that “It’s 
not easy as it gets worse.” While resources aimed at providing support to ALS patients and 
caregivers are beneficial, SP Sharron shared how that can also be very depressing. She shared, 
“very depressing because everyday somebody is diagnosed, and everyday people are losing 
somebody…so it’s hard to read about that.” While depression and other difficult emotions were 
identified throughout the ALS journey, several participants also expressed acceptance of living 
with ALS. 
Thematic Cluster 3d: Acceptance 
 All participants expressed feelings of acceptance over living with ALS.  They noted how 
it brought out their more positive characteristics and lead to their ability to make meaning out of 
it. PALS Frank shared how he grew to accept living with ALS. He noted, “I guess I'm getting 
used to it.  I'm probably a strong-willed type person. I don't let things bother me that much. I try 
and take it in and then just say, that's it. Nothing I can do.”  PALS Sarah shared similar 
sentiments, “So it's just accepting the journey I have, and I have a purpose.” The identity of 




being a caregiver was not something that SPs thought they would hold, until ALS was diagnosed 
in the PALS. SP Linda shared how she learned to cope with the disease’s progression, make 
adjustments, and manage the disappointments that came with its harsh reality. She shared…   
You learn to cope with the changes. And you adapt and you get through with that and so 
your life just kind of well, it's kind of a new world. But you, you know, you make the 
adjustments and you just go on and you kind of try to get through the disappointments. 
Things that you had planned to do, you'd hope to do, aren't going to happen now. 
Theme 4: Impacts on Spirituality  
 While purpose was noted within the aforementioned thematic cluster of acceptance, it 
also tied into how participants made sense of their experiences with ALS.  Some saw it as their 
way to make meaning out a devastating illness. With regard to religious affiliation, most 
participants identified as Christians, except for one PALS who did not identify as a religious or 
spiritual person. When discussing how their spirituality or faith had been impacted throughout 
their journey with ALS, two thematic clusters emerged to include, participants faith having been 
maintained and their faith having been questioned.   
Thematic Cluster 4a: Faith Maintained 
 For some participants, living with ALS had either no impact on their faith or had made 
their faith stronger. When explaining the impacts ALS had on spirituality, PALS Jon shared, “I 
have a strong sense of another life beyond this one. This ALS has made that more real to me and 
I am at peace.” PALS Sue explained why her faith and relationship with God had gotten better, 
“Because I’m living proof of what happened, the bad and ugly that happened to me in two years. 
But this [situation] is the best.” SP Kathy further expressed how her faith has given her strength 
as a caregiver, “So here's my thing, when I pray, which I pray a lot, God talks to me and He says, 




‘Kathy, you can do this. It's only for a moment.’” Although several PALS and SP participants 
explained that their faith had increased or had given them strength, others expressed that they 
had struggled with their faith since living with ALS.  
Thematic Cluster 4b: Faith Questioned 
 Participants shared that living with ALS had resulted in strains on their faith. SP Rosie 
explained that the inability to physically attend church had been difficult for them and their faith, 
“I don't know if you're church going people but when you, you know, you can believe and you 
can be a Christian, but it really takes being at the church, being with people to get fulfilled.” SP 
Linda shared her own struggle with her faith, “It's just kind of hard to understand how things 
work out the way they do. Trying to find peace has been one of my seemingly things, one of 
those things that I just can't quite get.” However, PALS Bryan found that time alleviated some of 
the doubt, “At first our faith was in doubt. However, with time we have come to terms with 
having an uncertain future and learned to cherish every minute together.”  
Theme 5: Healthcare System Interactions  
 Due to the nature of ALS, all participants reported that a part of their experience of living 
with ALS included being seen routinely in the healthcare system, resulting in this fifth emergent 
theme. Visits included time spent in primary care offices, specialists’ offices, assisted care 
facilities, and ALS clinics. Participants expressed pleasure with medical care received at the ALS 
clinics, they shared that additional support, knowledge, and guidance around certain issues 
would have helped more with their ALS experience. Thematic clusters within this theme include 
additional education for health care providers, the need for additional support from medical 
providers, and the appreciation of ALS clinics.  
 




Thematic Cluster 5a: Additional Education for Healthcare Providers 
Participants explained that they often had interactions with medical professionals who 
were not familiar with ALS. PALS Sarah explained, “A lot of just people who don’t specifically 
work closely with ALS know it’s a motor neuron disease, but they don’t know the effects of it.” 
Frank, another PALS, shared similar sentiments, “Even when I go to the hospital there, 
sometimes a doctor will be talking to you and he had no idea what was going on with me.” SP 
Daniel, explained that in addition to traditional medical providers need further education, others 
involved in medical care need additional knowledge as well, “The rescue squad and the fire 
departments need to know who in their area has it so they'll know how to take it when they get 
there.” 
Thematic Cluster 5b: Additional Support Needed from Medical Professionals 
 Participants also repeatedly spoke about their need for additional support from medical 
providers during and following the diagnosis period. SP Steve shared, “Once you’re diagnosed 
with ALS, a lot of medical doctors won't even see you for anything else.”  SP Rosie provided 
insight into the perceived lack of support during the diagnostic period:  
It was just frustrating, challenging too, that we had to find the doctor, had to get it going, 
get his diagnosis and, I don't know. I just felt like they [medical providers] just weren't 
helping us like they should. We had a problem that needed to be seen about and they just 
weren't doing anything about it. 
When explaining the additional support needed from non-ALS medical providers, SP Kathy 
shared, “If they could just be a more, empathetic, instead of just seeing the symptoms of the 
disease instead of the person” and Lisa, a PALS, explained that she just needed for the providers 
to listen, “Just listen. They [the providers] don’t listen.” 




Thematic Cluster 5c: Appreciation of ALS Clinics 
Participant groups expressed their appreciation of and satisfaction specifically with the 
ALS clinic. SP Ruby responded, “They [the ALS Clinic] were excellent. I mean, I would go back 
there before anything” and PALS Sarah reported, “I’m glad to see everybody because I don’t 
have to go days on end to different offices. I’m thankful for that.” SP Kathy appreciated how 
personable the providers are. She said, “So we really feel like the line of communication through 
ALS is completely wide open, I can call there. I have personal numbers they give me.” SP Daniel 
shared, “I think they [the ALS Clinic] have done a damn good job with all the knowledge 
they’ve got.”  
Exhaustive Description  
 Following the identification of themes from participants’ interview transcripts, an 
exhaustive description was developed. This exhaustive description is intended to capture all of 
the emergent themes and accurately represent the richness of the PALS and SP’s lived 
experiences (Colaizzi, 1978). The exhaustive description for this study is as follows: 
 PALS and SPs living with ALS experienced transformations of their relationships with 
family members and friends subsequent to receiving the diagnosis. Relationships between the 
PALS and SP often became closer throughout the ALS journey as PALS and SPs spent more 
time together and adjusted to patient and caregiver roles. Relationships with friends also 
increased in emotional closeness following diagnosis. In instances when social supports pulled 
away both emotionally and physically, it seemed as though these persons were unfamiliar with 
the nature and progression of the disease or simply did not know how to respond emotionally to 
the PALS’ progressive symptoms. As the disease progressed, social outings became more 
difficult physically and this led to a sense of social isolation for both the PALS and SPs.  




 PALS and SPs shared various difficulties related to the physical progression of ALS. 
General challenges in physical well-being were tied to fatigue and aches and pains associated 
with living with ALS. As symptoms progressed, participants reported greater difficulties with 
physical challenges, such as lifting and moving, as PALS required greater assistance with the 
increasing lack of mobility and with verbal communication. This loss of communication led to 
feelings of being shut off from the rest of the world. Several participant groups expressed how 
fortunate they felt to experience slower progression or to experience symptoms that began in the 
limbs versus starting with loss of speech. 
 Emotional challenges were experienced by all participant groups. PALS and SPs shared 
feelings of denial and shock over a diagnosis of ALS, often followed by feelings of anger and 
frustration in living with the disease. Participants reported experiencing moments of depression 
and other emotional difficulties as they coped with the loses that came with symptom 
progression. With the ever-changing progression of symptoms, participants shared that moments 
of emotional difficulties were followed by a peak and adjustment to physical changes until 
additional loss of ability brought about another round of emotional difficulties. With time, 
several PALS and SPs expressed that they had come to accept their journey with ALS having 
moved past the emotional difficulties, either through attempting to continuously find a new 
normal, learn and adapt to ever changing abilities, recognizing their purpose in living with ALS, 
or by simply choosing to stay positive.  
 Participants communicated the impacts that living with ALS had on their spiritual well-
being. Several participants conveyed that the diagnosis of ALS had not given them reason to 
question their faith with several reporting that the diagnosis had in fact made their faith even 
stronger. Some participants did express that they had struggled with their faith and finding peace 




with the diagnosis with the majority of those struggles fading with time. A few of the 
participants also found their faith to be a coping source as they found comfort in prayers and 
talking with God.  
 PALS and SPs living with ALS conveyed the importance of their interactions with 
healthcare providers throughout their illness journeys. Specialists in ALS clinics were valued for 
their knowledge of the disease and for their continuous communication with PALS and their 
families. However, participants also conveyed a strong need for increased support from medical 
professionals, especially during the diagnosis period. Participants shared their frustrations over 
the inability to reach a diagnosis in a timely manner and over non-ALS medical provider’s 
inability to recognize the first symptoms of ALS that may have led to a faster diagnosis. 
Similarly, participants expressed frustration with the general lack of knowledge about ALS in 
medical providers outside of ALS clinics, sharing that first responders, primary care providers, 
and even health providers in assisted living facilities should have at least a general knowledge of 
ALS and the proper care needed for PALS and SPs. Despite participant frustration with the lack 
of ALS knowledge and need for additional support from providers during and following 
diagnosis, it appears as though ALS clinics were ultimately seen by PALS and SPs valuable 
resources. ALS clinics seemed to provide a sense of responsiveness, critical care, and 
knowledge, especially when participants were experiencing relationships with family members 
and friends pulling away.   
Discussion  
 The purpose of this study was to explore the experiences of PALS and their identified 
primary SPs living with ALS and how it has impacted family functioning and health. Previously, 
two studies have attempted to understand the impact that ALS has on family dynamics and 




functioning. One study (Tramonti et al., 2014), including PALS and family caregivers, focused 
on family cohesion and adaptability. The study included individual responses to the FACES III 
Questionnaire (Olsson, 1986) and did not allow participants to provide verbal explanations to 
their responses. Furthermore, the participants completed the questionnaire individually, 
suggesting a potential limitation as the findings are based on singular experiences without 
considering multiple family perspectives simultaneously (Fingerman, 2001). Martin and 
Turnbull (2001) conducted a study on overall family relationship satisfaction after experiencing 
the loss of a family member with ALS. They found 67% of participants believed that the disease 
brought the family closer together. However, PALS were not participants and data was collected 
by only one member of the family system, again failing to consider multiple family perspectives. 
Additionally, the study fails to provide insight into the family system’s experience while living 
with ALS and does not consider all BPS-S components. Considering these previous studies, the 
current study attempted to add to the literature by including multiple members of ALS support 
systems in singular in-depths interviews that allowed participants to explain their own 
experiences related to the impacts of ALS on their family functioning and BPS-S health.  
One novel finding of including several members of the same support system in one 
interview is the broader understanding of the PALS and SPs experiences with the impacts of 
ALS on family functioning. While previous studies focused on the impacts of ALS on the 
individual patient (e.g., Mock & Boerner, 2010; Pagnini et al., 2012) or family caregiver (e.g., 
Tramonti et al., 2015; Siciliano et al., 2017), this qualitative study approached the topic from a 
systemic perspective (von Bertalanffy, 1950) including multiple members of the system. Some 
participants in the current study found that their experiences with ALS brought the family system 
closer together. This finding was consistent with what Beavers and Voeller (1983) noted when 




they developed their theory that illness can ignite a centripetal pull, leading the family unit to be 
more insular and interdependent. Additional participants seemed to experience centrifugal 
patterns (Beavers, 1981) within their support system, sharing that some SPs stepped away 
emotionally and physically due to not knowing how to offer support to those living with ALS.  
 The findings of the current study present an additional novel finding when considering 
participant explanations of the impact of ALS on their BPS-S health. Previous literature on BPS-
S health (Engel, 1970; 1980; Wright et al., 1996) of PALS and SPs reveals changes over the 
course of the disease to include increased fatigue and declining physical health simultaneous to 
the progression of ALS (Gelinas, O’Connor, & Miller, 1998; Oyebode, Smith, & Morrison, 
2013), depression and general emotional difficulties (Gauthier et al., 2007; Miyashita et al., 
2011) and the importance of spirituality and faith (Calvo et al., 2011; Trail et al., 2003). 
However, in the current study, participants also added specific perspectives as to how the 
progression of physical decline and subsequent decrease in verbal communication abilities left 
the families psychosocially in a more isolated and frustrated state. Although participants in the 
current study also shared their own experiences with depressive symptoms and general 
experiences with the emotional processes, all participants spoke of their ability to reach 
acceptance of the disease, which is not reported in previous studies. Finally, in agreement with 
the previous BPS-S literature on ALS (Calvo et al., 2011; Trail et al., 2003), participants shared 
how their continued involvement in church and other spiritual activities is important to their 
well-being.  
 A final novel finding of the current study is the shared experience of participants 
expressing the need for medical providers outside of ALS clinics to have increased knowledge of 
ALS and how to properly care for PALS. Although previous literature has studied the 




importance of multidisciplinary ALS clinics (Kiernan et al., 2011), the research does not seem to 
explore the lack of ALS related education for medical providers outside of those ALS clinics. In 
the current study, participants frequently expressed their perceived need for increased education 
for non-ALS providers based on poor experiences with primary care providers, hospital 
providers, and providers in assisted living facilities. They shared providers refusal to care for the 
PALS simply because of a lack of knowledge on how to properly do so and when they did 
receive care outside of the ALS clinic, there seemed to be no communication between outside 
providers and ALS clinic providers concerning that care.  
Future Research 
 Based on the findings of the current study, the following research recommendations 
should be considered. The participants shared experiences of their connected BPS-S health 
(Engle, 1970; 1980; Wright et al., 1996) revealing the importance of treating PALS and their 
SPs’ BPS-S health components simultaneously as these components are inherently connected 
and continuously interacting. For example, PALS and SP participants shared that biological 
challenges were directly related to their emotional and social well-being, which in turn impacted 
their spirituality, revealing first-hand the interactions between each of the BPS-S components. 
Future studies are needed that focus more on the immediate and longitudinal whole health needs 
of PALS and SPs, their interactional effects, and how ALS clinics that provide direct care for 
PALS and SPs impact short and long term BPSS health outcomes.  
 Participants’ perspectives surrounding the lack of ALS knowledge by non-ALS 
specialists should also be studied further. Similar to the recommendations of a recent study on 
neurology residents’ ability to empathetically deliver a diagnosis of ALS (Schellenber et al., 
2014), participants in this study endorsed the need for more education to non-ALS specialists on 




the diagnosis, treatment, and BPS-S health impacts of ALS on the patient and family system. 
Research could include Delphi studies (Dalkey & Helmer, 1963), where experts in ALS from a 
variety of specialties (e.g., medicine, behavioral health, pulmonary, occupational therapy) 
identify competences that non-ALS specialists should have to help expedite the diagnosis of 
ALS and BPSS care provided to PALS and SPs.  
 Finally, future studies on the experiences of living with ALS should continue to study 
family members and SPs conjointly to ensure that more robust systemic perspectives are 
represented in the literature, pivoting away from relying exclusively on individually oriented 
research to inform treatment. Previous studies largely focused on the perspective of one family 
member or the PALS to serve as the voice of the family system (e.g., Martin & Turnbull, 2001). 
This bias creates doubt in the trustworthiness of the findings and their transferability. Qualitative 
researchers have long argued that individual family members have different perspectives on the 
same experience (Reczek, 2014). The data provided from individual family members is therefore 
quite limited, with interviews including multiple members of the family providing the best 
understanding of the family relationship and family dynamics (Fingerman, 2001).  
Limitations  
 There are several limitations to this study. Firstly, the participants included in the study 
are both racially and regionally homogenous. The lived experiences of these participants may 
apply to other PALS and their SPs; however, generalization of findings is not entirely 
generalizable based on the demographics of current participants. Secondly, several participants 
expressed that their families had become much closer throughout their journey with ALS, 
reflecting a sense of centripetal families resulting from ALS (Beavers, 1981). However, it could 




be argued that centrifugal families, families who have become distant throughout their journey 
with ALS, may have had no desire to participate.  
An additional limitation exists in the related experiences of the lead researcher. The lead 
researcher experienced ALS first hand as a family member was diagnosed with and died from 
ALS. Although both the lead and triangulated researchers participated in continuous bracketing 
of bias throughout the analysis process, it is possible that the lead researcher’s own related 
experiences resulted in biases that could have entered into the interpretation of the data. 
Furthermore, the exclusion of PALS with frontotemporal dimentia (FTD) is an additional 
limitation. Current research finds that as many as 50% of PALS have symptoms of (FTD) 
(Ferarri et al., 2011), meaning that several potential participants were automatically excluded 
from the current study. Although these PALS were excluded due to the challenges involved with 
participation and communication, it is possible that additional themes may have emerged from 
these PALS’ and SPs’ experiences.  
Finally, in phenomenological studies, it is recommended to conduct additional interviews 
past the point of saturation to confirm that all themes have been revealed (Morse et al., 2002). 
These additional interviews were unable to be completed due to the inability to recruit additional 
eligible participants amid the COVID-19 pandemic and social distancing practices. Although a 
triangulated researcher and peer debriefer concluded that saturation was achieved, it is possible 
that additional themes might be revealed, and additional interviews would have confirmed this.   
Conclusion  
 The utilization of a phenomenological method allowed for the researchers to understand 
and describe the experiences of PALS and SPs living with ALS in an effort to reduce their 
explanations into one universally exhaustive description. Findings underscored the value of 




social relationships, specifically close familial, centrifugal, relationships (Beaver, 1981), the 
importance of treating PALS and their SPs from a BPS-S framework (Engel 1977; 1980; Wright 
et al., 1996) and the importance of continuous support and collaboration from and between both 
ALS specific and non-ALS medical providers with greater ALS education needed for the non-
ALS providers. In providing care for PALS and their SPs, medical providers should capitalize on 
the benefit of centrifugal family relationships, intervening when families seem to be pulling 
away. Moreover, non-ALS providers of PALS should attempt to gain an understanding of the 
basic care needs of these PALS and their SPs, making sure to remain in communication with 
ALS clinic providers. Caring for PALS and their SPs with their family relationships and BPS-S 
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Table 1  
Participant Demographics 
 PALS (n = 8) SPs (n = 9) 
Age  M = 65 M = 57 
Gender Male: 5 
Female: 3 
Other (transgender, gender neutral, etc): 0 
Prefer not to answer: 0 
Male: 2 
Female: 6 
Other (transgender, gender neutral, etc): 0 
Prefer not to answer: 0 
Highest level of school completed Highschool: 4 
Some college, but no degree: 0 
Associate’s Degree: 0 
Bachelor’s Degree: 3 
Master’s Degree: 1 
Highschool: 1 
Some college, but no degree: 3 
Associate’s Degree: 3 
Bachelor’s Degree: 2 
Master’s Degree: 0 
Current employment status Paid Employee: 0 
Disabled: 3 
Retired: 5 
Paid Employee: 5 
Disabled: 0 
Retired: 4 
Employment status at symptom onset Paid Employee: 3 
Disabled: 0 
Retired: 5 
Paid Employee: 5 
Disabled: 0 
Retired: 4 
Range of current household income $20,000 to $99,999 $20,000 to $99,999 








Relationship status Single, never married: 0 




Legally Separated: 0 
Single, never married: 0 




Legally Separated: 0 
Time in relationship 0 to 3 years: 0 0 to 3 years: 0 




3 to 5 years: 1 
5 to 10 years: 0 
10 to 15 years: 1 
15 to 20 years: 1 
20+ years: 4 
N/A: 1 
3 to 5 years: 1 
5 to 10 years: 0 
10 to 15 years: 1 
15 to 20 years: 1 
20+ years: 5 
N/A: 1 
Number of children M = 2 M = 2 
Number of children living in the home M = 1 M = 1 




Time since first symptoms M = 5 years N/A 
Time since diagnosis M = 3.5 years N/A 








Table 2  
Selected Examples of Narratives and Emergent Theme Formation 
Significant Statements Formulated Meanings Thematic Clusters Emergent Themes 
“I think it's brought us closer. I feel like 
we're more. We've grown closer almost 
because we've had to because. You 
know.  It's hard for people to be around 
people that are dying.” 
 
ALS has brought our 






“Maybe some of both. Some that they'll 
visit with me and just speak to him and 
leave because they know he can't talk. 
In fact, he has a brother that didn't 
come from the longest time.” 
 
Some friends or family 
don’t know what to do 







“I don't get to, you know, do some 
things by myself or go out with friends 
as much or out by myself as much 
anymore.” 
 
As a caregiver I don’t 








“When he was diagnosed his doctor 
told him he had about two years to live. 
That was seven years ago so we’re very 
fortunate his ALS progresses slowly.” 
 






“But it's like I said, without 
communication it's made it hard.” 








“But yeah, I've had just aches and 
pains. I mean, it's more than I've had 
before, and I know it's lack of exercise. 
 
ALS physically means 





“That's one of the reasons I haven't 
accepted the diagnosis. I know 
something's wrong, but other than my 
speech, I have the justification for 
everything except my speech.” 
 
I haven’t accepted the 
diagnosis. 
Denial  Emotional Processes 
“Emotionally, it can be really 
frustrating when I don't know what he 
wants, and he can't communicate that 
with me.” 
ALS is frustrating 
when I can’t 
understand what he 









“We both have less patience and can be 
more depressed.” 
We’ve become less 
patient and more 






“At first there was so much uncertainty, 
but over the years we have learned to 
expect change. We try to plan ahead by 
talking about how we’ll handle 
different situations. We try to stay 
positive and remember we’re prepared 
and can handle situations. It usually 
works.” 
 
We’ve learned to 
expect changes, stay 
positive. 
Acceptance Emotional Processes 
“At first our faith was in doubt. 
However, with time we have come to 
terms with having an uncertain future 
and learned to cherish every minute 
together.” 
 
With time our faith has 
allowed us to come to 
terms with 
uncertainties 
Faith Maintained Impacts on Spirituality 
“At first our faith was in doubt. 
However, with time we have come to 
terms with having an uncertain future 
and learned to cherish every minute 
together.” 
 
With time, our faith has 
allowed us to come to 
terms with 
uncertainties. 
Faith Questionined Impacts on Spirituality 
“So, a lot of just people who don't 
specifically work closely with ALS 
know it's in a motor neuron disease, but 
they don't know the effects of it. And 
they look at you like you're crazy you 
can't move your foot.” 
 
Those who don’t work 
closely with ALS don’t 





Health Care System 
Interactions 
“It was just frustrating, challenging too, 
that we had to find the doctor, had to 
get it going, get his diagnosis and. I 
don't know. I just felt like they just 
weren't helping us like they should.” 
 






Health Care System 
Interactions 
“Well, we love (the ALS clinic) 
because it’s smaller and more 
personal.” 
We love the ALS clinic 













Table 3  
Emergent Themes and Thematic Clusters 
Thematic Clusters Emergent Themes 
• Support Persons Becoming Closer 
• Support Persons Pulling away 
• Challenges with Social Interactions 
and Support 
Dynamic Transformations of Relational 
Systems 
• Responses to Slower Progression 
• Communication Challenges 
• General Physical Challenges   
Biological Changes and Well-being 
• Denial  
• Anger & Frustration 
• Depression and other emotional 
processes 
• Acceptance  
Emotional Processes 
• Faith Maintained  
• Faith Questioned  
Impacts on Spirituality 
• Additional Education for Health 
Care Providers  
• Additional Support Needed from 
Medical Professionals  
• Appreciation of ALS Clinics 















CHAPTER 6: AN ARGUMENT FOR INCREASING THE KNOWLEDGE OF ALS IN  
 
MEDICAL SCHOOL AND GRADUATE MEDICAL EDUCATION PROGRAMS 
           
(This manuscript was prepared in accordance with the submission reqirements for the 
Journal of Graduate Medical Education.) 
 Amyotrophic lateral sclerosis (ALS) is the most common progressive and fatal 
neurodegenerative disease1. Currently, 300,000 individuals are living with ALS in the United 
States2 with 7,000 newly diagnosed each year1. Characterized by motor neuron degeneration, 
progressive wasting away and weakness of skeletal muscles, ALS leads to eventual paralysis and 
death within three to five years of symptom onset1,3. Even though ALS is becoming increasingly 
common4, the preparation of specialists to staff ALS Clinics and healthcare professionals to care 
for patients and families living with ALS is limited. The following article shines a light on (a) a 
growing shortage of neurologists and ALS specialists, (b) the need for increased collaboration 
between ALS specialists and non-ALS specialists, and (c) opportunities for updating and 
expanding the ALS curriculum offered in medical school and graduate medical education 
programs.  
Shortage of Neurologists and ALS Specialists 
 While incidence rates of ALS are projected to increase4, there is a corresponding shortage 
of medical students going into neurology residencies and who specialize in caring for patients 
with ALS5. Neurophobia, a term coined in 1994, is used to describe medical students’ fear of 
neurology6. This fear often begins early in medical school as neurology is thought of as the most 
difficult subject to master7. Neurophobia, along with the negative perception of the complexity 
of the field of neurology, has led to a growing shortage of neurologists with one recent study 
finding that only 2.8% of medical students indicated intent to enter a neurology residency5. This 




shortage of neurology residents only compounds the challenge of increasing the number of ALS 
specialists to staff ALS clinics.  
 Multidisciplinary ALS clinics, in which care exclusively caters to patients with ALS, 
emerged in the mid-1990s8.  Since their emergence, research on ALS clinics has shown to reduce 
the risk of death from ALS by 45%, five years following diagnosis9. Unfortunately, these 
multidisciplinary ALS clinics have also been found to have disjointed collaboration and 
transitions between healthcare providers10, difficulty sharing a diagnosis of ALS with the patient 
and family3, and a lack of support in delivering evidenced-base care11. These limitations support 
the need for not only focusing on increasing the competencies among medical students and 
neurology residents in caring for ALS patients and families, but also support enhancing the 
education of all specialists (e.g., primary care) who manage health issues for these patients 
outside of ALS clinics.  
For example, primary care providers (PCPs), play an important role in the care 
management of patients and families living with ALS12. They are more prone to have biological, 
psychological, social, and spiritual historical knowledge about their patients and families, are 
often more easily accessible for patient care visits, and are leading the advancement of integrated 
care in the patient centered medical home12,13. Although PCPs prove valuable in the general care 
management of ALS, when patients seek care for other healthcare needs or due to inability to 
travel to ALS clinics, they expressed frustration at PCPs lack of knowledge related to ALS 
care14. Capitalizing on the strengths of PCPs and enhancing their knowledge about ALS, would 
position them to better recognize its initial symptoms, facilitate timelier referrals to neurology for 
diagnosis, and provide care that encompasses the patient’s entire biopsychosocial-spiritual health 
(BPS-S)12,14,-17. Due to the median length of survival from symptom onset being between two 




and four years12, a faster diagnosis would potentially allow for a greater quality of life and 
enhanced symptom management.  
The need for increased attention to caring for ALS patients and families in medical 
schools, residency programs, and through continuing medical education forums is directly 
grounded in research with patients and families diagnosed with ALS.  One study conducted by 
Schellenberg et al.18, found neurology residents’ communication skills and levels of empathy 
when delivering a diagnosis of ALS were less than optimal for patients. Patients reported 
dissatisfaction with the fast pace of these appointments, frustrations with their inability to ask 
questions, and/or lack of opportunity to confirm understanding of their diagnosis and its 
prognosis. Participants in an additional study further reported a desire for increased knowledge 
on the care management of ALS by medical providers outside of ALS clinics, greater support 
during and following the diagnosis period, and a greater inclusion of family members in 
treatment14. 
To ensure that medical providers outside of ALS clinics, have a base knowledge on the 
general care of patients with ALS, it is suggested that specific education pertaining to ALS is 
developed. Identifying gaps and implementing curriculum modifications would help expedite 
ALS diagnoses, improve care, and provide opportunities for greater collaboration. Due to the 
varying accrediting bodies in medical and residency education, which all have different 
standards, and in order to ensure that these additions are practical, it is further suggested that the 
recommended components be added to exisiting coursework or lectures. For example, each of 
these components could be introduced during a neurology lecture combined with a standardized 
patient simulation that includes a patient with ALS. These curriculum components may include: 




(a) general care management of ALS, (b) interdisciplinary and team-based care models, (c) 
family-centered care approaches, and (d) BPS-S treatment planning.  
General Care Management of ALS 
To ensure that medical providers outside of ALS clinics have a base knowledge, it is 
recommended that basic education on ALS include awareness to: (a) prevalence rates, (b) ALS 
diagnostic criteria, (c) varied presenting symptoms, (d) patterns of illness progression, (e) 
recognition of familial and sporadic ALS, (f) known environmental risk factors12, (g) empathetic 
delivery of an ALS diagnosis18, and (h) symptoms associated with the various onset types, limb, 
bulbar, or respiratory/trunk onset1. According to Nold12, base knowledge of these topics would 
allow providers outside of ALS specialty clinics to swiftly identify ALS and provide optimal 
care. It would also open up the opportunity to share care using interdisciplinary models of care. 
Interdisciplinary Care 
Although multidisciplinary clinics have proven highly effective in providing care for 
patients with ALS3, providing care from an interdisciplinary perspective might alleviate the 
challenges associated with multidisciplinary clinics19. In contrast to multidisciplinary clinics, 
interdisciplinary clinic teams meet regularly to discuss and collaboratively set treatment goals. 
They also jointly carry out treatment plans and are ideally on the same hierarchical level with a 
high degree of communication and cooperation among the team members. Including education 
on care from an interdisciplinary team-based perspective would expand those trained to treat 
ALS thereby alleviating patients’ previous frustrations with providers’ limited communication 
skills18 within and outside of ALS clinics14. With this information in mind, specific educational 
competencies should minimally include: (a) the value of collaborative care, (b) the creation of 
joint treatment goals, and (c) the importance of communication between and amongst various 




providers.  This focused effort to remove barriers in collaborating would help ensure that all 
team members, patients and family members are coordinating and exchanging information 
fluidly19. 
Family-Centered Care 
Increased education on family-centered ALS care would allow for the mitigation of 
previous frustrations with providers’ inability to provide empathetic support to patients with ALS 
and their families18. Family-centered care includes respect for patients’ values and preferences, 
the integration of care provided by various specialists and medical professionals, information 
about the disease provided in individualized ways, physical comforts from pain, emotional 
support, and the inclusion of family and friends20. When given the opportunity to share their own 
lived experiences with ALS, patients and their families (which may include non-related support 
persons) shared suggestions for improving family-centered ALS care14. They desired increased 
communication between their ALS specialists and non-specialist providers (i.e., PCPs), more 
attention given to family members and support persons, and increased emotional support during 
and following the diagnosis period. Williams et al.14 found patients and families living with ALS 
wanted their providers to be skilled in: (a) designing individualized treatment plans, (b) initiating 
and participating in integrated interdisciplinary care, (c) providing emotional support, and (d) 
incorporating involved family members and friends in understanding the illness and care 
management needed. Patients and families argued for providers who could consider the BPS-S 
health of a patient and their caregiver(s) to successfully treat the system as a unit. 
BPS-S Care 
 The majority of research regarding the treatment of ALS seems to primarily focus on 
biological treatments and clinical trials that seem to delay the physical progression of the disease 




21-23. Previous research on the BPS-S15-17 health of patients with ALS and their support persons 
has been disjointed, focusing on one individual component at a time. Thus far, research has 
failed to determine how each component impacts one another simultaneously14. Increased 
education on the BPS-S framework would assist providers in better understanding the systemic 
and relational implications of the disease by viewing health through a comprehensive lens. 
Specific competencies to be achieved related to the BPS-S framework would include education 
on: (a) general systems theory24 as the theoretical construct of the BPS-S framework, (b) 
Engel’s15,16 development of the biopsychosocial framework, (c) the subsequent addition of the 
spiritual component17, and (d) techniques for providing care to patients and families living with 
ALS.  
Conclusion 
 Since ALS was first described by French neurologist Jean-Martin Charcot 150 years ago, 
there continues to be no known cause or cure for this progressive neurodegenerative disease. 
ALS clinics have been integral in advancing the diagnosing process and care of patients with 
ALS. The essential nature of these clinics incidentally creates pressure for ALS clinics to 
adequately meet all healthcare needs appropriately suited for primary care, behavioral health, 
occupational therapy, and even speech therapy. However, there is evidence that merits the 
expansion of competencies in medical school, graduate medical education, and continuing 
education programs to include interdisciplinary, family-centered approaches which incorporate 
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APPENDIX B: RECRUITMENT, TELEPHONE, AND EMAIL SCRIPTS 
In-person Recruitment Script 
Hello, Ms./Mr. {insert name]. My name is Rachel Williams and I am a student at East 
Carolina University. I am working on a study to better understand how ALS impacts families and 
each member’s biological, psychological, social, and spiritual health. This information will help 
us to improve the quality of care available to patients and families impacted by ALS. I am 
wondering if it would be alright if I sit down with you and tell you a little more about this study 
so you can make a decision about whether or not you would like to participate? 
[If the participant agrees for the PI to continue with the recruitment process, she will do 
so. If the patient does not agree, the PI will thank the patient for his or her time and leave the 
room]. 
 The study has a few different parts to it. If you agree to participate today, I will ask you 
to sign a form stating that you agree to participate. I will then give you a brief survey to complete 
using this computer that helps us understand more about each person who agrees to participate. 
The survey will ask questions about you such as your age, gender, education level, and 
relationship status. The survey will take about 5 minutes to complete. The final part is an hour-
long, audio-recorded interview that will be done at a later date with myself and members of your 
support system/family of your choosing. Therefore, in order to participate you will need to 
provide the name and contact information for at least one non-professional support person in 
your life that might also be willing to participate. We can either contact that person together at 
this time or the research team can contact them at a later time, so long as you are willing to 
inform that we will be contating them concerning their participation in this study. In participating 
in the interviews, we have technology so that you or any members of your family do not even 




have to leave your homes to participate. You just need access to a phone or computer with a 
camera.   
 Please know that your decision whether or not to participate will not affect your care at 
the ALS clinic in any way. We want you to feel comfortable saying “no” if you do not wish to 
participate. Also, if you do decide to participate, know that you may choose to stop participating 
in the study at any time. It is your choice and you always have the right to change your mind.  
 Do you have any questions about the information I have shared with you? Do you have 
any concerns? 
 [PI will pause for questions and concerns. If participant has questions or concerns, PI 
will answer and address them to the best of her ability. If patient does not have questions or 
concerns, PI will continue with recruitment process]. 
 Would you like to participate? If so, we will need you to sign this informed consent 
document to show your agreement. 
 [If participant agrees, they will sign the informed consent document a computer will be 
made available or the REDCap survey link sent to the patient participant via mail. If the patient 












Telephone Indetified Support Person Recruitment Script 
Hello, Ms./Mr. {insert name]. I am contacting you because someone close to you with 
ALS has requested your participation in a study about ALS. The study is designed to help 
understand the patient and support person’s experience of ALS so that we may work to improve 
the care provided to all involved. I would like to explain the study to you further and hope that 
you might be available to join the person who recommended you for an interview. My name is 





















Telephone Recruitment Script 
Hello, Ms./Mr. {insert name]. The following information is provided to you as an 
opportunity to participate in a study that will help us to improve the quality of care to patients 
and families impacted by ALS. This study will help us to better understand how ALS impacts 
families and each member’s biological, psychological, social, and spiritual health.  
The study has a few different parts to it. If you agree to participate today, you will be 
asked to sign a form stating that you agree to participate. You will complete a brief survey to 
helps us understand more about each person who agrees to participate. The survey will ask 
questions about you such as your age, gender, education level, and relationship status. The 
survey will take about 5 minutes to complete. The final part of the study is an hour-long, audio-
recorded interview that will be done at a later date with the lead researcher and members of your 
support system/family of your choosing. Therefore, in order to participate you will need to 
provide the name and contact information for at least one non-professional support person in 
your life that might also be willing to participate. In participating in the interviews, we have 
technology so that even participates who do not live in the area may also participate.   
 Please know that your decision whether or not to participate will not affect your care at 
the ALS clinic in any way. We want you to feel comfortable saying “no” if you do not wish to 
participate. Also, if you do decide to participate, know that you may choose to stop participating 
in the study at any time. It is your choice and you always have the right to change your mind.  
 If you would like to participate we ask that you provide contact information that will be 
shared with the lead researcher who will only use this information to contact you to schedule an 
interview. If you have any questions or concerns the lead researcher, Rachel Williams, can be 
contacted by email, williamsra11@students.ecu.edu or by phone at 252-737-1417. 




Telephone Script for Interview Scheduling - Patient 
Hello, Ms./Mr. {insert name]. I am contacting you based on the interest in participating in 
a study about ALS that you shared with our triangulated researcher, who shared your contact 
information with me. As a reminder, this study is designed to help understand the patient and 
support person’s experience of ALS so that we may work to improve the care provided to all 
involved. The next step in the study is to schedule an interview with yourself and any members 
of your non-professional support system to be held at the Vidant ALS Clinic. We can schedule 
the interview now or you can contact me at a later date to do so. My name is Rachel Williams 



















Telephone Script for Interview Scheduling – Support Persons 
Hello, Ms./Mr. {insert name]. I am contacting you based on the interest you expressed 
about participating in a study about ALS, as a support person to someone who has ALS. As a 
reminder, this study is designed to help understand the patient and support person’s experience 
of ALS so that we may work to improve the care provided to all involved. The next step in the 
study is to schedule an interview with yourself, the patient with ALS, and any additional 
members of the patient’s non-professional support system to be held at the Vidant ALS Clinic.. 
We can schedule the interview now or you can contact me at a later date to do so. My name is 























Informed Consent to Participate in Research 
Information to consider before taking part in research that has no 
more than minimal risk. 
 
Title of Research Study: How ALS Impacts Family Functioning and Health 
 
Principal Investigator: Rachel E. Williams, MS, LMFTA 
Institution, Department or Division: Human Development and Family Science 
Address: 114 Redditt House, East Carolina University, Greenville, NC 27858 
Telephone #: (252) 737-1415 
 
Participant Full Name:  __________________________________Date of Birth:  ___________________                                            
Please PRINT clearly 
 
 
Researchers at East Carolina University (ECU) Vidant Medical Center and Vidant Medical Groups study 
issues related to society, health problems, environmental problems, behavior problems and the human 
condition.  To do this, we need the help of volunteers who are willing to take part in research. 
 
Why am I being invited to take part in this research? 
You are being invited to take part in this research because you area or you are a member of a patient’s 
support system. The decision to take part in this research is yours to make.  We hope that the information 
that you provide will help us learn how to better support and assist families living with ALS. 
 
If you volunteer to take part in this research, you will be one of about 40 people to do so.   
 
Are there reasons I should not take part in this research?  
I understand I should not volunteer for this study if I am: (a) a non-English speaker, (b) under 18 years of 
age, and/or (c) have screened positive for Frontotemporal Dementia or any other forms of dementia by the 
clinic staff at the Vidant ALS Clinic. 
 
What other choices do I have if I do not take part in this research? 
Participation in this research project is voluntary. You may choose not to participate at any time with no 
impact on the treatment you are receiving at the Vidant ALS Clinic. 
 
Where is the research going to take place and how long will it last? 
The research will occur at the following times and places: Vidant Medical Center and over the phone. 
Your contact information will be collected by the triangulated researcher when you express interest in 
participating in this study.  Your contact information will be shared with the lead researcher who will use 
it to schedule an interview with you and your participating support person. For the interview, you will 
need to come to the Vidant ALS Clinic one time during the study. Prior to the start of the interview, you 
will be asked to fill out a brief survey, which should take 5-10 minutes, at the Vidant Medical Center. 
You may complete it using your smartphone or a computer made available to you. During the interview 
we will ask you if you would like to participate in the verifying of the results. This portion of the study is 




optional, can be completed at home, and would take approximately 30 minutes. The total amount of time 
you will be asked to volunteer is between 30 minutes and two hours depending on the length of time it 
takes to complete the interview and on your participation in reviewing the results for accuracy.  
 
What will I be asked to do? 
You will be asked to do the following:  
• Complete the University & Medical Center Institutional Review Board (UMCIRB) HIPAA 
Privacy Authorization Form, which provides your authorization to use and disclose your 
protected health information for research. This form will be provided to you prior to the start of 
the interview. 
• Complete a brief online survey that asks about your demographic information (age, gender)  
• As the patient, you will provide the name and contact information of at least one member of your 
support team to participate in an interview with you.  
• Participate in a one-time, audio-recorded, interview. During the interview you will be asked to 
share your experiences of living with ALS. The audio-recorded interviews will be typed up for 
analysis and will be kept in a password-protected file. Audio files will be password-protected and 
stored on a secure server at East Carolina University. 
• At the end of the interview you will be asked if you would like to be involved in the process of 
double-checking the results (“member checking”) which will take place in two portions. The first 
portion will include checking your typed-up interview for accuracy and the second portion will 
include checking the results to see how well they match your experience.  If you are interested in 
participating in either of these portions of member checking, we will provide you with the 
transcripts and/or results by mail or e-mail, whichever is your preference. Participating in 
checking the typed-up responses from the interview will give you an opportunity to share any 
additional information you may not have thought of during the interview. Participating in 
checking the results will give you the opportunity to make sure those results are accurate or help 
us make corrections. Audio files will be erased after they are typed, and the member checking 
process is completed. The typed interviews will be stored electronically on a secure server at East 
Carolina University, which is password-protected. The typed interview documents will be kept in 
a locked filing cabinet in a locked office. Documents will be shredded and electronic files 
containing identifying information will be erased seven years after the project is completed. 
 
What might I experience if I take part in the research? 
There are possible risks (the chance of harm) when taking part in this research. This research will require 
your time and energy to complete. Some participants who have completed surveys and interviews on 
topics of mood, social support, and spirituality may experience discomfort with answering questions. 
Some participants may also experience negative feelings (such as anger, fear, grief, or sadness) from 
being asked to recall and talk about a difficult time (such as your experiences with ALS). Please know 
you may always ask to “skip” questions you are not comfortable with answering. You can also ask to stop 
a survey or interview at any time.  
 
In the case that you experience negative emotions or symptoms of anxiety or depression throughout the 
study, we will help connect you with behavioral health resources that you may choose to use. 
 
What are the possible benefits I may experience from taking part in this research?  
We do not know if you will get any benefits by taking part in this study. Hopefully, this research will help 
us learn more about how to best serve patients with ALS and their support systems. There may be no 
personal benefit from your participation, but the information gained by doing this research may help 
others in the future. However, other people who have participated in this type of research have 




experienced benefit from being able to talk about their experience with researchers. By participating in 
this research study, you may also experience these benefits. 
 
Will I be paid for taking part in this research? 
We will not be able pay you for the time you volunteer while being in this study.  
 
Will it cost me to take part in this research?  
It will not cost you any money to be part of the research. This research study is not for profit and is being 
completed as part of the Principal Investigator’s degree requirements. All researchers are donating their 
time to the study. 
 
Who will know that I took part in this research and learn personal information about me? 
ECU and the people and organizations listed below may know that you took part in this research and may 
see information about you that is normally kept private.  With your permission, these people may use your 
private information to do this research: 
• The University & Medical Center Institutional Review Board (UMCIRB) and its staff have 
responsibility for overseeing your welfare during this research and may need to see research records 
that identify you. 
• Any agency of the federal, state, or local government that regulates human research. This includes 
the Department of Health and Human Services (DHHS), the North Carolina Department of Health, 
and the Office for Human Research Protections. 
• People designated by Vidant Medical Center and Vidant Health. 
• If you are a patient at ECU or Vidant, a copy of the first page of this form will be placed in your 
medical records.   
 
How will you keep the information you collect about me secure?  How long will you keep 
it? 
Your name will only be attached to this informed consent document and a list kept by the Principal 
Investigator of the study participants. A list of study participants with contact information and your 
pseudo name used for the interview will be listed in a password-protected file on a secure server at East 
Carolina University. The audio file of the interview will be password-protected and stored on a secure 
server at East Carolina University. Hardcopies of your typed interview will be stored in a locked file 
cabinet. Your name will not be attached to these materials. Audio files will be erased after the interviews 
are typed and the member checking process is completed. After this study is complete, documents will be 
shredded and electronic files containing identifying information will be erased seven years after the 
project is completed. 
 
What if I decide I don’t want to continue in this research? 
You can stop at any time after it has already started. There will be no consequences if you stop and you 
will not be criticized.  You will not lose any benefits that you normally receive.  
 
Who should I contact if I have questions? 
The people conducting this study will be able to answer any questions concerning this research, now or in 
the future.  You may contact the Principal Investigator, Rachel Williams, at (252) 737-1415 (Fridays, 
9AM-5PM) or the Principal Investigator’s Supervisor, Jennifer Hodgson, PhD, at (252) 328-1349 
(Monday-Friday, 9AM-5PM). 
 
If you have questions about your rights as someone taking part in research, you may call the Office of 
Research Integrity & Compliance (ORIC) at phone number 252-744-2914 (days, 8:00 am-5:00 pm).  If 
you would like to report a complaint or concern about this research study, you may call the Director for 




Human Research Protections, at 252-744-2914 and the Vidant Medical Center Risk Management Office 
at 252-847-4473. 
 
Is there anything else I should know? 
The following research results will be provided to you: The results from the interviews will be shared 
with you as part of the member checking process. This will allow you to verify if that the results 
accurately reflect your experiences with ALS.  
 
I have decided I want to take part in this research.  What should I do now? 
The person obtaining informed consent will ask you to read the following and if you agree, you should 
sign this form:   
 
• I have read (or had read to me) all of the above information.   
• I have had an opportunity to ask questions about things in this research I did not understand and 
have received satisfactory answers.   
• I know that I can stop taking part in this study at any time.   
• By signing this informed consent form, I am not giving up any of my rights.   
• I have been given a copy of this consent document, and it is mine to keep.  
 
          _____________ 
Participant's Name (PRINT)                                 Signature                            Date   
 
 
 The participant is unable to sign and date due to the physical progression of ALS, however the 
participant has given consent through verbal or nonverbal communication.  
 
 
Person Obtaining Informed Consent:  I have conducted the initial informed consent process.  I have 
orally reviewed the contents of the consent document with the person who has consented above and 
answered all of the person’s questions about the research. 
 
             
Person Obtaining Consent (PRINT)                      Signature                                    Date   
 
 
             
Principal Investigator   (PRINT)                           Signature                                    Date   












UMCIRB HIPAA Privacy Authorization 
 
East Carolina University (ECU)/Vidant Medical Center (VMC):  Research Participant 
Authorization to Use and Disclose Protected Health Information for Research 
 
For use only with the research consent form for UMCIRB#:  19-002186 
Principal Investigator: Rachel Williams  
Title: How Amyotrophic Lateral Sclerosis Impacts Family Functioning and Health  
 
Location where research will be conducted 
The members of the research team will conduct the research study at: 
 East Carolina University (ECU)   VMC  ECU & VMC  Other         
 
When taking part in research, protected health information (PHI) is collected, used, and shared 
with others who are involved in the research.  Federal laws require that researchers and health 
care providers protect your PHI. Also, federal laws require that we get your permission to use 
collected PHI for the research. This permission is called authorization.  
 
In order to complete the research project in which you have decided to take part, the research 
team needs to collect and use some of your PHI as described below.   
 
What types of protected health information (PHI) about me will be used or disclosed? 
(Select all that apply.) 
ECU Health Care Component:                           Vidant Health Entity: 
[ ] ECU Physicians                                                  [ ] Entire Vidant Health system  
[ ] School of Dental Medicine                                 [ ] Vidant Medical Center  
[ ] Speech, Language, and Hearing Clinic              [ ] Other Vidant Health Entity  
[ ] Human Performance Lab    (please list):   
[ ] Physical Therapy                                                 
[ ] Student Health                 
[ ] Other ECU Health Entity 
(please list):      
 
Type of ECU Records:  Type of Vidant Records: 
[ ] Medical/clinic records  [ ] Medical/clinic records 
[ ] Billing records                                                [ ] Billing records                                                
[ ] Lab, Pathology and/or Radiology results           [ ] Lab, Pathology and/or Radiology 
results 
[ ] Mental Health records                [ ] Mental Health records 
[ ] PHI previously collected for research     [ ] PHI previously collected for research 
[ ] Records generated during this study  [ ] Records generated during this study 
[ ] Other:                                         [ ] Other: Name, Telephone Number, and   








Who will use or disclose my PHI? 
[ ]Principal Investigator 
[ ]Other members of the research team  
[ ]Other providers involved in your care during research procedures, outpatient/inpatient stays 
during which research is being performed, or physician office visits during which research is 
being performed. 
 
Who will receive my PHI?  
[ ]   Sponsor or other funding source to provide oversight for entire research project 
[ ]   Research investigators to conduct and oversee the research project          
[ ]   Principle Investigator and research team members to participate in the various research 
activities  
[ ]   FDA or other regulatory agencies to provide regulatory oversight        
[ ]   UMCIRB to provide continuing review of the research project 
[ ]   Institutional officials in connection with duties for monitoring research activity 
[ ]   Other providers involved in your care during research procedures, outpatient/inpatient 
stays during which research is being performed, or physician office visits during which research 
is being performed. 
[ ]   Researchers at other sites—List sites:       
[ ]   Data and Safety Monitoring Board and its staff 
[ ]   Contract Research Organization and its staff 
[ ]   Other       
 
We will share only the PHI listed above with the individuals/agencies listed above.  If we need to 
share other PHI or if we need to send PHI to other individuals/agencies not listed above, we will 
ask for your permission in writing again 
 
How my PHI may be released to others: 
ECU and VMC are required under law to protect your PHI.  However, those individuals or 
agencies who receive your PHI may not be required by the Federal privacy laws to protect it and 
may share your PHI with others without your permission, if permitted by the laws governing 
them.   
 
What if I do not sign this form? 
You will not be eligible to participate in this study if you do not sign this Authorization form.   
 
How may I revoke (take back) my authorization? 
You have the right to stop sharing your PHI.   To revoke (or take back) your authorization, you 
must give the Principal Investigator your request to revoke (or take back) your authorization in 
writing. If you request that we stop collecting your PHI for the study, you may be removed from 
the study.  If you are removed from the study, it will not affect your ability to receive standard 
medical care or affect payment, health plan enrollment or benefit eligibility.   PHI collected for 
the research study prior to revoking (or taking back) your Authorization will continue to be used 
for the purposes of the research 
study.  Also, the FDA (if involved with your study) can look at your PHI related to the study 
even if you withdraw this authorization. 




Restrictions on access to my PHI: 
You will not be able to see your PHI in your medical record related to this study until the study is 
complete.  If it is necessary for your care, your PHI will be provided to you or your physician. 
How long may the PHI about me be used or disclosed for this study? 
Research information continues to be looked at after the study is finished so it is difficult to say 
when use of your PHI will stop.  There is not an expiration date for this authorization to use and 
disclose your PHI for this study. 
 
If you have questions about the sharing of PHI related to this research study, call the principal 
investigator, Rachel Williams, at 252-737-1415. Also, you may telephone the University and 
Medical Center Institutional Review Board at 252-744-2914.  In addition, if you have concerns 
about confidentiality and privacy rights, you may phone the Privacy Officer at Vidant Medical 




To authorize the use and disclosure of your PHI for this study in the way that has been described 
in this form, please sign below and date when you signed this form.  A signed copy of this 
Authorization will be given to you for your records. 
 
 
Name of Participant or Authorized Representative (print)       Signature           Date  
 
 
If an Authorized Representative has signed on behalf of a Participant please print on the 
line above the authority of the Legal Representative to do so (such as parent, court-
appointed guardian, or power of attorney).  
 
 












APPENDIX D: REDCap SURVEY 
Demographics  
For Patients and Support Persons: 
1. How old are you? 
___________ 
 
2. To which gender identity do you most identify? 
A. Female 
B. Male 
C. Other (e.g., transgender, gender neutral, etc. Please specify: ____________) 
D. Prefer Not to Answer 
 
3. What is your race? (Select all that apply) 
A. American Indian or Alaskan Native 
B. Asian 
C. Black or African American 
D. Hawaiian or Other Pacific Islander 
E. White 
F. Other (Please specify:_____________) 
G. Prefer not to answer 
 
4. What is your ethnicity? 
A. Hispanic or Latino/Spanish Origin 
B. Not Hispanic or Latino/Spanish Origin 
C. Prefer not to answer 
 
5. What is the highest level or school you have completed your highest year of schooling 
completed? 
A. Less than high school 
B. High School/GED 
C. Some College, but no degree 
D. Associate degree in college (2-year) 
E. Bachelor’s degree in college (4-year) 
F. Master’s degree  
G. Doctoral degree 
H. Professional degree (JD, MD) 
 
6. Which statement best describes your current employement status? 
A. Working  
a. paid employee 
b. self-employed 
B. Not working  
a. temporary layoff from a job 










7. What was your employment status at time of symptom onset? 
A. Working  
a. paid employee 
b. self-employed 
B. Not working  
a. temporary layoff from a job 






8. What is your current yearly household income? 
A. Less than $10,000 
B. $10,000 to $19,999 
C. $20,000 to $29,999 
D. $30,000 to $39,999 
E. $40,000 to $49,999 
F. $50,000 to $59,000 
G. $60,000 to $69,999 
H. $70,000 to $79,999 
I. $80,000 to $89,999 
J. $90,000 to $99,999 
K. $100,000 or more 
 
9. What is your current health insurance status? 
A. Uninsured, Self-pay 
B. Insured by Medicaid or Medicare 
C. Insured by private insurance (i.e., Blue Cross & Blue Shield of NC, Cigna) 
D. Insured by Tricare 
 
10. What is your current relationship status? 
A. Single, never married 
B. In a committed relationship 
C. Married or civil union 
D. Widowed 
E. Divorced 
F. Legally Separated 
G. Other (Please Specify: ___________________) 
 




11. If you are currently in a relationship, how many years have you been in that relationship? 
A. 0 to 3 years 
B. 3 to 5 years 
C. 5 to 10 years 
D. 10 to 15 years 
E. 15 to 20 years 
F. 20 or more years 
G. Not applicable  
 
12. Do you have any children/stepchildren? 
A. Yes (how many: _________?) 
B. No 
 
13. How many of your children/stepchildren are living? ___________ deceased?_______ 
 
14. If you have children/stepchildren, how many of those children currently live with you? 
A. 0-2 
B. 3-5 
C. 5 or more 
 
15. If you have children, how many of those children do not currently live with you? 
A. 0-2 
B. 3-5 
C. 5 or more  
 








H. Other (Please specify: _________________) 
I. Prefer not to answer 
 
17. Do you have a history of mental illness? 
A. Yes (Please describe:________________) 
B. No 
 
18. Did you experience physical limitations of impairments prior to the onset of ALS?  









For Support Persons Only: 
 








For Patients Only:  
 
21. When did you first notice symptoms of ALS? _______ (approximate date) 
 
22. What date were you diagnosed with ALS? __________ 
 




E. Other (please specify_________) 
F. Unknown  
 
24. What is your relationship to the primary support person? For example: friend, parent, 


















APPENDIX E: INTERVIEW GUIDE 
Introduction 
 
Thank you for meeting with me today. I am a doctoral student in medical family therapy at 
East Carolina University and would like to better understand the experiences of families living 
with ALS. This project is part of my requirements for my degree but this topic is very personal 
and important to me as well. I am meeting with you because I am particularly interested in what 
it is like for patient and members of their support system to live with ALS and how it impacts  
the way you all function together.  
There are no right, or wrong answers and you may share anything related to your experience 
with ALS as it comes to mind. What you share with me today will only be used for this study.  I 
will not use anyone’s actual name or any information that may be used to identify you when I 
prepare the results for publication and presentation. The consent form you signed when we first 
met is your written agreement for the interview today.  
You may decide not to continue with the interview at any time and you may choose to skip a 
question if you do not feel comfortable answering it. If you wish to skip a question or stop 
entirely, please let me know and we will move to the next question or stop the interview 
completely. I will be recording the interview so that I can type up what was discussed and study 
the responses to the questions later. I do ask that you try not to use anyone’s real name as much 
as possible but rather refer to that person by your relationship with or to them. For example, my 
sister, doctor, friend, dad, etc.  
Before we begin, do any of you have a fake name that you would like for me to use when I 
type up the interview? If not, I can assign you one later.  




This interview will take about an hour and will be audio recorded. Do you have any 
questions before we begin?  
Grand Tour Question 
How do you believe ALS has impacted you and your support system? 
Probing Questions 
• What has having ALS meant to each of you? 
• Why have you chosen to participate in this study?  
• What are some challenges each of you have faced? 
o How has ALS impacted you physically (as the support person)? 
o How has ALS impacted you emotionally? 
o How has ALS impacted you socially? 
o How has ALS impacted you spiritually? 
• Describe in what ways, if any, the ALS symptom onset type (i.e., bulbar or limb) has 
impacted you and your support system?  
• What are some changes your family has encountered? 
o Have you become closer? 
§ In what ways? 
o Have you drifted apart? 
§ In what ways? 
• Can you describe a time when your or your support system felt most challenged during 
the course of your illness? 
• What positive things have you all experienced as a result of ALS? 




• What services (or assistance) have you needed but have not received to help you and your 
support system manage ALS? 
o What could health professionals like doctors and nurses have offered after 
diagnosis and throughout your journey with ALS? 






















APPENDIX F: COMMUNITY BASED RESOURCES 
Participation in the interview may evoke feelings of anxiety (feeling worried or nervous), 
depression (feeling down, sad, or hopeless), or emotional distress (feeling angry, fearful, 
frustrated, or greif-stricken). During the interview today, some of your answers let me know that 
you may be experiencing some of these feelings. I encourage you to do the following to make 
sure you get the help you need: 
1. Let your trusted family members and friends know that you are experiencing feelings 
of anxiety, depression, or emotional distress.  
2. Contact a behavioral health provider with whom you can meet and discuss your 
feelings.  
 
Here are some local resources:  
 
A. The Jim “Catfish” Hunter ALS Clinic, 2310 Stantonsburg Road in Greenville, NC. The 
clinic is in the Outpatient Rehabilitation Building adjacent to Vidant Medical Center. 
You may contact Natalie Cox at 252-847-1779 to schedule an appointment.  
 
B. The Greenville area ALS support group meets the 3rd Wednesday of every month from 
6:30-8:30 PM at the Vidant Rehabilitation Center Classroom, 2100 Stantonsburg Rd, 
Greenville, NC. The contact person is Katie Leegins-Vinson, LCSW, kleegins-
vinson@alsnc.org 
 
C. ECU Family Therapy Clinic, 612 East 10th St., Greenville, NC (252) 737-1415. Provides 
therapy to individuals, couples, and families on a sliding-fee scale.  
 
D. Trillium Health Resources, 201 W. 1st, Greenville, NC, (866) 998-2597. A local 
governmental agency that manages mental health, substance use, and 
intellectual/developmental disability services in eastern North Carolina. 
 
If you ever feel you are in crisis and need help immediately, here are some important contacts:  
A. REAL Crisis Intervention (252) 758-4357. 24/7 crisis line. Provides over-the-phone 
counseling and referrals.  
 






APPENDIX G: STATEMENTS OF BIAS 
Rachel Williams 
I, the lead researcher, have attempted to recognize and set aside any prior beliefs, biases, 
and preconceived notions related to individuals and families impacted by ALS. Specifically, I 
have realized that a motivating factor in conducting research on these topics is my own lived 
experience of my uncle’s diagnosis of and subsequent death due to ALS. I have recognized that 
the experiences I and my family have lived through may share some similarities with others 
impacted by the disease, but that ultimately, my own experience remains just that, my own.  
 In recent years, I have also become more involved with local area ALS support groups. 
These experiences have allowed me to grow in my understanding of how different experiences 
with this disease vary from person to person and family to family. These experiences have also 
provided several opportunities for to immerse myself within the ALS culture, so to speak, to 
observe and interact with people who are currently living through these experiences every day, 
and to ultimately set aside my biases and beliefs in real time. Ultimately, the death of my uncle 
to ALS, and the resulting distressing experiences my family lived through ingnited the spark that 
has resulted in the current study on ALS. However, more recent real life experiences and 
educational opportunities have allowed me to approach this topic from a position of 
inquisitiveness, without the need to overshadow other’s experiences and meaning making of 
those experiences with my own.  
In allowing the phenomenon to speak of itself (Colaizzi, 1978), I recognize my positions 
as a researcher and as a white, college-educated female and how these positions are pertinent to 
the conceptualization of this study. Furthermore, I acknowledge my own experiences with ALS 
and am committed to maintaining an awareness of those experiences throughout the study in 




order to manage the undue influences the biases resulting from these experiences may have on 
the study in general. In asking questions to gain a greater understanding and including a 
methodological component that explores participants’ experiences as they understand them 
























Colaizzi, P. F. (1978). Psychological research as the phenomenologist views it. In R. Valle & M. 
King (Eds.), Existential phenomenological alternatives in psychology (pp. 48-71). New 
York: Oxford University Press.  
 
Creswell, J. W., & Poth, C. N. (2018). Qualitative inquiry & research design: Choosing among 
five approaches (4th ed.). Los Angeles, CA: Sage. 
 
Hammersley, M., & Atkinson, P. (1995). Ethnography: Principles in practice (2nd ed.). New 
York, NY: Routledge.  
 
Merleau-Ponty, M. (1956). What is phenomenology? Cross Currents, 6, 59-70.  
 
Moustakas, C. (1994). Phenomenological research methods. Thousand Oaks, CA: Sage.  
 
Streubert, H. J., & Carpenter, D. R. (1999). Qualitative research in nursing: Advancing the 




















As the triangulated researcher, I recognize my position as a British, mixed race, college 
educated female living in North Carolina and how it may have affected perspective on ALS and 
subsequent disparities in several ways. Firstly, I realized that although my secular upbringing 
was common place in Great Britain, this was not necessarily the case in North Carolina and the 
surrounding southern states. A degree in Anthropology facilitated the my understanding of the 
significance and function of religion; from its place within a global society to its place within 
local interactions, such as individuals and their health.  
Secondly, having been brought up in Great Britain, I faced a drastically different racial 
climate compared to my current place of residence. Since living in North Carolina, I have 
become cognizant of the many disparities and inequalities people of color are subject to, 















APPENDIX H: REFLEXIVE JOURNAL SELECTED ENTRIES 
1/3/2020 
“After I got my transcript finished from the first interview, I’ve read over it and found that I need 
to go deeper with my questions. I’m finding that I ask the initial question, and receive an answer, 
but don’t tend to ask them to explain more or provide examples. I’m wondering if I’m 
subconsciously keeping myself from asking the more difficult questions? Am I a bit fearful of 
the answers? Am I a bit fearful of how “real” and close to home the answers might be? Am I a 
bit fearful of how it might be a little difficult for me to hear how the families are struggling? I’m 
not sure. I’m just thankful of my awareness of this and will make a concerted effort to dig deeper 
in future interviews. 
 
2/7/20 
“This was my longest interview so far and I’ve realized that for the past few interviews I’ve 
really been able to go through the entire interview guide and then explore other areas as needed, 
without fear of what the answers will be. I was really touched by the fact that this patient hadn’t 
had a relationship with her children for several years, but that bc of her illness they have 
rekindled their relationships and their love.” 
 
3/4/20 
“I’ve been reading through several of the transcripts just now. I’ve read through at least four of 
them and then have gone back to re-read them and pull out the significant statements. I’ve had a 
bit of a difficult time doing this. Some of the pieces of the interviews are really heavy, or at least 
they feel heavy to me. At the moment, I’m taking a step back and will make sure that I only work 




through these one at a time. I want to continue to make sure that whenever I’m working through 
this analysis that I’m able to honor the participant’s experiences and not let my own experience 
get in the way.” 
 
3/31/20 
Olivia and I have worked together through all of the steps of the analysis. She has previously 
shared with me that she does not have any prior experiences with anyone with ALS, which has 
helped me to bracket any biases that may have come up by chatting through things with her. I 
felt really good about our thematic saturation when she shared with me her experiences with 
analyzing the data from another study. She shared that she felt like all of our data fit very well 



















Adelman et al., 2004 2 3 3 3 1 3 * 
Alankaya et al., 2015 2 3 3 3 1 N/A * 
Atkins et al., 2009 2 3 3 3 1 3 * 
Bolmsjö et al., 2003 2 3 3 3 3 N/A * 
Bruletti et al., 2014  2 3 3 3 1 1 * 
Burke et al., 2017 3 3 3 3 1 3 * 
Calvo et al., 2011 2 3 3 3 1 N/A * 
Calvo et al., 2015 3 3 3 3 1 N/A * 
Chen et al., 2015 3 3 3 3 1 N/A * 
Chiò et al., 2005 3 3 3 3 1 N/A * 
Chiò et al., 2010 3 3 3 3 1 N/A * 
Creemers et al., 2016 1 1 3 3 1 2 * 
Galvin et al., 2016 3 3 3 3 3 N/A * 
Garcia et al., 2017 2 3 3 3 1 1 * 
Gauthier et al., 2006 3 3 3 3 1 3 * 
Gelinas et al., 1998 3 3 3 3 1 N/A * 
Goldstein et al., 1998 3 3 3 3 1 N/A * 
Goldstein et al., 2006 2 3 3 3 1 3 * 
Hecht et al., 2003 2 3 3 3 1 N/A * 
Hwang et al., 2014 3 2 3 3 1 N/A * 
Lillo et al., 2012 3 3 3 3 1 N/A * 
Lo Coco et al., 2005 3 3 1 3 1 N/A * 
Martin et al., 2002 2 3 3 3 3 N/A * 
Miyashita et al., 2009 2 3 3 3 3 N/A * 
Miyashita et al., 2011 3 3 3 3 1 N/A * 
Mock et al., 2010 2 3 3 3 3 N/A * 
Murphy et al., 2008 2 3 3 3 1 N/A * 
Olsson et al., 2010a 2 3 3 3 1 N/A * 









Olsson et al., 2010b 2 3 3 3 1 2 * 
Olsson Ozanne et al., 
2010 
2 3 3 3 1 N/A * 
Oyebode et al., 2013 3 3 3 3 3 N/A * 
Ozanne et al., 2014  2 3 3 3 2 N/A * 
Pagnini et al., 2010 2 3 3 3 3 N/A * 
Pagnini et al., 2011 2 3 3 3 1 N/A * 
Pagnini et al., 2012a 2 3 3 3 1 N/A * 
Pagnini et al., 2012b 3 3 3 3 1 N/A * 
Qutub et al., 2014 2 3 3 3 1 N/A * 
Rabkin et al., 2000 2 3 3 3 1 3 * 
Rabkin et al., 2009 3 3 3 3 1 1 * 
Roach et al., 2009 3 3 3 3 1 3 * 
Sciliano et al., 2017 2 3 3 3 1 N/A * 
Trail et al., 2003 3 3 3 3 1 N/A * 
Trail et al., 2004 3 3 3 3 3 N/A * 
Tramonti et al., 2014a  2 3 3 3 1 1 * 
Tramonti et al., 2014b 2 3 1 3 1 N/A * 
Tremolizzo et al., 2016 2 3 3 3 1 N/A * 
Vignola et al., 2008 3 3 3 3 1 2 * 
Watermeyer et al., 2015 2 3 3 3 1 N/A * 
Note. *** = Strong Rating; ** = Moderate Rating; * = Weak Rating 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
